









RECEPTOR MEDIATED TARGETING OF LIPOSOMES 
M.H.FRIEDE 
Thesis submitted in fulfilment 
of the requirements for the 
degree of DOCTOR of PHILOSOPHY 
in the Faculty of Science, 
University of Cape Town. 
1990 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 











CERTIFICATION OF SUPERVISOR 
In terms of paragraph eight of "General regulations for the 
degree of Ph.D." I as supervisor of the candidate, 
M.H.Friede, certify that I approve of the incorporation into
this thesis of material that has already been published or 
submitted for publication. 
Professor c. von Holt 
Head, Department of Biochemistry 




This thesis is the culmination of several years work during 
which time many people have assisted me. I wish to express 
my gratitude to thos~ who have made this thesis possible 
My supervisor, Prof. C. von Holt for his advice, support and 
encouragement throughout this project. 
The Council for Scientific and Industrial Research and the 
UCT Research Commitee for their financial support. 
All my friends and colleagues in the department, for their 
help, moral support and endless cups of coffee, especially; 
Wolf and Jerry for teaching me about peptides and proteins 
and for tolerating my mess. Pete, Brenda, and Fuzzy for 
looking after my cells and occasionally me. Jenny, Tony and 
Hugh for teaching me everything I wanted to know about 
molecular biology but was too afraid to ask. Very special 
thanks to Horst, Wolf and Sylva for amazing cuisine and 
support, and to Jenny for jazz, classics and pizza. 
To the staff of the department for all their help, 
especially Herman and James for making everything and fixing 
anything, Joyce, Dawn and Donald for administration, and 
Desmond and William for sweeping up failed experiments. 
To my parents for unquestioning support and encouragrnent, 
and to my grandfather, Dr.H.M.Friede, who's enquiring and 
analytical mind has been an inspiration to me at all times. 
To him I dedicate this thesis. 
ii 
SUMMARY 
The targeting of liposomes to cells and the delivery of the 
liposomal contents into the cells have been investigated 
using either a-melanocyte stimulating hormone or Ricin-B-
chain as ligands for promoting the binding of liposomes to 
cells. 
a-melanocyte stimulating hormone has been conjugated to 
liposomes and to Ricin-A-chain via the Lysii residue without 
significant loss of biological activity. The resulting 
conjugates were found to bind to Bl6 melanoma cells which 
express receptors for the hormone. Hormone targeted ricin 
was shown to be toxic to the cells, indicating receptor 
mediated internalisation of the conjugate. The hormone 
targeted liposomes however were unable to mediate the 
delivery of cytotoxic levels of methotrexate. 
Ricin-B-chain, a lectin which mediates membrane 
translocation of the toxic ricin-A-chain, was examined for 
its applicability for targeting of liposomes to cells. This 
lectin was shown to promote the binding of liposomes to 
cells and to mediate the delivery of cytotoxic 
concentrations of methotrexate. 
Further evidence of functional ricin-B-chain mediated 
intracellular delivery of the liposomal contents was shown 
by liposome mediated transformation of cells, and delivery 
of nuclease into the cell resultin in digestion of genomic 
DNA. 
The study demonstrates that a-melanocyte stimulating hormone 
is unsuitable as a ligand by which to achieve delivery of 
large quantities of material into cells, although cell-
specific targeting can be achieved. Ricin-B-chain is however 
ideally suited for this task, though is less cell-specific. 
This finding may be of use in studies in which investigators 
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RECEPTOR MEDIATED TARGETING OF LIPOSOMES 
Introduction 
In the last decade there has been a tremendous amount of 
interest in the use of liposomes as agents for the delivery 
of drugs or other biologically active materials into cells 
both in medicine and in molecular biology. Several 
comprehensive monographs on the subject have been published 
(Knight 1981, Gregoriadis 1984 ) so I shall not attempt to 
review the entire field, but rather to provide an overview 
of some aspects of it, and to provide a background to the 
arguments presented later in this thesis. 
Ever since its first postulation by Paul Ehrlich, the 
concept of the 'magic bullet', a construction that delivers 
a drug directly to the required site without its uptake in 
the rest of the body has been the holy grail of 
pharmacologists and physicians. Much of the research has 
focused on the linkage of cytotoxic or radio-opaque drugs 
directly to antibodies which then carry the drug to the 
desired site, however such constructs have limited 
usefulness in that an antibody molecule can carry only a 
limited number of drug molecules, and the construct is 
exposed to degradative conditions in the body. 
Liposomes were recognised as being potentially superior 
building blocks of such magic-bullets as they completely 
enclosed the entrapped drug or enzyme, protecting it from 
degradation while circulating, and minimising side-
reactions such as toxicity and allergy. Furthermore a 
l 
liposomes is capable of carrying several thousand fold more 
drug than a single antibody molecule. 
Most of the early work demonstrated that liposomes injected 
in vivo were rapidly taken up by the reticuloendothelial 
system (RES), which while useful for treatment of certain 
ailments such as lysosomal parasites eg. Leishmaniasis 
(Alving and Swartz 1974), severely restricted their use for 
delivery to the rest of the body. The possibility of 
redirecting the liposomes to the required cells was first 
investigated by modifying the liposomal surface with 
antibodies recognising determinants on the target cell 
surface (Gregoriadis and Neerunjun 1975). Since then many 
modifications to the liposomal surface have been 
investigated, including hormones, lectins, carbohydrates and 
a host of antibodies, however the use of such targeted 
liposomes in vivo has remained hampered by the rapid 
clearance of many preparations by the RES, and the 
inaccessibility of the target cells to the circulating 
liposomes (Foste 1984). Recently liposomes with modified 
size distributions and lipid compositions have been shown to 
evade the RES (Allen and Everest 1983, Allen et al 1988) and 
to have enhanced uptake by tumors (Gabizon and 
Papahadjopopoulos 1988). That such liposomes have immediate 
potential for diagnostic or therapeutic use is testified by 
the growing number of commercial liposome companies. This 
targeting however stems from the physical nature of the 
circulatory system, rather than a recognition by the 
liposomes of specific chemical determinants on the desired 
target. 
While active targeting of liposomes by recognition of 
surface determinants is hampered in therapy by undesired 
uptake of the liposomes and inaccessibility of the target to 
the circulating liposomes, it holds great potential as a 
tool in cell biology where it is able to promote the uptake 
2 
, 
of drugs or macromolecules into cells. Successful use of 
this application has allowed inter al ia ; the rescue or 
elimination of a subpopulation of cells (Leserman), the 
delivery of cAMP dependant protein kinase inhibitors into 
cells and investigation of the role of cAMP in hormone 
release (Reisine et al. 1986), and transformation of 
eukaryotic cells by liposome entrapped DNA (Machy et al. 
1988). 
Unfortunately the successful use of liposomes to achieve 
functional cellular uptake of the entrapped material is 
dependant on a number of factors including; liposome size 
and composition, the ligand attached to the liposome 
surface, the number and nature of the receptors for the 
ligand on the cell, the type of cell, and the entrapped 
material. 
Liposomes 
The preparation and characterisation of liposomes have been 
reviewed (Szoka and Papahadjopopoulos 1981), the following 
is a brief outline of liposomal parameters and how they 
affect liposome targeting. 
Composition 
Liposomes can be prepared from a wide variety of lipids, 
however the interaction of the resulting liposomes with 
cells and serum is highly dependant upon the choice of 
lipids. 
There exists within the literature two principle 
philosophies regarding the use of liposomes to deliver 
molecules into cells. The first relies on the virtually 
insignificant interaction of untargeted liposomes with cells 
and the use of ligands attached to the liposomes to increase 
3 
the interaction with a specific type of cell, and the second 
relies on a natural affinity of liposomes without any 
ligands for cells. The essential difference between the two 
approaches lies in the ionic charge of the lipid used. 
Most liposome preparations contain at least 50% (mol%) 
phosphatidylcholine (PC). Normally egg yolk 
phosphatidylcholine (EYPC) is used, which has a transition 
temperature (Tc) of -7 to -15 °C (Ladbrook and Chapman 1969) 
resulting in liposomes which are in a liquid crystal state 
above -7 °C. It is occasionally advantageous to use a 
defined lipid with a defined transition temperature, such as 
in the preparation of liposomes sensitive to temperature 
changes (Magin and Weinstein 1984), in which case pure 
synthetic lipids such as dipalmitoyl phosphatidylcholine 
(DPPC) are employed. Liposomes composed primarily of 
phosphatidylcholine do not, in the absence of additional 
ligands, bind significantly to cell membranes. 
Additional phospholipids or charged amphiphiles may be added 
to alter the surface charge of the liposomes and their 
interaction with cells : 
Phosphatidylserine (PS), which can be used to replace the 
phosphatidylcholine completely, induces a net negative 
charge on the liposomes. Liposomes composed of only PS and 
cholesterol bind to, and are endocytosed by, certain cell 
types (CV-1 and L929) very readily yet with other cell lines 
(T-lyrnphoma) associate very weakly (Straubinger et al. 
1983). Liposomes composed primarily of PS have also been 
shown to be superior to positively or neutrally charged 
vesicles for the delivery of ·macromolecules into cells 
(Fraley et al. 1981), ascribed to an ability of negatively 
charged fluid vesicles to fuse with cells, whereas neutral 
vesicles, or negatively charged solid vesicles being taken 
up primarily by endocytosis (Poste and Papahadjopopoulos 
4 
, 
1976). Contrasting to this argument is the demonstration 
that endocytosis is also the primary route of uptake for 
phosphatidylserine vesicles (Straubinger et al. 1983). The 
discrepancy in the proposed routes of uptake is ascribed to 
the assays employed to determine endocytosis and fusion and 
on detailed analysis, it would appear that endocytosis is 
indeed the primary route of uptake of liposomes, independent 
of the charge. It is thought that the binding of negatively 
charged liposomes to cells may be mediated by the presence 
of receptors for multiply negatively charged molecules on 
some cells (Fraley et al. 1981), 
5 
The incorporation of stearylamine imparts a positive charge 
to the liposomes, and in contrast to the above, it has been 
shown that positively charged liposomes rather than neutral 
or negatively charged, interact preferentially with cells 
(Szoka et al. 1980, Potter et al. 1985). The apparent 
discrepancy between the findings by various authors on the 
role of lipid charge on liposome cell interaction may result 
partially from the different assays employed to determine 
the interaction, and also from the condition of the cells, 
as it has been reported that the binding of positively 
charged liposomes to cells is highly dependant on whether 
the cells are in suspension or growing as monolayers (Fraley 
et al. 1981). 
Pure phosphatidylethanolamine does not readily form 
liposomes, however, if stabilised with acylated molecules 
such as antibodies modified with palmitic acid, vesicle 
formation is possible. The binding of the stabilising 
molecules to cell surfaces results in the destabilisation of 
the liposomes and subsequent release of their contents. Such 
target sensitive liposomes have been shown to deliver 
greater amounts of entrapped drugs than comparable 
insensitive liposomes (Ho et al. 1987) and under conditions 
, 
where delivery of the contents of bound liposomes to cells 
is limiting, may be the liposomes of choice .. 
If the incubations with cells are to be performed in the 
presence of serum, it is necessary to include cholesterol in 
the liposomes. Cholesterol up to 50 mol% affords significant 
protection of the liposomes to serum lipoproteins by 
tightening the packing of phospholipid molecules in the 
bilayer (Allen and Cleland, 1980) 
Preparation 
There exist a large variety of methods for preparing 
liposomes, each with its own advantages and disadvantages 
for a particular application, however two of the main types 
of liposomes in the literature on targeting are Small 
Unilamellar Vesicles (SUV) prepared by sonicating 
phospholipid dispersions (Papahadjopopoulos and Millar, 
1967), and large unilamellar vesicles (LUV) prepared either 
by the reverse phase evaporation procedure (REV)(Szoka and 
Papahadjopopoulos 1978) or calcium chelation 
(Papahadjopopoulos et al. 1975 ), 
The SUV have diameters between 20 and 50 nm. Liposomes this 
small are more readily endocytosed by some cells than are 
large liposomes (Machy and Leserman 1983, Matthay et al. 
1984 ) leading occasionally to situations in which only 
targeted SUV are able to deliver their contents into the 
cells, whereas LUV, while binding to the cells, do not exert 
any effect (Watanabe and Osawa 1987). 
SUV however have several disadvantages over LUV ( which are 







1) The encapsulation volume and efficiency are very low, 
typically in the range of 0.2-1 l per mole lipid, with an 
efficiency of 0.1-1% of the required material being 
entrapped. LUV by comparison entrap between 15 and 50% of 
the aqueous space, with a volume of 10 - 20 1 per mol lipid. 
The small aqueous space of SUV minimises their usefulness in 
encapsulating macromolecules, and the low efficiency can 
present problems if encapsulating expensive material. 
Furthermore the low internal volume implies that many 
liposomes have to be internalised to result in the 
equivalent uptake of one large vesicle. Since volume is 
related to the cube of the radius a five fold difference in 
radius represents a 125 fold difference in volume. Even wi: -
this difference in volume it is possible that greater 
delivery may be achieved in certain circumstances with SUV 
rather than LUV because of the ease of uptake of SUV rather 
than LUV. 
2) The preparation of SUV requires extensive sonication to 
which the material to be entrapped may be sensitive. While 
slight sonication is required for REV preparation it can be 
reduced to a level at which even DNA is not affected (Fraley 
et al. 1980). 
3) SUV are thermodynamically unstable structures, able to 
convert with time to larger structures (Larrabee 1979), a 
process which can be promoted by proteins (Utsumi et al. 
1989) and in the case of phosphatidylserine liposomes, by 
cations (Wilschut et al 1985 ). It is therefore conceivable 
that preparations of SUV change properties with time. 
The disadvantage of the REV type of liposomes over SUV is 
that the material to be entrapped comes into contact with 
organic solvents, which may cause denaturation. Furthermore 
diethylether, which is the most commonly used solvent for 
this purpose is frequently contaminated with peroxides, 
which, if not removed prior to liposome preparation, 
, 
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promotes both oxidation of the lipid and any entrapped 
protein. 
By contrast, the calcium chelation procedure is extremely 
mild, avoiding exposure to both organic solvents and 
sonication. It is however limited by the type of lipids 
which can be used, normally phosphatidylserine, and as noted 
above, liposomes prepared from this lipid interact non-
specifically with cell membranes, and hence in targeting 
experiments where binding to non-target cells is 
deleterious, this liposome type is not suitable. 
Linkage procedures 
Successful attachment of proteins to the outer surface of 
liposomes has been achieved by several methods. There are 
three principle techniques; 
1) Direct chemical coupling by the use of cross-linking 
agents such as EDC. This has been employed to link 
streptavidin at high density to PE containing liposomes 
(Rosenburg et al. 1987). These authors point out the 
possibility of contaminants within the organic solvents used 
for the liposome preparation interfering with the EDC 
reaction. In contrast to these results the binding of IgG to 
liposomes by EDC is not significantly greater than by 
adsorbtion (Endoh et al 1981). 
2) Acylation of the protein permits its binding to liposomes 
if present during liposome preparation (Huang et al. 1982, 
Weissig et al. 1986), or if added subsequent to liposome 
formation (Sinha and Karush 1979). This technique requires 
the exposure of the ligand to detergent. An alternative 
procedure based on the same philosophy is the coupling of 
ligands to empty liposomes via diazotised stearylamide, and 
8 
the subsequent dehydration and reconstitution of the 
liposomes in the presence of the material to be entrapped 
(Garcon et al. 1986).This avoids the use of detergent in the 
preparation of the acylated protein. 
The advantage of these procedures is that they do not expose 
the liposome contents to cross-linking reagents, and are 
capable of yielding very high efficiencies of linkage. 
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3) The covalent attachment of the protein to the liposome 
surface via interaction between a sulphydryl moeity on the 
protein and a sulphydryl-reactive group present on the 
liposomes. This resulting bond can be either a cleavable 
disulphide if the reaction was with a thiopyridyl group 
(Martin et al. 1981), or a stable thioether crosslink if a 
maleimido group was present on the liposomes (Martin and 
Papahadjopopoulos 1982). 
The advantages of this technique are that it is mild, not 
exposing the liposomes or the internal contents to oxidising 
conditions, does not permit homopolymer formation, and if 
the site of the sulphydryl on the protein is removed from 
its functional site, is likely to permit binding without 
affecting functional activity. However not all proteins 
possess free sulphydryl groups hence chemical methods such 
as reaction with S-acetyl thioacetate (SATA) (Derksen and 
Scherphof 1985) are required to introduce sulphydryl groups 
into such proteins. 
Several investigators employ an indirect method of 
targeting, in which free antibodies are bound to the target 
cells, and liposomes directed towards these antibodies 
either via protein A coupled.to the liposomes (Leserman et 
al. 1980) or via a biotin-avidin bridge (Rosenberg et al. 
1987, Trubeskya et al. 1988). The advantage of such 
methodology is that it obviates the requirement of linking 
each ligand of interest to the liposomes, hence several 
different ligands can be investigated using the same 
preparation of liposomes. 
Ligands 
A variety of ligands have been attached to the surface of 
liposomes to promote their interaction with specific cell 
types. It is becoming apparent that the choice of the ligand 
is crucial in determining the final efficacy of targeted 
liposomes, some ligands promoting binding but not uptake of 
the liposomes. 
Antibodies: 
The majority of cell-specific liposome targeting has relied 
on immunological techniques using antibodies, and in 
particular, monoclonal antibodies. These have an advantage 
over hormones and lectins as ligands by which to target 
liposomes, in that any cell line can be specifically 
targeted towards provided it expresses a specific antigen. 
This has been reviewed (Toonen and Crommelin 1983) hence the 
following is not exhaustive, but a selection of more recent 
data, or conflicting results. 
Much of the early work on antibody mediated targeting used 
antibodies directed against either the class 1 (H2Kk) (Huang 
et al. 1983, Heath et al. 1983, Machy et al. 1984, Leserman 
1984) or class 2 (H-2 I-Ak and I-Ek)(Machy et al. 1982) 
major histocompatability antigens. Apart from these more 
recent antibodies successfully used include antibodies 
against the carcinoembryonic antigen (Watanabe and Osawa 
1987), the human endothelial cell surface (Trubetskya et al. 
1988) and the neural cell adhesion molecule (Reisine et al. 
1986). 
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The requirement for the antigen to be expressed for liposome 
binding and uptake to occur has been demonstrated by the 
increased binding and toxicity of liposomes bearing anti-
H2Kk antibody towards mouse L-cells, compared to BALB cells 
which do not express the antigen (Heath et al. 1983). 
Similar results were obtained by Huang et al. (1983), 
however in testing the ability of the H2K antigen as a 
liposome target on different cell types (Machy et al. 1982) 
it has been found that identical antigens perform 
differently on different cell types, possibly as a function 
of the role of the antigen on that cell type . These authors 
found that binding of liposomes mediated via anti-H-2K 
antibodies was obtained on both T and B lymphocytes, and 
although both cell types were able to internalise liposomes 
targeted via other antibodies (H2 I-A), only T lymphocytes 
internalised these liposomes, indicating an internalising 
effect of the H-2K antigen on T lymphocytes absent in B 
lymphocytes. This indicates that the antigen plays an active 
functional role in the internalisation and delivery of 
liposomal contents. 
An active role of the target is further demonstrated in 
which anti-trinitrophenyl antibody binds liposomes at a very 
high density to lymphocytes modified with trinitrophenyl. 
These liposomes do not deliver their contents into the cells 
(Weinstein et al 1978), a possible consequence of the 
antigen in this case being non-specifically chemically 
modified membrane proteins and not a specifically 
endocytosed marker. 
In contrast to this however, it has been observed that anti-
HRBC (hors~ red blood cell) antibody specifically binds 
liposomes to erythrocytes (Martin and Papahadjopopoulos 
1981), and such binding is able to promote the delivery of 
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entrapped anti-malarial drug into the erythrocytes (Agrawal 
et al. 1987) significantly enhancing the efficacy of the 
drug. Since erythrocytes are unlikely to undergo 
endocytosis, this suggests that under certain conditions, 
internalisation of the liposomal contents can be achieved 
without the requirement for the antigen to be endocytosed. 
This leads to the question of the route of internalisation, 
discussed in the next section. 
Hormones 
Hormones offer several potential advantages over antibodies 
as ligands by which to promote the cell specific targeting 
of liposomes : 
Hormones frequently express very strong affinity for their 
receptors, with dissociation constants in the range of 10- 9 
to 10-12 M. This is in comparison to typical Ko of 10-s to 
10- 9 M for antibodies. This thousand fold difference in 
affinity may permit the specific binding of targeted 
liposomes to cells at a fraction of the concentration of 
antibody targeted liposomes. 
Since most peptide hormones are thought to be endocytosed 
subsequent to their interaction with the receptor, it is 
likely that the carriers to which they are bound will become 
internalised. By contrast, many antigenic determinants do 
not become endocytosed. 
The receptors for many hormones are restricted to specific 
cell types and recognition is often independent of species 
of origin of the cells. 
In spite of these advantages, very little research has been 
done on the use of hormones for targeting liposomes. 
Hormones have been extensively and successfully used for the 
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direct targeting of toxins to cells (Oeltmann 1985, Cawley 
et al. 1980) however liposome targeting has been limited to 
interacting avidin labelled liposomes with cells exposed to 
biotinylated nerve growth factor (NGF) (Rosenberg et al 
1987). These authors demonstrate hormone mediated binding of 
the liposomes to the cells, however the increase in binding 
above background is only four to five fold, and at a 
concentration of liposomes much higher than that expected 
from the affinity constant of avidin for biotin 
(approximately 10-ia M). 
Insulin has been successfully used to target Sendai virus 
envelopes to cells deficient in Sendai virus receptors 
(Gitman et al. 1985), however although it has been linked to 
liposomes (Cantenys et al. 1983) it has not been used to 
target the liposomes to cells. 
Lectins 
A wide variety of lectins are available and their 
specificities for sugars make them an interesting 
alternative to either antibodies or hormones. All cells 
exhibit glycoproteins on their cell surface, yet different 
cells frequently exhibit different sugars on the 
glycoproteins, a difference that could be exploited by 
lectin targeting. 
A variety of lectins have been used to target either drugs 
or liposomes to cells. Daunomycin has been directly linked 
to Concanavalin-A (Con-A) and targeted to tumor cells in 
vivo. Significant increase in survival time demonstrates 
successful targeting towards the tumor (Kitao and Hattori 
1977). Wheat germ agglutinin (WGA), Phytohemagglutinin 
(PHA) and Ricci nus convnunis agglutinin (RCA) have been used 
to promote the attachment of sialoglycoprotein bearing 
liposomes to erythrocytes (Juliano and Stamp 1976) by first 
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incubating the cells with the lectin, and then adding the 
glycoprotein-bearing liposomes. No investigation of uptake 
of the liposomes was performed, however the ability of the 
free hapten sugar to release bound liposomes suggests that 
WGA and PHA promote internalisation, whereas RCA does not. 
Liposomes have been targeted to cells using concanavalin A 
(Con A) or Phaseolus vulgarus phytohaemagglutinin (PHA) 
(Salame and Patel 1986), however most of the lectin-bound 
liposomes could be removed by treatment with trypsin, 
indicating that internalisation of the liposomes had not 
been promoted by the lectin. In this experiment the 
liposomes used were MLV, and no selection for size is 
reported, hence the liposomes may have been too large for 
endocytosis. 
WGA linked to SUV via a thioether linkage has been shown to 
promote the binding of liposomes to a glycophorin, to which 
the lectin binds, and the targeting efficiency dependant on 
the degree of coupling of the lectin to the liposomes 
(Hutchinson and Jones 1988). 
Routes and assays of internalisation 
The choice of the internal contents of the liposomes, and 
hence also of the assay for the delivery of liposomal 
contents into the cells, can have a very significant effect 
on the conclusions drawn from the experiment. 
Possibly the simplest assaying procedure is the inclusion of 
a fluorescent dye within the liposomes, and the microscopic 
and spectrophotometric determination of fluorescence 
associated with the cells subsequent to incubation. The two 
most commonly used materials for this are calcein and 
carboxy-fluorescein (CF), however the two dyes behave 
differently upon internalisation (Straubinger et al. 1983) 
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CF, although charged at neutral pH, losses its charge at 
intralysosomal pH and is able to diffuse into the cytoplasm, 
resulting in the appearance of diffuse fluorescence, an 
event which is inhibited by the addition of lysosomotropic 
amines such as ammonium chloride or chloroquin . The diffuse 
fluorescence, which may be incorrectly interpreted as being 
due to fusion of liposomes with the cells, is not observed 
when calcein, which is more highly charged and does not loss 
its charge in acidic environment, is used. These authors 
conclude that the punctate fluorescence observed with 
calcein, and with CF in the presence of NH.Cl is due to 
endocytosis of the liposomes, and that liposome-plasma 
membrane fusion is a rare event. 
The self quenching of carboxyfluorescein which results from 
its dimeric association at high concentrations (Chen and 
Knutson 1988), and which is relaxed when the dye becomes 
diluted, provides a sensetive assay for the release of the 
dye from lumen of the liposome. Total cell associated 
fluorescence can be determined by lysing the cells and the 
cell-associated liposomes in detergent, and comparison with 
the fluorescence prior to lysis provides an indication of 
what proportion of the cell associated fluorescence was not 
due to liposomally entrapped dye. Such an assay has been 
used to monitor the fusion of liposomes with cells 
(Weinstein et al. 1984), however, as stated above, the 
ability of the dye to escape from endocytotic vesicles into 
the cytoplasm hinders the interpretation of results from 
this assay. 
A widely used assay of liposomal uptake is the inclusion 
within the liposomes of the cytotoxic drug methotrexate 
(MTX), the effect of which is easily determined by 
monitoring the uptake of radiolabelled nucleotides. Using 
this assay, several investigators (Heath et al. 1983, Huang 
et al. 1983, Machy et al. 1982) reach the conclusion that 
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endocytosis is the primary route of uptake of liposomes by 
cells since the addition of lysosomotropic agents such as 
NH4Cl or chloroquin afford the cell some degree of 
protection against the liposomally entrapped drug. Such 
agents have no effect on the toxicity of the free drug. A 
problem with the use of drugs such as methotrexate, is that 
they are toxic to the cell in the absence of liposomes and 
hence toxicity due to leakage from the liposomes prior to 
uptake by the cells is difficult to distinguish. For this 
reason it is advantageous to use drugs modified so that they 
are unable to enter the cells unaided. Heath et al. (1983) 
have adopted this protocol by using a modified MTX which is 
unable to be taken up by the cells. Interestingly these 
authors are able to obtain almost 100% protection of 
toxicity with NH4Cl, whereas other authors using 
underivatised MTX obtain between 20 and 50% protection. This 
discrepancy might be due to liposomal leakage at the site of 
attachment to the cell, and subsequent entry of the native 
drug, which is at a locally high concentration, through the 
plasma membrane. 
Since erythrocytes are not actively endocytotic, they are 
unlikely to take up liposomes by endocytosis, and hence the 
observation that anti-malarial drugs in liposomes targeted 
towards erythrocytes have an enhanced efficacy (Agrawal et 
al. 1987) suggests that either fusion of the liposomes with 
the cells, or leakage from the bound liposomes into the 
cell, is taking place. 
A similar approach has been taken by Watanabe and Osawa 
(1987) who encapsulate either the toxic lectin ricin, or its 
enzymatic component ricin-A-chain in liposomes. The A-chain 
component ~s highly toxic once inside the cell, but is 
unable to enter the cells unaided, making it an excellent 
monitor of liposomal effect. The lack of toxicity of 
targeted liposomes containing A-chain compared to that of 
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liposomes containing ricin indicates that leakage of bound 
liposomes does occur. 
The cellular expression of liposomally entrapped DNA or RNA 
provides an unequivocal demonstration of functional delivery 
of the liposomal contents into the cells (reviewed later on 
in the thesis) as it is unlikely that genetic material can 
enter the cell unaided. The assay involves either the 
encapsulation of viral DNA or RNA such as SV40 (Fraley et 
al. 1980), or TMV-RNA (Nagata 1984), and monitoring the 
infectivity, or the encapsulation of a plasmid carrying the 
gene for an enzyme which confers resistance against a 
nutritional or chemical restraint eg. Thymidine kinase 
(Schaefer-Ridder et al. 1982) or phosphotransferase 
(Nakatsuji et al. 1987). 
Swmnary 
It is evident that although the simple targeting of 
liposomes to cells presents no problem in vitro, the 
subsequent functional delivery of the liposomal contents to 
the cells is highly dependant on the nature of the liposome, 
the choice of the target to which the liposome is directed, 




MELANOCYTE STIMULATING HORMONE TARGETING OF LIPOSOMES 
This project was initiated to study the feasibility of using 
small peptide hormones as a means of targeting liposomes to 
cells which carry receptors for the hormones. The advantages 
which hormones should have over antibodies as ligands for 
targeting have been discussed in chapter 1. At the time this 
project started there were no reports in the literature of 
hormone mediated targeting of liposomes. Insulin had been 
bound to liposomes (Cantenys et al. 1983), but no 
demonstration of biological activity of the resulting 
conjugate was demonstrated, and no attempts had been made to 
bind the liposomes to cells. 
a-Melanocyte stimulating hormone (a-MSH) was chosen as a 
model peptide to study this approach because it is a small 
peptide whose physical and chemical properties have been 
fairly well characterized, and there exists a wide variety 
of melanoma cell lines which bear receptors to the hormone. 
The published figures for the binding constant of ~-MSH (Ko 
= 3 X 10- 9 M Varga et al. 1974) suggested that the affinity 
of the receptor for the peptide was several orders of 
magnitude greater than most antibodies express towards 
antigens and hence targeting should be achievable at lower 
concentrations of liposomes than for antibody mediated 
targeting. Furthermore, since melanoma is a pathological 
condition, and melanoma cells exhibit receptors for a-MSH, 
it was hoped that investigations into a-MSH mediated 
targeting of liposomes in vitro, might shed light on the 
possibility of utilising a similar approach in vivo. 
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Melanocyte stimulating hormone. 
a-MSH is a linear tridecapeptide with the sequence -
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, 
(Haris and Lerner 1957). It is synthesised in, and secreted 
from the pars intermedia of the vertebrate pituitary, and is 
responsible for a variety of physiological effects, the most 
well characterized of which is control of skin pigmentation 
(for a review see: Sawyer et al. 1983). It also plays a role 
on tissue lipolysis (Ramachandran et al. 1976) and pain and 
behavior (Walker et al. 1980). 
Biological activity assays. 
The melanotropic effect of a-MSH is exerted by either 
melanosome dispersion, in the case of dermal melanocytes, or 
melanin synthesis in epidermal melanocytes and melanoma 
cells. The net effect of this is darkening of the cells, 
which can be measured by light reflectance either in vitro 
using frog (Rana pipiens ) skin (Shitzwne et al 1954) or 
lizard (Anolis carol inensis) skin (Goldman and Hadley 1969), 
or in vivo (Hogben and Slome 1931, Castrucci et al. 1984). 
In tissue culture, using melanoma cells the biological 
effect can be assayed by: 
1) Spectrophotometric assay for the melanin content of the 
cells (Lee et al. 1972). This assay requires the cells to be 
grown for up to 48 hours in the presence of the hormone 
before the increase in melanin content becomes significant, 
and is subject to a number of unknown factors including 
serwn components (Jerdan et al 1985) and melanogenic 
potential (Niles and Makarski 1978). 
2) Tyrosinase activity assay (Pomerantz 1966). The process 
of melanin synthesis within the cell requires an increase in 
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the activity of the enzyme tyrosine hydroxylase, which 
converts L-Tyrosine to L-dopa, the precursor of melanin. 
This activity is expressed in cells within 30 minutes of 
exposing the cells to a-MSH and reaches a plateau after 40 
hours (Legros et al. 1981). The assay for this activity 
relies on the conversion of 3,5- 3 H-tyrosine to dopa, 
resulting in the formation of tritiated water. The tritiated 
water is separated from the tritiated tyrosine still in the 
reaction mixture by passage through a charcoal column. A 
second purification step of passage through a Dowex-50 
column (Korner and Pawalek 1977) improves the accuracy of 
the measurement. This assay can be performed on living cells 
in tissue culture medium, however it is then affected by the 
rate of tyrosine transport into the cells (Pawalek 1979), 
and should be compared to assays of the cell homogenate. 
3) Adenylate cyclase assay (Kreiner et al. 1973). When 
melanoma cells are exposed to a-MSH there is a rapid (within 
10 minutes) increase in the levels of cAMP. In the case of 
Cloudman S-91 cells this increase is only found in those 
cells in the G2 phase of the cell cycle (Varga et al. 1974) 
indicating that the receptor to the hormone is only 
expressed in those cells during that phase. The accumulation 
of cAMP in the cells is directly linked to melanogenesis, as 
cAMP alone is able to induce an increase in the tyrosinase 
activity, and this increase is independent of the cell cycle 
(Varga et al. 1974), and as such has been implicated as the 
intracellular mediator for the response of melanocytes to a-
MSH (for review see: Sawyer et al. 1983). Contrasting this 
hypothesis is the observation that a-MSH-tobacco mosaic 
virus conjugates are capable of tyrosinase activation 
independently of adenylate cyclase activation (Wunderlin 
1984). It is possible that cAMP accumulation in melanoma 
cells in response to a-MSH is similar to its accumulation in 
PC12 cells exposed to NGF (Cho et al. 1989), mediating some 
but not all of the hormonal effects, possibly acting as one 
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of a number of required second messengers . Intracellular 
cAMP levels are also linked to the metastatic potential of 
the cells (Sheppard et al. 1984) although the physiological 
relevance of this remains unclear. 
The increase in the intracellular concentration of cAMP is 
readily monitored using one of several commercially 
available kits (Amersham, NEN). The assay is simple and 
rapid, and can be performed on a large number of samples in 
one day. That the cells need only be exposed to the hormone 
for several minutes obviates the need for strict sterility 
which is required for the other assays. 
While there is a wide variety of biological assays 
available, not·all the assays yield the same results when 
comparing the potency of a-MSH and its derivatives, possibly 
due to slightly differing structures of the receptors 
between frog skin and lizard skin (Wilkes et al 1983),and 
inaccessibility to the receptor in skin for large conjugates 
(DiPasquale et al. 1978). 
Receptor characterisation 
The characterisation of the a-MSH receptor has been achieved 
primarily by interaction of Cloudman 591 cells with 
iodinated ~-MSH (Varga et al. 1974). These authors observed 
that binding to the receptor occurs only in the G2 phase of 
the cell cycle, and consequently, in asynchronous culture, 
only a fraction of the cells bind the hormone. Binding of 
labelled hormone to the receptor has been shown to occur in 
discreet areas on the cell membrane, thought to be 
associated with an area that is related to the Golgi 
complex, and internalisation of the hormone results in the 
localisation of the label within the Golgi complex (Varga et 
al. 1976). The receptor has also been shown to be sensitive 
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to proteolysis, and treatment of the cells with trypsin or 
chymotrypsin resulted in loss of hormone binding capacity. 
It is likely that results obtained from studies with ~-MSH 
hold true for a-MSH as the effects of the two hormones are 
non-additive (van Calker et al. 1983), suggesting the 
presence of a single receptor type. 
Quantitation of the receptor yields approximately 10 4 
receptors per cell, with an affinity constant of 3 X 10 8 
1/mol. Similar figures have been obtained using indirect 
labelling of the Cloud.man S91 MSH receptor with fluorescent 
conjugates of a-MSH and ferritin (DiPasquale et al. 1977). 
Apart from Cloud.man S91 cells, many other cell lines have 
been found that exhibit a response to a-MSH, including B16 
mouse melanoma cells (Lee et al. 1972), human melanoma cells 
(Legross et al 1981, Fuller and Meyskens 1981), and brain 
cells (van Calker et al. 1983). 
Attempts to use iodinated a-MSH as a probe for the receptor 
have been hampered by the tremendous loss of biological 
activity that occurs when a-MSH is iodinated. The 
inactivation is due both to the use of oxidising conditions 
during the iodination, resulting in the oxidation of Met4, 
and the presence of a bulky group on the Tyr2 (Sawyer et al. 
1977). The excellent purification properties of HPLC have 
however permitted the preparation of monoiodo- a-MSH with 
35% of its biological activity still retained (Eberle and 
Hubscher 1979) and monoiodo ~-MSH with full biological 
activity (Lambert et al. 1982). 
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Synthetic Derivatives of a-MSH 
If a-MSH is to be used as a ligand to target liposomes, it 
will have to be linked to the liposomes. The position on the 
peptide at which to achieve this without destroying the 
affinity for the receptor is best chosen by examining which 
parts of the peptide can be modified without concomitant 
loss of biological activity. 
a-MSH, partial sequences of a-MSH, and analogues in which 
some of the residues have been replaced with alternative 
amino acids have been synthetically prepared (Eberle et al. 
1975) and tested for biological activity in a number of 
systems. This has resulted in the elucidation of the 
presence of two message sequences within a-MSH that are able 
to trigger the hormonal response on amphibian skin, the 
first being the central region of the peptide -His-Phe-Arg-
Trp- and the second being the C-terminal Gly-Lys-Pro-Val-
NH2, Replacement of Met4 with Nle and replacement of the L-
Phe7 with D-Phe results in a melanotropin with 60 times the 
potency of native a-MSH in the frog skin assay, and ten 
times the potency in the lizard skin assay (Wilkes et al. 
1983). A cyclic derivative in which the Met4 and Glyio were 
replaced by cysteine was found to have a 10000 fold greater 
potency than a-MSH in darkening frog skin, and substantially 
prolonged activity. In contrast it was only 30 fold more 
active than the native peptide in the lizard skin assay, and 
only three fold more potent than a-MSH in stimulating 
adenylate cyclase in Cloudman 591 melanoma cells. Cyclic 
lactam analogues of the peptide have also been synthesised 
and their structure and biological potency elucidated (Sugg 
et al. 1988). 
These results suggest that across species, receptors to 
melanotropins differ in their conformational requirements 
for recognition of the melanotropin, but that a generally 
preferred conformation exists (Sawyer et al. 1983). Proton 
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NMR analysis of the aqueous solution conformation of 
melanotropin analogues (Sugg et al. 1986) has shown this 
conformation to comprise a left handed turn of the backbone 
going from Hiss to Trpg, and a close spatial relationship 
between the side chains of Hiss and Phe7. 
Any modification or alteration to the peptide which 
destabilises this preferred conformation is thus likely to 
have the effect of reducing its biological activity. Thus 
loss of a positive charge by substituting either Ser or Nle 
at Lys11 , which is often used for linking the peptide to 
carriers, results in the activity being significantly 
reduced to approximately 5% of the original, however 
replacement of the Lys11 with ornithine, which does not 
result in loss of positive charge, causes only a slight 
(35%) decrease in activity (Eberle 1981). 
Therefore if biological activity is desired, the preparation 
of any conjugate of a-MSH should be done in a manner to not 
cause significant alterations to the preferred conformation. 
This is best achieved by linking the peptide to the carrier 
via its amino terminus which is not involved in receptor 
recognition, however the absence of a primary amino group at 
the amino terminus of the native hormone necessitates that 
for this protocol to be followed the peptide must be 
prepared synthetically. 
MSH conjugates 
MSH has been conjugated to a variety of carriers, and the 
biological activities of the resulting conjugates assayed. 
a-MSH has been covalently linked to ferritin by carbodiimide 
activation of a ferritin-FITC and conjugation to a-MSH via 
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the Lysii (DiPasquale et al. 1978). The resulting conjugate 
contained 5 a-MSH molecules per ferritin molecule. It 
exhibited tyrosinase activity stimulation of 0.3 , and frog 
skin darkening potency of 0.1 compared to that of the native 
peptide. Furthermore it bound specifically to Cloudman S91 
cells, and the binding could be inhibited by free a-MSH. The 
authors take great care to ensure that the observed 
biological activity is not due to release of hormone from 
the conjugate. By this conjugation procedure the charge on 
Lysii is lost, yet a fairly high biological activity 
remains. 
In contrast to these results conjugation of a-MSH to human 
serum albumin to yield a similar ratio of 5 hormone 
molecules per carrier molecule has been achieved by linkage 
through the Lysii position and the N-terminal position 
(Eberle 1981). In this case when the conjugate was linked 
via the Lysii position the biological activity (both 
tyrosinase and frog skin melanophore dispersion) was 0.01 
that of free native a-MSH. When the linkage was through the 
N-terminus (achieved using _a synthetically prepared peptide 
containing a maleimido group at the N-terminus and 
conjugating to thiolated albumin) the conjugate had activity 
equal to that of the native hormone. The linkage via the 
lysine was achieved by condensing N-maleimido-Lysii-a-MSH 
with thiolated albumin, resulting in a thioester linkage in 
which the charge on the lysine is lost and a maleimide group 
introduced. 
If the a-MSH was linked via its N-terminus to tobacco mosaic 
virus resulting in a conjugate with 300-500 hormone 
molecules bound per carrier (Kriwaczek et al. 1978, Eberle 
1981) the biological activity was significantly increased. 
This increase in activity is best explained by a cooperative 
affinity phenomenon (Kriwaczek 1978) in which one carrier 
molecule is able to interact with several receptors 
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simultaneously, and the receptors experience a high local 
concentration of the hormone because several hormone 
molecules are held in place. 
Several conjugates have also been made using ~-MSH which 
being a larger peptide (Asp-Glu-Gly--Pro-Tyr-Lys-Met-Glu-
His-Phe-Arg-Trp-Gly-Ser-Pro-Lys-Asp) is more amenable to 
modification without affecting biological activity. it is 
likely that the receptors for a-MSH and ~-MSH are the same. 
~-MSH has been covalently coupled to Sepharose beads (Varga 
et al. 1974) and the resulting beads stimulated both 
tyrosinase activity and melanisation at a concentration of 
hormone similar to that of the free peptide. Since the major 
surface area on a sepharose bead is internal (our estimate 
in this laboratory is in the order of 98%- results not 
shown), most bound hormone would be inaccessible to the 
receptor, hence the high biological activity must represent 
release (possibly enzymatic) of a biologically active 
portion of the ~-MSH from the conjugate and its subsequent 
interaction with the cells. Since the incubation was 
performed for 48 hours under conditions in which proteolytic 
cleavage is possible, this warns that interpretation of the 
results of biological activity assays with hormone-carrier 
complexes should bear in mind the possibility of fragments 
of the peptide being cleaved off or being released due to 
solvolysis (Tesser et al. 1974). ~-MSH being a longer 
molecule, is possibly more susceptible to proteolytic 
cleavage resulting in a biologically active fragment. 
Conjugates of ~-MSH with daunomycin (Varga et al. 1977, 
Varga 1985) have been prepared and found to be specifically 
toxic to melanoma cells, and the toxicity can be inhibited 
by the presence of free hormone. This suggests that the 
receptor for MSH does permit the specific internalisation of 
the conjugate. That the cells obtain protection from the 
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conjugate by the addition of lysosomotropic amines suggests 
that the conjugate is taken up by an endocytotic process, 
and passes through the lysosomes, where its processing is 
required for it to be toxic. The concentration of conjugate 
required to kill 50% of the cells was two orders of 
magnitude greater than the dissociation constant of the 
native peptide. Since 50% of the receptors should be 
occupied at a concentration equal to the dissociation 
constant, this indicates that there has been a decrease in 
the affinity of the hormone for the receptor. 
Conclusion 
a-MSH is a peptide hormone with a very high affinity 
(compared to antibodies) for a receptor which is expressed 
on several cell types. Chemical modification of the peptide 
is possible without significant loss of biological activity, 
and evidence from ~-MSH suggests that the receptor promotes 
binding and internalisation of hormone conjugates, making a-






MSH MEDIATED TARGETING OF LIPOSOMES 
Introduction 
Lacking the facilities with which to synthesise derivatives 
of MSH carrying chemically active moieties at the amino 
terminus (eg maleimido groups), I decided to investigate the 
possibility of linking the peptide to the carrier via the 
Lysii but maintaining the positive charge. This was based on 
the observation that substitution of Ornithine for Lysine at 
position 11 did not drastically reduce the biological 
activity (Eberle 1981). To achieve this, MSH was derivatised 
with dithiobispropionimidate (OTBP), a cleavable cross 
linker which interacts with amino groups via its imidate 
moiety leaving a positive charge, although displaced, and 
can be cleaved with OTT to expose a thiol group. This thiol 
group could then be used to conjugate the peptide to a 
carrier. 
Peptide thiolation 
MSH was modified with OTBP and reduced as described in 
methods and purified on HPLC. The resulting peaks from HPLC 
(fig 3.1) were analysed for peptide content by amino acid 
analysis and for sulphydryl content by colorimetric 
determination with OTNB (dithiobisnitrobenzoic acid). 
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A requirement of the linkage procedure is that the 
thiolated peptide is not contaminated with free thiol groups 
(eg OTT). As shown in fig 3.1 HPLC gives excellent 


















































Fig 3.1 : HPLC of MSH modified with dithiobis 
propionimidate. The peptide and its derivatives were eluted 
off Cia µ-Bondapak column with a 0-70% acetonitrile gradient 
in 0.05% trifluoracetic acid. Absorbance (lower trace) 
monitored at 230 run. Sulphydryl content (dotted area) 
monitored by reaction of aliquots with DTNB. Arrow shows 




contained both peptide and thiol, and this peak which was 
assumed to represent the modified peptide was clearly 
separated from any unmodified peptide and reducing agent. 
Since the elution buffer contained 0.05% TFA the oxidation 
of the exposed thiol is extremely unlikely, however the 
thiolated peptide was prepared fresh whenever needed. 
Biological activity 
To determine whether modifying MSH with DTBP had altered its 
ability to be recognised by the receptor, the thiolated 
peptide (MSH-SH) was assayed for biological activity by 
monitoring peptide induced stimulation of both adenylate 
cyclase activity and tyrosine hydroxylase activity. 
Since the time response of MSH mediated adenylate cyclase 
activation varies between cell lines it was necessary to 
establish the time response of the cell line used. The cell 
line used was the B16-Fi subclone of the B16 mouse melanoma 
line. 
Fig 3.2 shows the effect of 10- 7 M MSH or MSH-SH on the 
accumulation of cAMP in Bl6-Fi cells with time. Maximal 
stimulation is achieved by both the native and modified 
peptide after 30 minutes of incubation, a significantly 
lower time response than that published for cultured brain 
cells (van Calker et al 1983), however similar to that for 
Cloudman 591 cells (Fuller and Viskochil 1979). For 
subsequent experiments an incubation time of 30 minutes was 
employed. 
Interestingly, although the magnitude of stimulation was 
approximately the same for both the native and modified 
peptide, the decay of cAMP in the cell was significantly 
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Fig 3.2: Time course of the increase in the level of cAMP 
evoked in Bl6-Fi mouse melanoma cells by lQ- 7 M MSH, MSH-SH 
or a control of no peptide. At 15 minute intervals after 
adding peptide to the cells the medium was decanted and cAMP 
extracted with 0.2M HCl in ethanol. The quantitation of the 
cAMP was performed using a conunercial cAMP assay kit 
(Amersham) and expressed as pmoles cAMP per well. Each point 
in the control was assayed once. Each point in the 
experiment is the average of duplicates. 
L 
10 
I -¥- MSH 
8 i 









r (]) 0 4 E r 0.. i 
r 
2 ! 
' 0 [ 
-11 -10 -9 -8 -7 -6 -5 
log hormone (M) 
Fig 3.3: Dose-response curves of the accumulation of cAMP 
evoked by MSH or MSH-SH in Bl6-Fi cells. The response is 
expressed as pmoles cAMP per well. Each well contained 10 5 
cells. Results shown are the average of duplicates performed 
on the same sample of cells. Variability within each assay 
was low, however between assays performed on different days 
the absolute values varied. This is explained in the text. 
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that there may be a slightly altered interaction of the 
thiolated derivative with the receptor compared to that of 
the native peptide; possibly a slower dissociation of 
receptor and peptide resulting in a longer stimulation of 
adenylate cyclase and hence a slower decay of intracellular 
cAMP. 
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The dose-response of adenylate cyclase to both MSH and 
thiolated MSH is shown in fig 3.3, demonstrating that the 
modification of the peptide has not caused a decrease in its 
ability to stimulate adenylate cyclase via the MSH receptor. 
Since the adenylate cyclase stimulation is an immediate 
response to the hormone, it is indicative of hormone-
receptor interaction, and hence it appears that the modified 
hormone is able to interact with the MSH receptor as well as 
the native peptide. The peptides express an ECso of 9 X lQ- 9 
M, within the range of most published figures. 
That the modified peptide is able to interact with the 
receptor is not sufficient proof that it is able to exert 
full biological effect, and hence the ability of both 
peptides to stimulate tyrosinase activity were investigated. 
The results are shown in fig 3.4, demonstrating that the 
modified peptide is slightly less able to promote tyrosinase 
stimulation than MSH is. The native peptide exhibits an ECso 
of 8 nM, compared to the thiolated derivative with an ECso 
of 20 nM. Since both peptides are able to stimulate 
adenylate cyclase to the same extent, yet differ in their 
abilities to stimulate tyrosinase, it is possible that their 
interaction with the receptor is identical, but interact 
differently with a post-receptor processing element. ~-MSH-
Daunomycin conjugates have also been shown to be recognised 
by the receptor and yet to exhibit no tyrosinase 
stimulation, a phenomena ascribed to decreased 
susceptibility of the modified peptide to proteolysis within 
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Fig 3.4 : Dose-response curves of tyrosinase activity in 
Bl6-Fi cells. Cells were incubated in McCoys SA medium 
suplemented with 10% fetal calf serum with increasing 
concentrations of hormone. After 24 hrs 0.5 µCi of L-[3,5-
3H]tyrosine was added and incubation continued for a further 
24 hrs at which time the amount of 3H20 in the medium was 
assayed. The results are expressed as dpm 3H20 per hr per 
well averaged on duplicates. 
l 
which may be required for full biological activity to be 
exerted (Varga 1985). 
These results show that the modified MSH is able to interact 
with the MSH receptor as strongly as the native peptide, and 
hence appears that it may be able to function as a ligand by 
which to target liposomes to cells. 
That there has not been a decrease in the biological 
activity is surprising. Although the positive charge has 
been maintained one would expect the introduction of a 
larger group at the lysine to cause some decrease in 
activity by hindering the formation of the turn in the Phe-
Arg-Trp region. Two possible explanations exist for the 
maintenance of full adenylate cyclase activation potential. 
1) The displacement of the positive charge from the epsilon-
amino of Lysii three atoms further away onto the imidate of 
the modifying reagent DTBP, may allow closer, and hence 
stronger, electrostatic interaction of the positive charge 
on Lysii with the negative charge on Glus. This may function 
to stabilise the turn in the peptide, and hence maintain its 
affinity for the receptor. 
2) The exposed thiol on the modified peptide may be able to 
interact with a similar moiety within the receptor, 
increasing the strength of interaction of the peptide with 
the receptor, and thus canceling the decrease in affinity 
due to the introduction of a large side-group. A reaction 
with the receptor may also account for the slower decay of 
adenylate cyclase activity observed with the thiolated 
peptide. 
It was noted during these studies that occasionally 
preparations of the modified peptide exhibited biological 




able to induce the adenylate cyclase to a much higher level 
than MSH alone. Quantitation of the sulphydryl content of 
these samples showed it to exceed the peptide content, 
indicating the presence of a contaminating thiol compound. 
This compound was identified to be a contaminant introduced 
with the mercaptoethanol which co-eluted with the MSH-SH on 
the HPLC. To avoid this all further preparations were 
prepared using OTT as a reducing agent. This observation, 
and the published reports of thiol compounds in stimulating 
melanogenisis (Horowitz 1957), and the non-identical 
biological behavior of thio-ether and disulphide conjugates 
of MSH-TMV (Wunderlin et al. 1985) supported this argument. 
Since the modified peptide contained a free sulphydryl, it 
is possible that this moeity was responsible for the 
observed high biological activity, possibly through an 
interaction with a sulphydryl within the receptor. If this 
were the case then blocking the sulphydryl on the peptide 
should result in a lower biological activity. 
Carboxymethyl-MSH (CM-MSH). 
To ascertain whether the high biological activity was due to 
the presence of a sulphydryl, the sulphydryl moeity of MSH-
SH was blocked on an analytical scale using radiolabelled 
iodoacetic acid as described in methods. 
Purification of the reaction mixture on HPLC (Fig 3.5 A), 
and monitoring of the radioactive content of the fractions, 
demonstrated that MSH-SH exposes a sulphydryl which can be 
carboxymethylated to nearly 100% efficiency resulting in a 
radiolabelled, blocked, modified peptide. To confirm that 
the modification was due to the sulphydryl, MSH was subject 
to identicle reaction conditions and purification (Fig 3.5 
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Fig 3.5 : HPLC purification of products after interaction of 
MSH-SH (A) or MSH (B) with 3 H-iodoacetic acid. Lower trace 
is absorbance monitored at 230 nm, hatched area is 
radioactivity, monitored by counting aliquots in 
scintillation fluid. Dashed line indicates the gradient of 
acetonitrile in 0.05% TFA. 
, 
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indicating that there was an exposed thiol group on MSH-SH, 
and that on interaction with iodoacetic acid, this group 
became carboxymethylated. 
MSH-SH was then carboxymethylated on a preparative scale to 
prepare CM-MSH for biological activity assays. Blocking 
procedure was as above but using non-radioactive iodoacetic 
acid, and 30 ug of peptide. The peak isolated from HPLC was 
quantitated by amino acid analysis and assayed for 
biological activity. 
Biological activity of CM-MSH 
CM-MSH was compared against MSH-SH for its ability to 
activate adenylate cyclase. 
The results are shown in fig 3.6, demonstrating that the 
carboxymethylated derivative does express a lower biological 
activity. ECSO for MSH-SH is 8 X l0- 9 M whereas for CM-MSH 
it is 1.5 X 10-s M, or 0.63 times as active. 
This decrease in activity could be due to blocking of the 
sulphydryl moeity, preventing its interaction with the 
receptor if such an interaction does occur, or due to the 
introduction of a further bulky group onto the hormone, 
altering the conformation and interfering with the hormone-
receptor interaction. 
This line of investigation was not pursued further as it was 
felt that the CM-MSH closely resembled the likely structural 
configuration of MSH-SH linked to a carrier via a thioether 
linkage, and that a biological activity of 0.63 proved that 
it was recognised by, and interacted with the receptor. 
33 
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Fig 3.6: Dose-response curve for adenylate cyclase 
activation of Bl6 cells by MSH-SH or its carboxymethylated 
derivative CM-MSH. Data points for MSH-SH are averages of 
duplicates, for CM-MSH averages of triplicates. 
Comparison of biological activity assays. 
It was found that the adenylate cyclase assay gave far more 
reproducible results, could be performed on a larger number 
of samples, and was technically easier to perform than the 
tyrosinase activity assay, and hence was used for all 
subsequent assays of biological activity. Furthermore, as 
discussed previously, the adenylate cyclase activity assay 
provides an indication of interaction with the receptor, 
whereas the tyrosinase or melanisation assays appear to 
require additional post-receptor processing and hence may 
not be indicative of receptor interaction. 
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The increase in the level of adenylate cyclase activity was 
found to be highly dependant on the r~cent history of the 
cells. Cells in mid-log phase which had been regularly 
subcultured expressed a ten fold stimulation of basal 
cellular cAMP, however if they had been allowed to grow to 
confluence prior to subculturing into the flask from which 
they were assayed, the response was only a two fold 
stimulation (results not shown). Likewise if the cells were 
left in the multi-well dishes for several days and assayed 
during the stationary phase of their growth, the response 
was significantly diminished. 
The variable response of the B16 cell line to MSH has been 
investigated by Sheppard et al.(1984) who found that clones 
of the B16 cell line that were highly metastatic also 
displayed a large (50 to 70 fold) increase in basal cAMP 
levels in response to MSH or forskolin exposure. Clones with 
low metastatic potential dispiayed only a 2 to 3 fold 
increase in basal level. Their conclusion is that cAMP 
metabolism is linked with biochemical pathways responsible 
for formation of metastasis. Their finding contrasts that of 
Niles and Makarski (1978), who, in monitoring tyrosine 
L 
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hydroxylase increase in response to MSH found that cells of 
high metastatic potential were not significantly responsive 
to MSH, whereas those of low metastatic potential were. In 
the paper by Sheppard et al.(1984) this disparity is 
explained as being due to the use by the earlier authors, of 
heterogenous polyclonal B16 lines in which changes to the 
balance of cellular subpopulations may have occurred. 
The cell line used in these experiments was the Bl6-Fi 
subclone, supposedly of low metastatic potential and hence 
of low MSH responsiveness. The results presented here do 
however show that the cell line was responsive to MSH, 
although with a lower magnitude of response than that 
published for highly metastatic subclones. This, and the 
variable responsiveness to MSH with cell history was 
therefore assumed to be due to the presence of both 
responsive and non-responsive subpopulations within the cell 
line. 
For this reason the passaging and assaying procedure was 
standardised to maximise the observed response. If the 
control (MSH) response in any experiment resulted in less 
than six-fold stimulation of basal cAMP, the results were 
discarded and the experiment repeated using cells from a 
lower passage number. 
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Chapter 4 
CONJUGATION OF a-MSH TO CARRIERS 
MSH containing a small amount of tracer i 25 I MSH (prepared 
by the lactoperoxidase method and purified as described in 
methods) was derivatised with DTBP and purified as 
described. The radiolabelled fraction of the sample eluted 
from the HPLC slightly later and hence broader fractions had 
to be collected to ensure the presence of the tracer with 
the hormone (Fig 4.1). The MSH-SH thus obtained had a 
specific activity of 30 mCi/mmol. After drying and 
redisolving in PBS it was used for conjugation to liposomes. 
Liposome preparation: 
Liposomes prepared by the reverse phase evaporation 
procedure (REV) (Szoka and Papahadjopopoulos 1978) were 
chosen because they fulfilled the criteria required for the 
experiments : They are large unilammelar liposomes with a 
high entrapment efficiency, capable of encapsulating 
macromolecules. 
The liposomes were prepared to contain 50 mol% cholesterol 
to minimise leakage induced by serum proteins, 45 mol % 
Phosphatidylcholine (PC) to minimise nonspecific binding, 
and 2.5 mol % N-[3-(2-pyridyldithio)propionyl] 
phosphatidylethanolamine (PDP-PE) for coupling of thiolated 
ligands to liposomes through a disulphide linkage (Martin et 
al. 1981). Oicetyl phosphate (2.5 mol%) was also included to 
minimise aggregation of liposomes (Rosenberg et al. 1987). 
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Fig 4.1: HPLC trace of preparation of radioiodinated MSH-SH. 
MSH containing a trace of i 25 I-MSH was derivatised with DTBP 
and reduced as described in methods. Lower trace is 
absorbance at 230 run, dotted area is dpm of 125 ! determined 
by counting 0.2 ml aliquots. The fraction collected and used 
as preparative i 25 I-MSH-SH is shown bracketed. 
which imparts a slight negative charge to the liposomes 
significantly facilitated liposome preparation, and 
purification. Although it is possible that the negative 
charge may increase the non-specific binding of liposornes to 
cells, the aggregation of liposomes which occasionally 
occurred when liposomes were prepared without this component 
was avoided. 
The liposomes were extruded through sterile 0.2 µm 
polycarbonate membranes immediately after preparation. This 
served to decrease the heterogeneity of the liposome size 
distribution, and also to sterilise the liposomes and hence 
minimise any degradation that may occur due to bacterial 
contamination. Prior to conjugation the liposomes were 
separated from unentrapped material by flotation on Ficoll 
gradients (Fraley et al. 1981). 
Characterisation of the liposomes was achieved by freeze 
fracture electron microscopy, which showed them to be 
unilamellar and of an average size of 200 run (Fig 4.2). 
Confirmation of the size distribution performed by scanning 
electron microscopy of liposomes on 0.2 µm polycarbonate 
membranes and on cells is shown later on in the thesis. 
The inclusion of a fluorescent marker (Calcein) within the 
liposomes during their preparation allowed the assessment of 
the encapsulation efficiency (see methods) which was shown 
to be between 15 and 20 % with an entrapment of 
approximately 5 µ1/µmol lipid and also permitted a rapid 
analysis of the stability of the liposomes. The theoretical 
encapsulation efficiency of 200 run diameter liposomes based 
on the calculations of Guiot and Baudhuin (1984) is 14%, 
hence the efficiency of encapsulation confirms the electron 
microscopy findings. 
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Fig 4.2: Freeze fracture electron micrograph of reverse 
phase evaporation vesicle (REV) demonstrating unilamelar 
nature of vesicle. Conditions for microscopy are described 
in methods. (Bar= 200 run). 
, 
l 
Conjugation to liposomes 
100 ug of MSH-SH with tracer 125 I-MSH-SH was added to 
liposomes composed of PC/ Chol/ DCP / PDP-PE 
(45:50:2.5:2.5 mol%, 10 µmoles total phospholipid) as 
described in methods, incubated overnight and dialysed to 
remove unbound peptide. Under optimal conditions 60 % of the 
peptide could be bound to the vesicles, representing 
approximately 2000 molecules of MSH per liposome. The ratio 
of PDP-PE to peptide is 10. Increasing this figure did not 
increase the amount of peptide which bound to the liposomes 
(results not shown). 
Dansyl derivatives of MSH and ACTH have been shown to bind 
to lipid vesicles from aqueous solution (Schwyzer 1979) and 
ACTH1-24 has been shown to spontaneously insert into lipid 
membranes (Gremlich et al. 1983), hence it is possible that 
the binding of the MSH to the liposomes was not due to 
covalent coupling to the PE-DTP, but due to a hydrophobic 
association with the bilayer. Incubation of the conjugated 
liposomes in 10 mM DTT for 4 hours followed by dialysis to 
remove the released peptide resulted in 97% of the 
radioactivity appearing in the dialysis buffer, 
demonstrating that the peptide could be quantitatively 
released from the liposomes under reducing conditions, and 
the association is therefore not due to membrane insertion. 
To assay whether the conjugation of MSH to the liposomes 
perturbed the bilayer, liposomes were prepared containing 
100 mM Calcein and were conjugated to MSH. The rate of 
leakage of calcein from the liposomes was assayed by 
monitoring the increase in fluorescence due to the 
unquenching of the fluorescent dye. The results are shown in 




of the liposomes does not promote leakage, and in fact 
appears to provide a small degree of protection from serum 
induced leakage, possibly by acting as a protective 'shell' 
on the liposome surface decreasing the ease of access of 
serum lipoproteins to the bilayer. 
PBS PBS+FCS 
Lip 4.5% 19.0% 
Lip-MSH 4.3% 16.5% 
Table 4.1 : % efflux of calcein over a 24 hour period from 
liposomes with or without MSH bound to the surface in PBS 
with or without 10% fetal calf serum. 10 nrnoles lipid was 
incubated in 1.0 ml buffer or buffer with FCS. Fluorescence 
after 24 hours was compared to fluorescence after adding 10 
µl of 10% Triton X-100 which lysed the liposomes and 
resulted in 100% leakage. 
Biological activity of liposome-MSH conjugate 
Having bound the hormone to the liposomes it was necessary 
to test whether the bound hormone was able to be recognised 
by the hormone receptor, and to elicit any biological 
response. This was achieved by assaying the ability of the 
liposomes to elicit adenylate cyclase activity in Bl6 cells 
by the same protocol as for MSH activity determination. 
Fig 4.3 shows the comparison of the adenylate cyclase 
stimulation of both MSH and of MSH bound to liposomes. For 
the MSH bound to liposomes the hormone concentration is 
based on the total number of MSH molecules bound to the 
liposomes. 
Within the time period of the assay the liposomes were able 
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Fig 4.3: Adenylate cyclase activation of B16 cells by MSH 
and by MSH bound to liposomes (LIP-MSH). The incubation was 
performed in PBS/Ca••/Mg•• for 30 minutes and cAMP 
determined as described in methods. For LIP-MSH the MSH 
concentration is expressed as the total amount of MSH 
present. Data points for MSH are from duplicates, for LIP-
MSH from quadruplicates. 
I 
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only 73 % of that achieved by free MSH, and required 20 fold 
as much MSH to do so. 
That there is adenylate cyclase activation by the 
liposomally bound MSH shows that the immobilised hormone is 
recognised by the receptor, however a quantitative 
comparison of the biological activity of immobilised hormone 
with that of the free hormone is not valid because of the 
reasons outlined below. 
1) On a liposome the bound peptide should be evenly 
distributed, covering the entire sphere, and hence only a 
small proportion will be available at the receptor site. 
Most of the hormone is therefore not available for 
interaction and does not contribute towards the biological 
activity. Since lateral mobility is possible within the 
liposomal membrane there may be accumulation of hormone at 
the receptor, it is however impossible to ascertain what 
proportion of the peptide is available to interact at the 
plasma membrane surface. If several ligands on the same 
liposome each react with a receptor (which is possible), 
this will increase the effective local concentration of the 
ligands at the receptor and hence increase the apparent 
association constant in a manner similar to the super-
hormone activity of TMV-MSH (Kriwaczek et al. 1978). This is 
discussed later. 
2) The large size of the liposomes compared with receptor 
may prevent many of the receptors from interacting with 
liposomes, possibly explaining the lower maximal response as 
being due to only a proportion of the receptors being 
occupied. The magnitude of this effect will be increased if 
the receptors are locally concentrated, and not spread out 
over the entire cell surface. 
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3) Sterically constrained MSH may interact with the 
receptors in a manner not conducive to activation of the 
adenylate cyclase. Thus, If receptor aggregation is a 
prerequisite for adenylate cyclase activation then liposome-
bound MSH, because of the relatively large size of the 
liposomes may inhibit this. Since the liposomal membrane is 
in a liquid crystal state at the temperatures of the 
incubation, there is a certain degree of mobility of the 
peptide on the surface of the liposome which might permit 
aggregation of hormone-occupied receptor, but at a slower 
rate than for free hormone. This would slow down the 
activation. It is interesting to compare the lower adenylate 
cyclase activation observed here with the absence of 
adenylate cyclase activation observed in the case of TMV-
bound MSH (Wunderlin et al. 1985) for which, due to the 
ridgidity of the complex, aggregation may be impossible, 
preventing activation. Alternatively, if receptor 
internalisation is a prerequisite for adenylate cyclase 
activation, the immobilisation of the hormone on liposomes 
could hinder this activation, accounting for the lower level 
of stimulation. 
4) The observed activity could be due to hormone released 
from the liposomes. To determine whether here had been any 
release of hormone from the surface of the liposomes the 
supernatant from the cell-liposome incubation above was 
passed over a sepharose This was checked by passing the 
incubation medium over a Sepharose 4B column. 1.2 X 10 6 DPM 
(4 ug peptide in 2 ml) were applied to the column, and 900 
DPM eluted in the outer volume, indicating a 0.075 % release 
of peptide, equivalent to 0.003 ug. This could not account 
for the 5% observed activity. 
Hence a biological activity of 5% with respect to ligand 
present is meaningful only as far as confirming that there 




suggesting the possibility of hormone mediating binding of 
the liposomes to the receptors. 
Binding to cells 
MSH-SH was coupled to liposomes that contained the 
fluorescent marker Calcein. These liposomes, and a control 
of liposomes to which no MSH had been linked were added at 
increasing concentrations to B16 cells in PBS/Ca/Mg and 
incubated for 30 minutes at 37 degrees,and then washed four 
times with ice-cold PBS/Ca/Mg. The cells and bound liposomes 
were then lysed with 1% Triton-X-100 and analysed for 
fluorescence. 
Fig 4.4 shows the results of this experiment expressed as 
the number of liposomes bound per cell. The figure of 1.2 X 
1013 liposomes / 10 µmol phospholipid is calculated 
according to Guiot and Baudhuin (1984) assuming an average 
diameter of 200 nm. 
The results indicate that at low concentration of liposomes 
there is a definite specific binding of the targeted 
liposomes to the cells, however at higher concentrations of 
lipid, the non-specific binding becomes increasingly more 
significant. Subtracting the binding of un-targeted 
liposomes from that of targeted liposomes gives the figure 
for specific (hormone mediated) binding which reaches a 
maximum at a lipid concentration of 200 µM, corresponding to 
a hormone concentration of 7.2 X 10- 7 M. 
The affinity of the binding calculated from the specific 
binding curve gives a Ko of 2.7 X lQ- 7 M with respect to the 
hormone, two orders of magnitude lower than that of MSH. A 
direct comparison of this figure with that of the Ko of free 
MSH is meaningless because of the multimeric nature of the 
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Fig 4.4: Binding of liposomes to B16 cells. 10 5 cells in 
monolayer were incubated in 1.0 ml PBS/Ca/Mg with increasing 
concentrations of either targeted (LIP-MSH) or untargeted 
(LIP) liposomes containing 100 mM calcein for 30 minutes at 
37°C. The number of liposomes bound per cell was calculated 
from the fluorescence associated with the cell and assuming 
the number of vesicles in the preparation to be 1.2 X 1013 • 
Subtraction of the figures for untargeted binding from 
targeted binding gives specific binding. Results shown are 
the average of triplicates performed on the same sample. 
------- --- -, 
surface of the liposome, only a small proportion can be 
available at any moment for interaction with the receptor. 
This quantitiy is unknown and hence the calculation of the 
Ko, which assumes all the hormone present to be available 
for binding, is severely underestimated. A more valid 
assesment of the affinity of the conjugate for the receptor 
is obtained from inhibition studies presented later. 
The interpretation of the increase in binding due to the 
targeting, and also of the number of liposomes bound per 
cell requires cognizance of the cell cycle dependant 
expression, and hence liposome binding, of the cells. As 
published (Varga et al. 1974), and as shown by fluorescence 
micrographs later in this thesis, only 20 to 30% of the 
cells in an asynchronous culture bind MSH. The non-specific 
binding of liposomes is however independent of the cell 
cycle, and hence the figure for specific binding obtained by 
subtracting targeted from untargeted binding is correct for 
the entire cell population, but is only 20 to 30% of the 
correct figure for those cells participating in the targeted 
binding. Thus, while the entire sample exhibits a maximum 
increase in binding due to targeting of only three fold, and 
a saturation of specific binding of 230 liposomes per cell, 
when calculated for the proportion of cells which actually 
participate in MSH mediated targeting, the figures become; a 
12 fold increase in binding due to targeting, and a maximum 
specific binding of approximately 1000 liposomes per cell. 
Since the cell surface should be able to accommodate at 
least 10000 liposomes by area, the plateau reached at 1000 
liposomes per cell is indicative of either; 
1) The number of receptors being very much lower that the 
published figure of 10 4 per cell for Cloudman S91 cells 





2) Only a proportion of the receptors are in a conformation 
in which they are able to bind liposomes, or; 
3) Only a small proportion of the receptors are available to 
bind the liposomes because of a patchy distribution and 
steric hindrance by the liposomes. 
Inhibition of binding 
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To further prove that the binding of the liposomes to the 
cells was due to a recognition of the bound MSH by the MSH 
receptor, inhibition studies with free MSH were performed by 
incubating targeted liposomes with cells in the presence of 
increasing concentrations of free MSH. The results are shown 
in fig 4.5, which shows that the binding can be inhibited by 
the addition of an excess of free MSH,. indicating that the 
binding is due to hormone-receptor interactions, however the 
amount of MSH required to inhibit the binding is large. At a 
concentration of 3 X 10- 5 M (30 runoles free MSH, three 
orders of magnitude greater than the Ko), which represents 
a 40 fold excess of free MSH, only 60 % of the specific 
binding has been inhibited, and a stoichometric quantity of 
free MSH does not decrease the binding at all. 
The requirement of non-stoichometric quantities of free 
ligand to inhibit the binding of targeted liposomes has 
previously been shown in the experiments of Heath et al. 
(1983) where a 20 fold excess of free antibody is required 
to inhibit antibody mediated binding of liposomes by 75%, 
leading these authors to speculate that liposomally bound 
antibody has a higher affinity for the antigen than the free 
antibody. 
If we apply such reasoning to this experiment, then it 
implies that the Ko of the MSH bound to the liposomes is at 
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Fig 4.5: Inhibition of binding of targeted liposomes by MSH. 
Targeted liposomes (200 nmoles phospholipid, 0.72 nmoles 
bound MSH per ml) were incubated with cells in 1 ml 
PBS/Ca/Mg containing increasing quantities of free MSH and 
binding determined as for the previous experiment. At this 
concentration of liposomes a non-specific binding of 140-150 
liposomes / cell occurs (see fig 4.4). Data points are 
average of duplicates. 
l 
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giving it a Ko of approximately 1 X 10-io M. From the direct 
binding studies, the liposome complex as a whole exhibits a 
Ko of 2.7 X 10- 7 M with respect to all of the MSH on the 
liposome, of which only a small proportion actually 
interacts with the receptor. Since there are on average 2000 
MSH molecules per liposome, dividing the Ko of the LIP-MSH 
complex by the number of ligands yields an individual Ko of 
1.3 X 10-io M, very close to the figure obtained from the 
inhibition studies, suggesting that each liposome is able to 
interact with only one receptor at any one moment. 
Fluorescence microscopy of MSH-targeted liposomes 
To obtain some idea of the morphological distribution of the 
liposomes on the cells, fluorescence microscopy of calcein 
loaded liposomes interacting with the cells was performed. 
Liposomes at 100 µM lipid which gives maximal difference 
between specific and non-specific binding were incubated 
with cells growing on glass cover slips for 1 hour at 37°C. 
The time-period and temperature were chosen so that any 
internalisation of the liposomes by an endocytotic pathway 
could take place and hopefully be detected. Fig 4.6 is a 
typicall field of view, demonstrating that the binding of 
the liposomes to the cells occurs primarily on the cell 
body, although some binding to the dendritic extrusions is 
also evident. The appearance of very bright fluorescence in 
the middle of the cell body suggest that the receptors are 
not evenly distributed, and that the bright fluorescence is 
due to the binding of a large number of liposomes to an area 
of high receptor density. Such binding is simmilar to that 
observed by Varga et al. (1976), who found binding of MSH to 
melanoma cells occurred in a region of the cell surface 
overlying the golgi complex. It is possible that the bright 






That the fluorescence is primarily punctate suggests that 
the liposomes are still bound to the surface of the cell, 
and any calcein that may have been internalised is trapped 
within vesicles in the cell. Calcein is a highly acidic 
molecule and as such unlikely to lose its charge and be able 
to leak out of acidic vesicles. Hence, unless there has been 
fusion of the vesicles with the cell, internalised calcein 
will appear punctate. It was not readily discernable whether 
the non-peripheral fluorescence was on the cell or within 
it. 
Not all of the cells aquired fluorescence, and in any field 
of view, only 20 to 30 % of the cells present could be 
detected by fluorescence. This is particularly evident from 
the fluorescent micrographs of FITC-labelled MSH-ricin-A-
chain conjugates (chapter 5) in which both the fluorescent 
and non-fluorescent cells appear in the same micrograph. 
That the hormone mediated binding of liposomes occurred on 
only 20 to 30 % of the cells suggest that the B16 cell line, 
similar to the Cloudman S91 line, exhibits a cell-cycle 
dependant expression of the MSH receptor (Varga et al. 
1974), and hence in an asynchronous culture, approximately 
only 30% of the cells express the receptor at any time. 
Anomalous binding 
It was observed that occasionally ( the event was noticed 
five times out of an estimated 1 X 10 7 cells observed) a 
cell appeared within the B16 cell line that had a 
significantly higher affinity for the targeted liposomes and 
were much larger than the normal B16 cell. These cells were 
noticed because they bound very significantly more liposomes 
than their neighboring cells. Once located by fluorescence 
microscopy (fig 4.6 A), phase contrast microscopy (fig 4.6 
B) showed these cells to be up to five times the diameter of 
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Fig 4.6: Fluorescence microscopy of binding of calcein 
loaded MSH-targeted liposomes to Bl6 melanoma cells. 
Liposomes were incubated with cells growing on glass 
coverslips in PBS/Ca/Mg for 60 minutes at 37°C. Bar is 5 µm. 
A 
B 
Fig 4.7: Microscopy of anomolous binding of MSH-targeted 
liposomes to a contaminant or mutant within the Bl6 melanoma 
cell line. Incubation was performed as described previously. 
(A) Fluorescence microscopy, (B) phase-contrast of same 
field. Bar is 5 µm . 
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the normal cells, and with a very large nucleus. The binding 
of fluorescent targeted liposomes to these cells is so much 
greater than the binding to the surrounding cells that 
features such as long axons growing over other cells are 
easily distinguished. The binding is primarily on the cell 
body, however distinct binding to the axons has occurred and 
some perinuclear diffuse fluorescence suggests that 
internalisation has occurred, however there is so much 
fluorescence that it is difficult to distinguish 
internalised from surface bound. 
The very low frequency of observation of these cells ( 1 in 
2 X 10 6 ) and the observation that there were never two 
together, suggests that these represent a spontaneous 
mutation of the cell, and are not a subpopulation within the 
cell line. The low frequency of observation also precludes 
the conclusion that because they were only observed with 
targeted liposomes, the increased binding is definitely due 
to an altered MSH receptor parameter. It is possible though 
unlikely, that they could be binding the liposomes via a 
different determinant, and were not observed in the control 
experiments because more time was spent observing the 
binding of targeted liposomes. 
That such cells could occur within a population warns that 
spectroscopic data on liposome binding should always be 
confirmed with microscopy. These cells were not investigated 
further. 
Targeted delivery of methotrexate 
Having shown that the binding of MSH to the liposomes 
resulted in their specific binding to melanoma cells, it 
remained to be shown whether such binding promoted the 
delivery of the liposomal contents into the cells. The 
inhibition of 3 H-thyrnidine uptake into cellular DNA in 
-' 
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response to cytoplasmic accumulation of methotrexate, an 
inhibitor of the folate metabolism pathway, was chosen as 
the assay of liposomal delivery. 
Liposornes were prepared containing 1 mM MTX, which, at 15% 
encapsulation resulted in an encapsulated drug : lipid ratio 
of 4 rnmol/mol. The liposomes, both targeted and untargeted, 
and free MTX were tested for their ability to inhibit 
cellular proliferation of Bl6 cells. This was achieved by 
incubating the cells with increasing quantities of the drug 
for 24 hours, and then adding 3 H-thymidine and continuing 
incubation for a further 24 hours at which time the 
incorporation of the radio-labelled nucleotide was assayed. 
The results are shown in fig 4.8, which demonstrates that 
the free drug is able to inhibit the incorporation of 3 H-Thy 
into cellular DNA with an ID5o of 500 nM. In comparison to 
this the ID5o for both targeted and untargeted liposomally 
entrapped MTX is 2100 nM. This indicates that there has been 
no significant increase in the delivery of the drug into the 
cells by targeting with MSH. Since the cells were shown to 
bind targeted liposomes specifically, this result initially 
suggests that the specifically bound liposomes are unable to 
deliver their contents into the cell, a possible consequence 
of the MSH receptors not mediating endocytosis, or of the 
liposomes being too large for MSH-mediated endocytosis. 
A more detailed examination of the data, and of the 
experimental protocol provide some insight into the absence 
of target specific toxicity. 
The very high ID50 of free MTX (500 nM) compared with that 
published for other cells which have an average ID50 of 10 
nM (Piper et al. 1982) and that found for hepatoma cells 
(ID5o = 60 nM, see chapter 6), suggests that the Bl6 cells 
express some form of resistance to the drug. Cell lines are 
1 
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known to become resistant to rnethotrexate by one of two 
routes ; 
1) Increased intracellular levels of dihyrofolate reductase, 
the enzyme inhibited by MTX, or; 2) the loss of the active 
transport system by which MTX enters the cell. 
The untargeted liposomes have an ID5o of 2.1 µM, this 
toxicity due to probably to leakage of the drug from the 
liposomes into the medium, and perhaps also to non-specific 
binding of the liposomes to the cells and delivery of the 
contents via either constitutive (non receptor-mediated) 
endocytosis or a fusion event. Assuming the rate of leakage 
of the MTX to be similar to that of calcein (a reasonable 
assumption since they are both charged molecules of 
approximately the same size), the leakage after 48 hours 
would yield a free drug concentration .in the region of of 
600 nM, however this concentration would not have been 
present during the entire time period as leakage is a time 
dependant process. Therefore, some of the toxicity is due to 
intracellular delivery of non-specifically bound liposomes, 
and since it is unlikely that this represents more than a 
few percent of the total liposomes present, this toxicity 
results from the delivery of only a small concentration of 
MTX. 
These results are in qualitative agreement with those of 
Heath et al. (1983) who used a derivative of MTX still able 
to inhibit dihydrofolic acid reductase, but much less able 
to enter the cell than MTX. A similar ID5o of 1 to 2 µMis 
obtained for untargeted liposomal toxicity of this drug. To 
follow an argument these authors present, since the K~ of 
MTX on the enzyme dihyrofolic'acid reductase is in the order 
of 5 nM (Piper et al. 1982), then an intracellular 
concentration of MTX of 5-10 nM should inhibit cellular 
growth, and such an internal concentration can be achieved 
by the cytosolic delivery of only a few liposomes. In this 
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experiment, the volume of the B16 cells (15 µm diameter) is 
2.3 Xl0 6 times greater than that of a liposome (200 nm 
diameter), and since the liposomes contain 1 rnM MTX, only 23 
liposomes are required to deliver their contents into the 
cytoplasm to achieve a cellular concentration of 10 nM. 
There is however an assumption made here that the 
microenvironrnent of the DHFR enzyme is identicle to the 
gross cytoplasmic environment, which is not necessarily so, 
and any compartmentalisation of the enzyme could raise this 
figure by several orders of magnitude. 
At the concentration at which the liposomally entrapped MTX 
exhibits toxicity, the lipid concentration is 500 µM. From 
the binding studies, at this concentration untargeted 
liposomes bind 230 liposomes per cell. The same number of 
liposomes can be bound in the case of targeted liposomes at 
a concentration of approximately 100 µM, hence it is 
surprising that the targeted liposomes do not exhibit at 
least a five fold increase in toxicity. Two postulates can 
be proposed to account for this. 
The first is based on the experimental protocol. While 
several authors (eg. Huang et al. 1983) perform the above 
type of experiment by incubating the liposomes with the 
cells for a short time period followed by washing the cells 
and then continuing incubation, the cell cycle dependant 
expression of the receptor required that the liposomes were 
present in the medium for at least one doubling-time (approx 
28 hrs). During this time period there may have been no 
further binding of targeted liposomes to the receptor, it 
being occupied, the non-specific binding however may have 
increased, being subject to no such constraints, resulting 
in insignificant differences in binding (and hence toxicity) 
between the two types of liposomes. The possible release of 
hormone from the liposomes in medium should not interfere 
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with the binding as it was shown previously that a vast 
excess of free hormone is required to inhibit binding. 
The second postulate proposes that the MSH receptor is 
unable to promote the internalisation of the specifically 
bound liposomes, similar to the observation of binding 
without internalisation by Machy et al. (1982), whereas 
there is a chance of a non-specifically bound liposome being 
endocytosed by a constitutive process. It is also possible 
that some of the liposomes were specifically endocytosed, 
however because of the low number of specifically bound 
liposomes, this did not show above the background. Leserman 
et al (1983) have found that cells expressing a low copy 
number of the receptor, although still binding targeted 
liposomes, no longer exhibit sensitivity to the liposomes. 
Conclusion 
MSH can be modified and bound to a liposome without 
significantly altering its biological activity, and the 
resulting liposome expresses an affinity for the receptor 
greater than that of the free hormone. The liposomes can be 
specifically bound to cells expressing a receptor for the 
hormone, however the number of liposomes thus bound is 
small. Liposomes targeted to the cells do not appear to be 
able to promote the intracellular delivery of their contents 
to a level greater than that of non-specifically bound 
liposomes, however the reasons for this are not clear. 
At this stage it was decided to investigate whether the MSH 
receptor on Bl6 cells was able to promote the 
internalisation of non-liposomal structures, to shed light 
on whether the failure to achieve specific toxicity was a 








Since MSH targeting of liposomes resulted in specific 
binding of the liposomes, albeit at a low level, yet no 
specific toxicity, it remained to be ascertained whether the 
MSH receptor on B16 cells was able to function as a receptor 
for internalising other targeted carriers, and hence whether 
the failure of the MSH targeted liposomes to deliver their 
contents to the cytoplasm was a function of the liposome 
characteristics rather than of the receptor. To investigate 
this, a hybrid toxin was constructed by conjugating the 
highly toxic A-chain of ricin (RTA) to the thiolated MSH, 
and testing the conjugate for cell-specific toxicity. 
Introduction 
Selective toxicity by specifically targeting drugs into 
cells is hampered by the high intracellular concentration of 
the drugs required to elicit an effect. In an attempt to 
overcome this problem many researchers have been 
investigating the targeting of toxic enzymes into the cell, 
where by nature of their enzymatic activity, only one or two 
molecules of the toxin should be sufficient to mediate a 
cytotoxic effect. A major advantage of using toxins over 
drugs is that unlike small drugs such as MTX, toxic enzymes 
are unable to enter the cells by themselves, and as such, 
have a very low toxicity unless associated with an agent 
which promotes their uptake. Any effective targeting is 
hence easily observed above the background toxicity. 
The two toxins most widely investigated for this purpose 
have been ricin, a highly potent toxin isolated from the 
castor bean Rici nus communis, and Diptheria toxin, a toxin 
secreted by the pathogen Corynebacterium diptheriae. 
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Both of these toxins are comprised of two subunits ; 
An enzymatically active component, the A-chain, which by 
itself exhibits very little toxicity towards whole cells, 
being unable to gain entry into the cell, yet is highly 
toxic in cell-free toxicity assays, inactivating the protein 
biosynthetic machinery. In the case of ricin, by cleaving 
the N-glycosidic bond of A4324 of the 28S rRNA in a 
hydrolytic fashion (Endo and Tsurig 1987), and in the case 
of diptheria toxin by ADP-ribosylation of elongation factor 
2 (Pappenheimer 1977). 
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A binding component, with specificity for cell surface 
receptors, is thought to be responsible for mediating the 
internalisation of the A-chain. In the case of ricin the B-
chain is a lectin, exhibiting specificity for terminal non-
reducing sugars, and hence delivery of the A-chain can be 
inhibited by the presence of lactose or galactose. The B-
chain exhibits no enzymatic activity and is not toxic. 
The concept behind the chimaeric toxin constructs is that 
replacing the B-chain with a ligand specific for a cell 
surface determinant will target the otherwise ineffective A-
chain to the cell, and, hopefully promote its 
internalisation and hence mediate a specific toxicity. A 
large variety of such chimaeras have been investigated and 
it has been found that simply targeting the toxin to a cell 
does not necessarily result in toxicity. 
A variety of monoclonal antibodies, with specificity for 
different antigens, have been compared for their efficacy in 
mediating RTA-antibody conjugate toxicity (Preijers et al. 
1988). Large differences in cytotoxicity were found, 
correlating significantly with the degree of internalisation 
of the the antibody. This was found to be a function of the 
nature of the antigen, and not the magnitude of its surface 
expression. Hence some immunotoxins which bound to a large 
r 
extent were less toxic than other irrununotoxins which had 
fewer conjugates bound per cell, but to an antigen that 
promoted the internalisation of the conjugate. 
A comparison of two antibodies for the same antigen, but 
with differing affinities (Youle and Neville 1982) 
demonstrates that antibody affinity as well as number of 
available sites affects the rate of entry of the A-chain 
into the cell. By analysis of the kinetics of toxicity of 
RTA irrununotoxins in the presence and absence of ricin B-
chain, these authors further demonstrate that the ricin B-
chain significantly enhances the cytosolic delivery of the 
A-chain, even if it was not responsible for the cell-surface 
binding of the A-chain. That this potentiation of the 
internalisation does not require the galactose-binding site 
of the B-chain nor its non-covalent association with the A-
chain has been demonstrated by denaturation of the B-chain 
(Vitetta 1986, Wawrzynczak et al. 1988), however the 
mechanism by which it achieves this remains unclear. 
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Conjugation to hormones has also been achieved. The 
diptheria toxin A-chain (DTA) linked to human chorionic 
gonadotropin has been shown to be specifically toxic towards 
cells bearing receptors for this hormone, yet not toxic to 
cells lacking the receptor (Oeltmann 1985), demonstrating 
that the hCG receptor internalises the chimaera via a 
pathway that allows access of the toxin to the cytosol. DTA 
linked to EGF is however non-toxic to cells expressing EGF 
receptors even though binding of the conjugate to the cells 
occurs(Cawley et al. 1980), In contrast to this RTA-EGF 
conjugates were found to be highly toxic to the cells, 
demonstrating that internalisation and subsequent toxicity 
is also dependant on the toxin. The reason for the 
difference between these two conjugates is not clear, but 
could be due to the ability of RTA to associate with 
membranes by itself, or due to an ability to escape from the 
- ---~-~------~ ----------------------------
endocytotic pathway into the cytosol. That Chloroquine is 
able to potentiate the toxicity of the RTA-EGF conjugate 
suggests that the toxin is internalised in endocytotic 
vesicles. 
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Simply binding the toxic component to the cell surface via 
the non-specific interaction of avidin with cell membranes 
has been shown to allow significantly increased binding, but 
no increase in the toxicity of biotinylated Diptheria toxin 
towards cells, indicating the requirement of specific 
receptors for translocation of toxins into the cytosol 
(Stenmark et al. 1988). 
All of these conjugates discussed have been prepared 
synthetically, making use of the single exposed sulphydryl 
moeity on the toxin fragments to form a disulphide linkage 
to the ligands. The genetic construction and expression in 
E.coli of a fusion protein comprising diptheria toxin and 
MSH has been described (Murphy et al. 1986). The fusion gene 
directs the expression of a diptheria toxin related MSH 
hybrid protein in which the toxin receptor binding domain 
has been replaced with MSH sequences. The resulting protein 
was shown to be toxic towards melanoma cells yet not toxic 
towards cells lacking the MSH receptor. Toxicity can be 
calculated from the figures they quote as being in the order 
of 0.03-0.06 nM. This data suggests that in this cell line 
(NEL-Ml) the MSH receptor promotes internalisation of a MSH 
targeted carrier. That NH4Cl abolishes the cytotoxic 
activity shows that the internalised protein passes through 
an acidic vesicle, suggesting that the MSH receptor promotes 
internalisation through an endocytotic pathway. (Unlike 
ricin which becomes more toxic in the presence of 
lysosomotropic agents, diptheria toxin toxicity is inhibited 




It was felt that the construction of a RTA-MSH conjugate 
using the sulphydryl of the MSH-SH to couple to the 
sulphydryl of the RTA, and the analysis of the constructs 
toxicity on B16 melanoma cells, would provide some insight 
into the use of the MSH receptor for targeting to these 
cells. 
Conjugation 
The protocol for conjugating thiolated MSH to RTA was 
adopted from the method of Youle and Neville (1982). The 
thiol on the MSH-SH ( with tracer 125 I-MSH-SH )was reacted 
with 5,5'-dithiobis-(2-nitro benzoic acid) (DTNB), and 
following separation on HPLC, conjugated to freshly reduced 
RTA. 
The peptide was incubated with the toxin at a 1.5 fold molar 
excess. Hence after dialysis if 100% conjugation had 
occurred one would expect 66% of the added radioactivity to 
remain associated with the toxin. Of the 4 X 10 6 DPM added, 
only 2.1 X 10 6 remained bound to the toxin, indicating that 
considerable (75 %) conjugation had taken place, although 
the conjugation was not quantitative. 
To confirm that the associated radioactivity represented 
covalently bound peptide an aliquot of the conjugate was 
treated with 50 mM OTT for 2 hours and then dialysed against 
PBS. Virtually quantitative release of the radioactivity 
into the dialysate was achieved indicating the conjugation 





Three quality control checks are required on newly 
synthesised toxin conjugates (Cumber et al. 1985) . 
1) Inhibition of protein biosynthesis in a cell free system 
to ensure that the A-chain retains enzymatic activity. 
2) Antigen binding capacity, or in this case, recognition of 
the hormone by assaying biological activity of the 
conjugate, and the binding specificity of the labeled 
conjugate to cells bearing the receptor. 
3) Cytotoxicity, in this case the toxicity of the conjugate 
to melanoma cells compared with the toxicity of the free A-
chain. 
Inhibition of protein biosynthesis 
After incubation with 50 mM OTT for 1 hr the released A-
chain was assayed for its ability to inhibit protein 
biosynthesis in the rabbit reticulocyte lysate assay as 
described in methods. Pure A-chain was assayed as a 
comparison. To ensure that they were being tested at the 
same concentration, the concentrations of the conjugate and 
A-chain were checked by monitoring absorbance at 280 nm. The 
results of the protein biosynthesis inhibition are shown in 
fig 5.1. 
The A-chain released from the conjugate had an IC5o of 
approximately 15 to 20 ng/ml, compared with the IC5o of 10 
ng/ml for the pure A-chain. This represents a slight 
decrease in the toxicity of the A-chain, possibly due to 
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Fig 5.1 : Inhibition of protein biosynthesis in a cell free 
system by RTA and RTA-MSH. The toxins were reduced for 1 hr 
in 50 mM OTT before being incubated at increasing 
concentrations with a rabbit reticulocyte lysate assay. 
Trichloracetic acid precipitable material was determined for 
each incubation after 10, 30 and 60 minutes, and velocity 
(DPM/min) determined from the linear region of DPM vs. Time. 
The results are expressed as a percentage of the velocity of 
the control (no toxin). Two aliquots were counted for each 
time point, and the experiment was performed twice and the 







of the dilutions used for the assay, and the potency of the 
toxin, it was felt that this decrease in toxicity was not 
serious. 
Biological activity 
In order for the conjugate to bind to the cell specifically 
it must be recognised by the receptor. To determine whether 
the RTA-MSH conjugate was recognised by the MSH receptor, 
the ability of the conjugate to stimulate adenylate cyclase 
was assayed, and compared to that of native MSH. The results 
(fig 5.2) indicate that the conjugate has only 15 to 20 % of 
the adenylate cyclase stimulating activity that the free 
hormone has. This activity is lower than expected 
considering that the carboxymethyl derivative exhibited at 
least 50% activity, and the structure in the vicinity of the 
hormone is the same for both constructs. Several possible 
reasons exist which may account for the lower biological 
activity; 
1) Association of the MSH with hydrophobic domains of the 
RTA, decreasing its accesability to the receptor. 
2) Association of the RTA with the cell membrane once 
brought into the vicinity of the membrane by the MSH, 
decreasing the accesability of the MSH to the receptor. 
As pointed out previously it is possible for hormone 
conjugates to interact fully with the receptor and yet 
exhibit no, or diminished hormonal biological effect because 
of an interaction of the molecule attached to the hormone 
with the pathway required for the biological effect to be 
elicited. Hence it is also possible that in this case there 
has been an interaction of the RTA with a component of the 
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Fig 5.2: Adenylate cyclase activation by MSH and by MSH-RTA 
conjugate. Bl6 cells were exposed to increasing 
concentrations of the hormone or hormone conjugate for 30 
minutes and the intracellular cAMP analysed as described in 
methods. Data points are average of triplicates. 
' ' 
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Irrespective of which cause is responsible for the lower 
biological activity, that the conjugate exhibits biological 
activity suggests that it interacts with the receptor, and 
hence should target the toxin to the cell. This is best 
tested by monitoring the binding. 
Binding 
An aliquot of RTA-MSH was made fluorescent by treatment with 
FITC as described in methods. Incubation of the FITC-RTA-MSH 
conjugate with cells at 37 degrees for 3 hours resulted in 
approximately 30% of the cells aquiring fluorescence (see 
fig 5.3). That only a fraction of the cells aquire 
fluorescence is due probably to the cell-cycle-phase 
dependant expression of the MSH receptor, and hence binding 
of the fluorescent conjugate. The fluorescence appears to be 
fairly diffuse, suggesting that there may have been 
internalisation of the complex, although at the edges of the 
cells discreet punctate fluorescence is evident, indicative 
of compartmentalisation of the fluorescence, possibly in 
endocytotic vesicles. The fluorescence does not cover the 
cells evenly, being associated mainly with the cell body, 
and very little on the dendritic protrusions, a possible 
consequence of the distribution of the receptor. 
To confirm that the uptake of fluorescence was due to the 
MSH an aliquot of the conjugate was treated with 50 mM DTT 
for 2 hrs prior to incubation with the cells. No significant 
fluorescence was seen to be associated with the cells 
(results not shown), although it was observed that after 3 
hrs incubation there was a very low level of fluorescence 
associated with all of the cells, indicative of non-specific 
binding. 
This result shows that MSH-mediated binding of the complex 
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Fig 5.3: Fluorescence microscopy of MSH-RTA-FITC conjugates. 
B16 cells in mid-log-phase growing on glass cover slips were 
incubated with 10-s M MSH-RTA-FITC for 3 hours at 37°C in 
PBS/Ca/Mg and then washed in PBS. Photography was performed 
by illuminating the cells with UV light only for 60 seconds 
and then illuminating with visible light for 10 seconds 
permitting non-fluorescent cells to be detected. Arrow A 
points to a fluorecent cell, arrow B to a non-fluorescent 





incubation appears to be much greater than the non-specific 
binding. Hence it is possible that the complex will exhibit 
specific receptor mediated toxicity. 
Cytotoxicity 
Ricin, ricin A-chain, and RTA-MSH were added to melanoma 
cells in complete medium with serum, and incubated for 48 
hours at which time the cells were analysed for protein 
biosynthesis as described in methods. 
Fig 5.4 shows ricin to be the most toxic of the compunds 
tested, with an ID5o of 20 ng. The addition of lactose 
protects the cells to a large extent from the ricin 
toxicity, raising the ID5o to 800 ng/ml. The ricin A chain 
is much less toxic, having an ID5o of 10 µg/ml. That there 
is no protection of toxicity due to RTA by lactose shows 
that the RTA is not contaminated with any ricin, and hence 
the toxicity is due to a non-specific binding and 
internalisation. The RTA-MSH conjugate expresses a virtually 
negligible increase in toxicity towards the melanoma cells, 
with an !050 of 5 µg/ml, however some of this toxicity is 
inhibitable by the addition of 6 µM MSH (10 µg/ml) 
decreasing the toxicity of the hybrid to an ID5o of 
approximately 20 µg/ml. 
That the toxicity of the conjugate can be inhibited by the 
addition of free hormone (added at a 40 fold molar excess at 
the ID5o concentration) shows that some of the toxicity of 
the conjugate is indeed due to a specific receptor 
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Fig 5.4: Inhibition of protein synthesis in B16 cells after 
exposure to ricin or ricin-A-chain hybrids for 48 hours. 
10 4 cells in 0.1 ml were exposed to increasing 
concentrations of ricin, ricin + 50 mM lactose, ricin-A-
chain, ricin-A-chain + 50 mM lactose, RTA-MSH, RTA-MSH + 6 
µM MSH. Protein biosynthesis was assayed after 48 hours as 
described in methods. Data points are average of duplicates 
for ricin and ricin+lactose, and of quadruplicates for other 
data points. Where variance bars are not shown it is to 
prevent cluttering of the diagram, and variance is similar 





to non-specific binding. The fact that the conjugate in the 
presence of free hormone is half as toxic as the A-chain 
alone correlates well with the finding that the conjugated 
A-chain is only half as toxic in the cell-free protein 
biosynthesis assay. Since the toxicity of the A-chain has 
been decreased, the real increase in toxicity due to 
conjugation is in the order of four fold. 
A four fold increase in toxicity is negligible considering 
the potent increases in toxicity which have been obtained 
using toxin-antibody conjugates by other authors. At the 
IDso the concentration of conjugate is 1.5 X lQ- 7 M, at 
least ten fold greater than the expected Ko of the conjugate 
even allowing for the 85% decrease in biological activity, 
and hence the receptors should be significantly occupied 
even at ten fold lower concentrations. From this one can 
assume that specific binding is taking place even at lower 
concentrations, but that the internalisation of the 
conjugates A-chain into the cytoplasm is limiting. Several 
factors could cause this : 
1) Specific binding to the receptor is occurring, but the 
receptor does not promote endocytosis. 
2) Specific endocytosis of the conjugate is taking place but 
the conjugate is unable to gain access to the cytoplasm, 
either due to rapid degradation in the lysosomes, or an 
inability to cross the lysosomal membrane. 
3) The low copy number of receptor, coupled with the phase 
dependant expression of the receptor result in a very low 
and slow uptake of the conjugate, possibly further 
complicated by the degradation of the conjugate in the 
medium, due both to proteolytic degradation of the hormone 







To determine to what extent the last possibility could be 
responsible, an aliquot of the conjugate was incubated with 
cells and full medium for 48 hours and then dialysed. 84% of 
the radioactivity was retained by the dialysis membrane, 
showing that some degradation of the conjugate had occurred, 
but not enough to account for the lack of specificity. 
Considering the first two possibilities, if endocytosis of 
the conjugate is occurring, then the addition to the 
incubation medium of a substance which affects the 
endocytotic pathway will elicit a change in the toxicity of 
the conjugate. 
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Lysosomotropic agents such as NH4Cl, chloroquin, monnensin 
and the carboxylic ionophore Br-X-537A, are known to alter 
the toxicity of toxic proteins such as abrin, ricin and 
diptheria toxin (Sandvig and Olsnes 1982) by altering either 
the pH of the lysosomes, or perturbing the vesicular traffic 
(Tartakoff 1983), and in the case of ricin, this results in 
an increased toxicity. Since the A-chain of ricin is thought 
to enter the cytoplasm from the trans-Golgi-network (van 
Deurs et al. 1988), it is likely that anything affecting the 
quantity of ricin-A-chain conjugate reaching this organelle 
will affect the efficacy of the toxin. 
To investigate the effect of a lysosomotropic agent on the 
toxicity of RTA-MSH conjugates, cells were incubated with 
either~~cin-A-chain or the conjugate in the presence and 
absence of 5 rnM NH4Cl, and the toxicity assayed. 
As is shown in fig 5.5, when NH4Cl is present the conjugate 
exhibits an ID5o of 0.2 µg/ml, a twenty fold increase in 
toxicity compared to incubation in the absence of NH4Cl. The 
ricin-A-chain on the other hand does not exhibit any change 
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Fig 5.5: Effect of NH4Cl on the toxicity of RTA and RTA-MSH 
towards Bl6 cells. Cells were incubated as for fig 5.4, 
except that the incubation was performed in the presence or 
absence of 5 mM NH4Cl. Data points are average of 
quadruplicates. 
the conjugate exhibits 50% less toxicity than the native A-
chain, this represents a net 80 fold increase in toxicity of 
the conjugate compared to RTA, The effective concentration 
of MSH at the LDso of 0.2 µg/ml conjugate is 6.4 X lQ- 9 M, 
slightly higher than that of native MSH, but lower than that 
of the RTA-MSH as anticipated from the biological activity 
assay. 
This indicates that the MSH effectively targets the A-chain 
to the cell, and promotes its uptake into the cell, however 
the uptake is by an endocytotic pathway from which the A-
chain is not readily able to escape into the cytosol. The 
addition of the lysosomotropic agent to the incubation 
medium alters the receptor-mediated endocytotic mechanism in 
some way, perhaps by raising the pH of the lysosomes, and 
facilitates the cytoplasmic release of intact A-chain. This 
is similar to the observed requirement for carboxylic 
ionophores to be present in order for anti-transferin 
receptor linked conjugates to be toxic (Raso et al. 1988), 
an effect thought to be due to either redirection of the 
intracellular distribution of the endocytosed conjugates, or 
due to facilitation of translocation of molecules through 
the vesicle membranes. 
The toxicity of the A-chain alone is however unaffected by 
NH4Cl, suggesting that it enters via a route from which it 
gains ~ady access to the cytosol. The entry of the A-chain 
into the cell is probably achieved by non-specific 
endocytosis, and hence the disparity of response to a 
lysosomotropic agent suggests that MSH-mediated endocytosis 
follows a different path to that of non-specific 
endocytosis. A close association of the MSH receptor with 
the Golgi complex has been demonstrated, and it has been 
suggested that receptor recycling occurs in this body (Varga 
et al 1976). Since A-chain entry to the cytoplasm is thought 
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to occur in the trans-Golgi-network (van Deurs et al. 1988), 
the recycling route may prevent normal access of the 
conjugate to the trans-Golgi-network hence limiting its 
toxicity. Raising the lysosomal pH may then permit escape to 
the cytoplasm at a site distinct from the Golgi apparatus. 
Contrasting these results are the observation that 
lysosomotropic agents (NH4Cl, chloroquine, methylamine) 
inhibit the specific toxicity of MSH-Daunomycin conjugates 
(Varga 1985), possibly because enzymatic cleavage of this 
complex is required for interaction of the daunomycin with 
DNA, and the enzymes responsible are less effective at the 
higher pH induced by the lysosomotropic agents. The ricin-A-
chain conjugate on the other hand does not require such 
enzymes and probably escapes most readily from vesicles with 
a higher pH and less proteolytic activity. 
The concentration of MSH-daunomycin conjugate required to 
mediate 50% killing of the cells was approximately 3 X lQ- 7 
M (Varga et al. 1977), two orders of magnitude greater than 
the Ko of the hormone. In the case of the RTA-MSH conjugate 
however, the equivalent toxicity is achieved at a 
concentration of only 6.4 X lQ- 9 M, a consequence of using 
a potent enzyme toxin rather than a drug. The MSH-diptheria 
toxin conjugate prepared by Murphy et al. (1986) exhibits a 
Ko in the region of 6 X 10-ii M, two orders of magnitude 
lower than the toxicity of my MSH-RTA, possibly due to the 
higher"'bi.ological activity of the genetically constructed 
toxin, and a greater ease of exit into the cytoplasm by the 
toxin component. 
Conclusion 
MSH thiolated at Lysii and conjugated to ricin-A-chain 
through a disulphide bond is able to promote the binding of 
the ricin-A-chain to B16 cells via the MSH receptor and to 
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promote its internalisation. The internalisation however 
follows a route not amenable to the translocation of the 
toxin into the cytoplasm. The addition of a lysosomotropic 
agent increases the ability of the toxin to escape into the 
cytoplasm, resulting in an 80 fold increase in toxicity of 
the conjugate compared with that of the untargeted A-chain. 
Since MSH is able to promote the internalisation and 
subsequent toxicity of the ricin-A-chain, it is apparent 
that MSH does mediate endocytosis at the receptor, and hence 
its failure to achieve the parallel for methotrexate-
containing liposomes needs to be reexamined. 
Several explanations exist at this stage; 
1) Internalisation of the bound liposomes is taking place, 
but the methotrexate is unable to gain access to the 
cytosol. This is unlikely because the influence of NH4Cl on 
the toxicity of RTA-MSH suggests that an acidic vesicle is 
encountered during internalisation, and published reports on 
the effect of NH4Cl on liposomally delivered methotrexate 
all point towards the requirement for an acidic environment 
for methotrexate delivery (Machy et al. 1982, Heath et al. 
1983, Huang et al. 1983). 
2) Internalisation and delivery are taking place, however, 
becausS--of the low number of liposomes bound to the cell, 
the quantity of drug delivered is so low that it is not 
discernible above the background non-specific 
internalisation. This is possible, and made more probable by 
the cell-cycle dependant expression of the receptor which 
permits receptor-mediated internalisation to occur for only 
a fraction of the cell-cycle. If the cell experiences 
internalisation only during the G2 phase of the cell cycle, 
it may be able to overcome the THFR inhibition in the S- and 
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Gl phases. The non-specific binding however is not dependant 
on the cell-cycle and hence may become relatively more 
toxic. 
3) No internalisation of specifically bound liposomes is 
taking place because the liposomes are either too large for 
internalisation via the receptor, or perhaps only some of 
the receptors mediate endocytosis, and the number of 
internalised liposomes is too low to be discernible. 
At this stage it was considered that it would be convenient 
to have an alternative ligand by which to target liposomes, 
one which definitely did promote the binding and uptake of 
liposomes into cells, and which was not subject to the 
problems of cell cycle dependant expression nor a variable 
cell line. It was hoped that such a ligand would permit the 
elucidation of how many liposomes per cell were required for 
toxicity, and hence provide more insight into the parameters 
affecting liposomal delivery, and the apparent absence of 
MSH-mediated liposome delivery. 
The ligand chosen for this purpose was the ricin-B-chain 
(RTB), chosen because it appears able to significantly 
promote the cellular internalisation of molecules bound to 
it (discussed in next chapter), interacts with galactosyl 
residues on cells and hence should be able to target to most 
cell types, has an exposed sulphydryl moeity making it 
convenient to attach to liposornes, and, after preparing the 
ricin-A-chain, I had a lot of the material available. 
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Chapter 6 
RICIN-B-CHAIN TARGETING OF LIPOSOMES 
The wide variety of lectins available, and their 
specificities for sugars, make them an interesting 
alternative to either antibodies or hormones. All cells 
exhibit glycoproteins on their cell surface, yet different 
cells frequently exhibit different sugars on the 
glycoproteins, a difference that could be exploited by 
lectin targeting. 
A variety of lectins have been used to target either drugs 
or liposomes to cells. Wheat germ agglutinin, Phaseolus 
vulgarus phytohaemagglutinin and ricin agglutinin have been 
used to promote the attachment of sialoglycoprotein bearing 
liposomes to erythrocytes (Juliano and Stamp 1976) by first 
incubating the cells with the lectin, and then adding 
glycoprotein-bearing liposomes. No investigation of uptake 
of the liposomes was performed, however the ability of the 
free hapten sugar to release bound liposomes suggests that 
wheat germ agglutinin and phytohaemagglutinin promote 
internalisation, whereas ricin agglutinin does not. 
Liposomes have also been targeted to cells using 
concanavalin A (Con A) or Phaseolus vulgarus 
phytohaemagglutinin (Salame and Patel 1986), however most of 
the lectin-bound liposomes could be removed by treatment 
with trypsin, indicating that internalisation of the 
liposomes had not been promoted by the lectin. It must be 
noted however that in these experiments the liposomes used 
were multilammelar vesicles, and no selection for size was 









Wheat germ agglutinin linked to SUV via a thioether linkage 
has been shown to promote the binding of liposomes to a 
glycophorin model surface, and the targeting efficiency 
dependant on the degree of coupling of the lectin to the 
liposomes (Hutchinson and Jones 1988), however, as in the 
above experiments, no functional delivery of liposomal 
contents to cells was demonstrated. 
Daunomycin has been directly linked to Con-A and targeted 
to tumour cells in vivo. Significant increase in survival 
time demonstrates successful targeting towards the tumour 
(Kitao and Hattori 1977), and suggests that lectins may be 
useable as agents for promoting the uptake of other bound 
molecules or carriers. 
The B-chain of the ricin toxin (RTB) is a lectin with a 
specificity for galactosyl residues, however apart from its 
lectin properties it appears to be able to significantly 
promote the internalisation of surface-bound ricin-A chain, 
and this ability is independent of its lectin property 
(Youle et al. 1982, Vitetta et al. 1983, Wawrzynczak et al. 
1988). Ricin-B-chain has been conjugated to Insulin, and 
shown to promote the internalisation and a biological effect 
of insulin on cells which lack the insulin receptor (Hofmann 
et al. 1983), demonstrating apparent intracellular 
recognition of Insulin, and also the ability of RTB to 
promote the uptake of bound molecules. This experiment does 
not pr""'9 that the B-chain promoted cytosolic delivery, but 
does suggest that there was internalisation. Biological 
effect could be mediated from within the lysosome, or by a 
cleavage product leaking out of the lysosome. 
Precisely what property of the B-chain it is that promotes 
the internalisation of the A-chain is not known. The B-chain 
has been shown to insert into membranes in the absence of 





1974 ) . Photolabelling experiments demonstrate that B-chain 
is able to insert into membranes with glycoprotein, but that 
binding of the B-chain to the glycoprotein significantly 
enhances its insertion (Ishida et al. 1983). This data 
suggests that there is a hydrophobic domain on the B-chain 
that might be responsible for promoting uptake, however the 
above experiments also demonstrate that the A-chain is also 
able to insert into membranes, and since the A-chain alone 
or conjugated to an antibody is less toxic than whole ricin, 
membrane insertion alone is insufficient for promoting 
cytosolic delivery. An alternative hypothesis is that the 
oligosacharide moeity of the B-chain is recognised by 
sacharide binding receptors on the cell, and that this 
determines the toxicity (Wawrzynczak et al. 1988). 
Since most cells are likely to express galactosyl residues 
on their surfaces it is likely that RTB will be able to 
target a carrier to most cell lines, and further, since it 
appears to promote the internalisation of protein molecules 
attached to it, it may be able to function as a ligand by 
which to mediate the delivery of liposomal contents into 
most cells, and hence function as a model by which to 
compare other targeting systems. 
RTB purification and characterisation 
RTB wali't~repared by reduction of pure ricin (see methods) 
with OTT and affinity chromatography on Sepharose 4B. The 
absence of contaminating whole ricin was confirmed by the 
lack of toxicity of the RTB on Hepatoma cells on which an 
LDso of greater than 1 mg/ml was obtained. 
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Binding of RTB to liposomes 
The finding by Utsumi et al. (1984) that the 
carboxymethylated B-chain from ricin bound to phospholipid 
vesicles with a fairly high affinity (Ka= 14.5 X 10 5 M-i 
for DPPC vesicles) led me to try to use this affinity of the 
B-chain for bilayers to bind RTB directly to liposomes. 
i 25 I-B-chain or iodinated carboxymethyl B-chain (prepared as 
described in methods) were incubated at 2 mg/ml with 
liposomes (phosphatidylcholine /cholesterol/ dicetyl 
phosphate 47.5:50:2.5 mol% ,10 µmol/ml) at 20 °C for 30 
minutes. Liposomes were then separated from unbound protein 
by discontinuous density gradient centrifugation in Ficoll, 
and liposome-bound protein determined by counting the 
radioactivity. 
Under these conditions approximately 5% of the radioactivity 
for both the native and carboxymethylated B-chains remained 
associated with the liposomes, representing 10 µg of protein 
bound per µmol lipid, significantly less than that expected 
from the data in the publication by Utsumi et al. although 
still representing approximately 160 lectin molecules bound 
per liposome. 
Before such non-specifically bound ligand can be used for 
targeting, it is necessary to determine the stability of the 
associa1:ion of the ligand and liposome. For this purpose the 
liposomes prepared and purified as above were incubated in 
1.0 ml 0.1 mg/ml bovine serum albumin in PBS at 25°C for 2 
hours and then repurifying the liposomes by gradient density 
centrifugation. Less than 10% of the initially associated 
radioactivi.ty remained associated with the liposomes, 
indicating that significant dissociation of the bound lectin 
had taken place, and hence that this procedure was of no use 
in preparing targeted liposomes. 
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To overcome the problems of dissociatable non-specific 
binding of RTB to the liposomes I utilised the available 
sulphydryl of the B-chain to covalently bind the protein to 
liposomes through a thioether bond by the method of Martin 
and Papahadjopopoulos (1982) using the sulphydryl reactive 
phospholipid derivative N-[4-(p-maleimidophenyl) butyryl] 
phosphatidylethanolamine (MPB-PE). This reagent was used in 
preference to N-[3-(2-pyridyldithio)propionyl] 
phosphatidylethanolamine because the resulting thioether 
linkage is resistant to reduction and is hence likely to be 
more stable in serum than the disulphide link obtained using 
PDP-PE, and definitely more stable than using hydrophobic 
non-specific association. 
Freshly reduced and dialysed RTB was incubated with 
liposomes (EYPC / Chol I DCP I MBP-PE, 9.5:10:0.25:0.25 
mol%) containing 100 rnM calcein for 8 hours at room 
temperature and unbound protein separated from the liposomes 
by gradient density centrifugation. Bound protein was 
quantitated by radioactivity measurement. 
Increasing the initial concentration of RTB resulted in 
greater amounts of RTB becoming bound to the liposomes (fig 
6.1). This shows a roughly linear relntionship between 
initial concentration and the amount bound, however at high 
concenn=ation of RTB (above 2 mg/ml) the vesicles tended to 
aggregate and separation of unbound protein on ficoll 
gradients became difficult. Using an RTB concentration of 1 
mg/ml 270 µg of protein became bound to the liposomes 
representing 27% efficiency of binding and resulting in 
approximately 450 molecules becoming bound per vesicle. 
Since other researchers have observed that RTB is able to 
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Fig 6.1: Binding of iodinated Ricin-B-chain to liposomes. 
Increasing quantities of freshly reduced iodinated RTB were 
added to freshly prepared liposomes and incubated for 8 
hours at 25°C. Liposomes were separated from unbound protein 
by Ficoll gradient density centrifugation, and the amount of 
bound protein determined by counting the radioactivity. 
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release of encapsulated contents (Utsumi e al. 1984), and 
also to promote the fusion of SUV (Utsumi et al. 1989), it 
was neccesary to determine whether the covalent linkage of 
RTB to the liposomes had altered their integrity in any way. 
Liposomes containing 100 mM calcein, with RTB bound, or as a 
control, without RTB bound, were incubated in either PBS or 
PBS with 10% fetal calf serum and the leakage after 24 hours 
determined by fluorescence. The results in table 6.1 
demonstrate that there is no significant increase in the 
rate of leakage, implying that the RTB does not 
significantly perturb liquid crysteline membranes. These 
results are partially in conflict with those of Utsumi et 
al. (1984, 1989), however these authors used small 
unilammelar vesicles composed of DPPC, which is in a gel 
state at the temperature of incubation with the RTB, and 
monitored changes induced at the phase transition which are 
likely to be highly sensitive to contaminants within the 
membrane and also to curvature and torsional stress on the 
membrane. The liposomes I used were in a liquid-crysteline 
state at all times, and the membranes were not stressed. 
% Leakage 
PBS PBS+FCS 
Lip 4.0 18.0 
Lip-RTB s.o 20.0 
-
Table 6.1 : % efflux of calcein over a 24 hour period from 
liposomes with or without MSH bound to the surface in PBS 
with or without 10% fetal calf serum. 10 nmoles lipid was 
incubated in 1.0 ml buffer or buffer with FCS. Fluorescence 
after 24 hours was compared to fluorescence after adding 10 
·µl of 10% Triton X-100 which lysed the liposomes and 
resulted in 100% leakage. 
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Thus RTB has been covalently bound to liposomes without 
significant perturbation of the bilayer structure. It 
remained to be ascertained whether the galactose binding 
property remained intact and was able to mediate the binding 
of liposomes to cells. 
Binding to cells 
To determine the interaction of RTB targeted liposomes with 
cells, Hepatoma cells were used instead of Melanoma cells. 
The reasoning behind this was that the Bl6 melanoma line 
used for the previous experiments appeared to be polyclonal 
and also abnormally resistant to methotrexate. It was felt 
that interpretation of the results of liposome targeting 
towards hepatoma cells, which I knew from earlier 
experiments to be highly sensitive to both methotrexate and 
ricin, would be less subject to variables within the cell 
line. 
Incubating increasing quantities of fluorescent targeted 
liposomes, and, as controls, untargeted liposomes, and 
targeted liposomes in the presence of 10 mM lactose which 
should compete with the galactosyl residues for the lectin 
binding site, with hepatoma cells in suspension, resulted in 
significantly increased binding of targeted liposomes 
compared to that of the controls (fig 6.2). 
-· 
The number of targeted liposomes binding to the cells 
reaches a plateau of 11000 liposomes per cell at a 
phospholipid concentration of 100 µM. Untargeted liposomes 
at the same concentration bind ·only 90 liposomes per cell, 
hardly noticeable on the graph, hence the ricin-B-chain 
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Fig 6.2: Binding of calcein containing RTB targeted 
liposomes to Hepatoma cells in suspension. 2.5 X 10 5 cells 
in 1.0 ml PBS were incubated with increasing concentrations 
of either RTE-targeted liposomes, RTE-targeted liposomes in 
the presence of 10 mM lactose, or untargeted liposomes. 
Incubations were performed at 4°C for 1 hour after which the 
cells were washed three times in PBS, lysed with 1% triton 
X-100, and fluorescence determined. The cells had been 
released from monolayer growth with EDTA only, as trypsin 
might decrease·the total surface glycoprotein and hence the 
number of RTB binding sites. Data points are average of 
triplicate. Variation betwen experiments performed on 
different days was within the variation shown on the graph. 
Not all of the increase is due to the galactose binding 
properties of the lectin, as demonstrated by the binding of 
RTE-targeted liposomes in the presence of lactose. This 
sugar is able to compete for the galactose binding site on 
ricin, and hence the binding of 1000 liposomes per cell at 
100 µM lipid in the presence of lactose indicates that 10% 
of the RTE-mediated binding is due to an alternative 
association of the ricin-B-chain with the cells. This is 
similar to the inability of lactose to .completely abolish 
the binding of ricin or RTE to Newcastle Disease Virus 
membranes (Ishida et al. 1982) and could be due to non-
specific association, or to receptors on the cells 
recognising sacharide chains on the protein, or possibly via 
the weak glucose binding site on RTB (Villafranca and 
Robertus 1981 ). 
Taking the average diameter of the liposomes to be 200 nm, 
and an average cell diameter of 15 µm, and assuming that the 
liposomes pack as solid spheres and do not exhibit 
significant repulsion, one can expect to pack at most 20000 
liposomes on the surface of the cell. The influence of a 
hydration sphere around the vesicle or mutual repulsion will 
rapidly decrease this figure, hence the observed plateau of 
11000 liposomes per cell is likely to be a function of the 
available space, not of receptors. (The number of receptors 
for ricin on Hepatoma cells I calculated to be 2.5 X 10 7 -
see chapter 4). This figure is similar to that obtained by 
Fraley.-e.t al. (1981) who used negatively charged liposomes 
and obtained a binding of approximately 30 nmol lipid/ 5 X 
10 6 cells, which is equivalent to 7000 liposomes per cell. 
RTE mediated binding reaches saturation at a much lower 
concentration of lipid than that reported for negatively 
charged liposomes ( > lrnM lipid Fraley et al. 1981). 
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The maximal level of binding was reached at a concentration 
of liposomes representing 1.2 X 10 11 liposomes present in 
the incubation medium. There were 2.5 X 10 5 cells present 
hence a total of 2% of the added liposomes were bound to the 
cells. This figure is lower than that reported for the 
optimal association of negatively charged liposomes with 
cells (Fraley et al. 1981), however these authors used 20 
times as many cells per incubation, allowing many more 
liposomes to bind, hence a comparison of binding efficiency 
is not really informative. A better comparison is the 
concentration of lipid required to achieve maximal binding. 
For the case of RTE-mediated binding this is achieved at 100 
µM, however the association of negatively charged lipid with 
cells approaches saturation only at concentrations above 1 
mM. The concentration of RTB at 100 µM lipid is 8 X 10-a M, 
approximately the same as Ko of ricin. Since some of the RTB 
is unavailable for interaction with the cells, due to its 
physical orientation on the liposomes, this implies that the 
multimeric association of the ligand that is available for 
interaction is greater than that of the free ligand. 
Fluorescence Microscopy 
To further elucidate the events occurring, fluorescence 
microscopy of targeted liposomes containing 100 mM calcein, 
interacting with Hepatoma cells was performed (fig 6.3). At 
high c"11.centrations of liposomes (fig 6.3B) the binding is 
so extensive that the cell is lost in a haze of 
fluorescence, however when the incubations are performed at 
lower concentrations (fig 6.3A) the fluorescence is seen to 
be associated mainly with the periphery of the cell and 
appears to _be punctate. There is some apparently diffuse 
fluorescence, but whether this is due to delivery of calcein 




Fig 6.3: Fluorescence microscopy of interaction of RTB 
targeted liposomes with hepatoma cells. 2.5 X 10 5 cells in 
suspension in PBS were incubated with either 10 nmoles (A) 
or 100 nmoles (B) targeted liposomes containing 100 mM 
calcein. Bar= 10 µm. 
fluorescence of liposomes out of the field of focus, could 
not be determined from this experiment. 
Scanning electron microscopy 
Scanning electron microscopy was used to give some idea of 
the morphology and. arrangement of bound liposomes on the 
cells. 
Liposomes were first examined on 0.2 µm polycarbonate 
membranes (fig 6.4A) to provide a control of the conditions 
required for fixing and staining the liposomes, as well as 
to size the liposomes and to visualise what non-cell-
associated liposomes resembled. The conditions used for 
fixing and staining are described under methods. Liposomes 
are seen on a polycarbonate membrane as discreet spheres 
with a diameter of 0.2 µm. 
The binding of untargeted liposomes to hepatoma cells is 
shown in fig 6.4B. A few liposomes are discernible, however 
far fewer than in fig 6.4C and 6,4D which show the binding 
of targeted liposomes and demonstrate the very high degree 
of binding achievable by targeted liposomes. The cell 
surface in fig 6.4B is smoother than that in 6.4C in which 
ruffling of the plasma membrane appears to be taking place, 
indicad.ng that the binding of the multimeric lectin 
promotes a change in the cytoskeletal structure, possibly 
associated with an endocytotic mechanism. Similar ruffling 
is observed in other cells in response to glycerol treatment 
(Fraley et al 1981) which is thought to promote endocytosis, 
and hence its presence here may indicate that the ricin-B-
chain liposomes, unlike the control liposomes, not only bind 
to the cell, but also mediate endocytosis. 
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A B 
Fig 6.4: Scanning electron microscopy of liposomes and 
cells. Liposomes associated with either 0.2 µm polycarbonate 
membranes (A) or hepatoma cells growing on glass coverslips 
(B,C,D) were fixed with osmium tetroxide and formaldehyde 
and processed for electron microscopy as described in 
methods. Liposomes were added to cells at 100 nmoles lipid/ 
ml and incubated at 37°C for 1 hour. Untargeted liposomes 
(B), ricin-B-chain targeted liposomes (C,D). 
Some of the liposomes have become long sausage-like 
structures. This is possibly a result of the fixation 
procedure in which adjacent liposomes may become bound to 
one-another. 
The diffuse fluorescence in the fluorescence microscopy, and 
the ruffled surface in scanning electron microscopy suggest 
that there may be internalisation of the liposomes taking 
place. To investigate whether there is an energy dependant 
endocytotic process taking place, the differences in binding 
of targeted liposomes to cells at 4°C and at 37°C were 
investigated. RTE-targeted liposomes were incubated with 
cells at either 4°C or 37°C for 1 hour, and then the ability 




no lactose 11000 (270) 11500 (320) lip/cell 
lactose 2100 (100) 3400 (180) lip/cell 
% lactose resistant 19 29 
Table o.2: Incubation temperature dependence of lactose 
mediated dissociation of ricin-B-chain targeted liposomes 
from hepatoma cells. 2.5 X 10 5 cells in 1.0 ml PBS were 
incubated with 100 nmoles targeted liposomes for 1 hour at 
4°C or 37°C. Aliquots were either washed immediately or 
incubated with 50 rnM lactose in PBS for 10 minutes at 4°C 
and then washed. Cells were then lysed with 1% triton X-100 
and cell associated fluorescence determined. (Standard 
deviation shown in brackets). 
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This demonstrates that incubation at 37°C results in a 
statistically insignificant (500 liposomes per cell) 
increased association of liposomes with cells compared with 
that at 4°C. 
The ability of lactose to remove bound liposomes appears to 
be lower than its ability to inhibit binding. Thus when 
present during the incubation at 4 degrees in the previous 
experiment to determine concentration dependence of binding, 
900 liposomes were bound per cell, however when added after 
incubation, 2100 liposomes remained bound. This difference 
could be due to any or all of the following effects : 
1) Steric hindrance of bound liposomes preventing lactose 
competition for binding. 
2) Increased non-specific interaction as a result of being 
brought into close proximety by the specific interaction. 
3) Uptake, probably by a fusion process since endocytosis is 
unlikely to occur at 4°C, of the bound liposomes into the 
cell. 
The number of liposomes associated with cells following 
lactose treatment after a 37°C incubation is significantly 
greater than after the 4°C incubation. The difference of 
1300 liposomes per cell reflects events occurring at 37°C 
which result in decreased susceptibility to release of 
liposomes that do not occur at 4°C. The most likely event to 
cause tn~s is endocytosis, however it is possible that other 
events such as glycoprotein aggregation are temperature 
dependant processes and may mask the liposome-cell 
interaction site from lactose, decreasing the effectiveness 
of the sugar to compete for the binding. 
The discrepancy between the binding at 4 °C and at 37 °C of 
1300 liposome/cell with lactose treatmentcompared with the 
negligible difference without lactose treatment, reflects 
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simply that not all events that inhibit the release of 
liposomes permit the binding of new liposomes. For example 
inhibition of release due to an active masking process will 
not expose new binding sites. 
This data therefore suggests, though not conclusively, that 
the ricin-B-chain is able to promote the uptake of liposomes 
into the cell, and that the uptake is in the order of 10 to 
20% of the liposomes bound. To confirm that internalisation 
of the liposomal contents was occurring, the ability of RTB 
to promote the internalisation and toxicity of methotrexate 
containing liposomes was investigated. 
Cytotoxicity 
The intracellular delivery of the liposomal contents was 
monitored by measuring the ability of methotrexate, free or 
encapsulated in targeted or control liposomes, to inhibit 
the incorporation of 3 H-thymidine into cells after exposure 
of the cells to the drug for 24 hours. The results are shown 
in fig 6.5, which shows that the free drug exhibits an IDso 
of 60 nM. In contrast to this, the drug when encapsulated in 
untargeted liposomes has an ID5a of 800 nM, which probably 
represents leakage of the drug from the liposomes into the 
medium and the subsequent·entry as free drug into the cell. 
The rate of leakage in medium containing 10% fetal calf 
serum was shown to be 19% over 24 hours, and hence by the 
end of"i:he incubation period the.concentration of free drug 
will be 160 nM, above the ID50, although it will not have 
been at this level the entire time. Targeted liposomes on 
the other hand exhibit an IDsa of 80 nM, marginally less 
toxic than that of the free drug but 10 times greater 
toxicity than that of untargeted liposomes, indicating that 
the ricin-B-chain has been able to promote the intracellular 
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Pig 6.5: Growth inhibition by methotrexate in targeted 
liposomes. 1 mM MTX-containing Liposomes targeted with 
ricin-B-chain or untargeted, or free MTX were incubated at 
the drug concentration shown with hepatoma cells for 24 
hours. 3 H-Thy incorporation into cellular DNA was assayed as 






While the significantly higher toxicity of targeted 
liposomes compared to that of untargeted liposomes is 
suggestive of liposomal internalisation, and this is further 
supported by the fluorescence binding data, the possibility 
that the toxicity is due to leakage of bound liposomes, with 
subsequent high concentration of drug at the cell membrane 
leading to internalisation of the free drug, cannot, at this 
stage, be excluded. This demonstrates the problems of using 
a marker for liposomal delivery which can by itself gain 
access to the cell. 
Because of the possibility of toxicity due to leakage, any 
assessment of how many liposomes have delivered their 
contents to the cytosol is difficult, however assuming that 
an uptake process has occurred, the following arguments 
present themselves: 
At the ID5o of 80 nM for targeted liposomes, the lipid 
concentration is 20 µM. This concentration corresponds to 20 
nmoles/ml, which from fig 6.1 corresponds to 2500 liposomes 
binding to the cell within 1 hour. By fluorescence (table 
6.2) approximately 10% of bound liposomes are internalised 
within 1 hour. Therefore at this concentration approximately 
250 liposomes are taken up into the cell within the first 
hour of incubation. By comparison the calculations presented 
previously indicate that the contents of only 20 to 30 
liposomes need enter the cytosol for toxicity. Even assuming 
that no further binding or uptake occurs after the first 
hour, a discrepancy between these two arguments exists. 
Severar 'explanations exist; 
1) Only 10% of the liposomes internalised release their 
contents to the cytoplasm, the rest are vesicularised. Or, 
2) The calculations for the amount of methotrexate required 
in the cytoplasm are incorrect due to compartmentalisation 
within the .cell, Or, 
3) The assessment by lactose release of bound liposomes is 
overestimating the uptake. 
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In order to demonstrate unequivocally whether or not the 
liposomes deliver their contents directly into the cell, and 
to obtain a more accurate assessment of how many liposomes 
deliver their contents, the material contained within the 
liposomes must not be able to cross the plasma membrane in 
the free form. In following this philosophy, the ricin-B-
chain targeting of liposomes to cells was followed by two 
alternative assays; 
1) Transformation of cells by liposomes containing foreign 
DNA, and, 
2) The digestion of cellular DNA by liposome mediated 
delivery of nuclease into the cell. 
The results of these two routes of investigation are given 




Liposome mediated transformation 
Because of the problems experienced in interpreting the 
results from experiments in which the liposomal contents 
were able to gain access to the cytoplasm in the free form, 
liposomes containing foreign DNA, which is by itself unable 
to enter the cell, were incubated with cells, and the 
subsequent transformation monitored. Liposome mediated 
transformation of eukaryotic cells thus provides both an 
unequivocal demonstration of the intracellular delivery of 
liposomal contents, and may also provide a method by which 
to transform cells which are refractory to other 
transformation procedures. 
Gene transfer 
Apart from the use of viral vectors, a variety of methods 
exist for introducing foreign genetic material into 
mammalian cells, each method differing in efficiency of 
transformation, applicability to cell types, technical 
difficulty and reproducibility. 
Precipitation of complexes of the DNA with calciwn phosphate 
(Graham and Van der Eb, 1973) is technically simple although 
requires a carefully controlled pH, and many cells are 
refractory to this procedure as the uptake is an essentially -. 
phagocytotic process. Becoming more widely used is the 
method of electroporation (Potter et al. 1984), in which the 
cells in the presence of DNA are exposed to a short but 
intense electric field, inducing transient pores in the 
plasma membrane through which the DNA can diffuse. This 
procedure is widely applicable, however requires fine-tuning 
for each cell type used. 
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Alternative, though less frequently used techniques include 
scrape loading (Fechheimer et al. 1987) , poly-ornithine 
mediated transformation(Bond and Wold 1987), and laser 
micropuncture (Tao et al. 1987). While the latter is 
extremely efficient, it requires highly specialised 
equipment, and is not applicable to large numbers of cells. 
The same is true of microinjection, which while yielding 
high frequencies of gene transfer is technically demanding 
and not applicable to large cell numbers. 
Targeted delivery of DNA to hepatoma cells has been achieved 
by binding DNA to a poly-lysine-asialorosmomucoid complex. 
The resulting complex was highly efficient at transfecting 
hepatoma cells which express receptors for asialoproteins, 
but less infective for other cell types. 
Liposome mediated transformation 
Liposomes have been used to transform mammalian cells, and a 
wide variety of efficiencies have been reported (reviewed 
Lurquin 1984); 
Untargeted phosphatidylserine liposomes carrying the 
thymidine kinase gene have been reported to stably transform 
FM3Atk- cells (mouse mammary carcinoma) with an efficiency 
of 0.02 (Itani et al. 1987). The liposomes used were 
prepared by the calcium induced fusion method. REV liposome 
mediat~· transfer of the same plasmid to mouse Ltk- cells 
was far less efficient (Schaefer-Ridder et al. 1982), 
yielding only 200 colonies per 10 6 cells, an efficiency of 
0.0002. In both cases the liposomes were prepared from PS, 
although in the latter, 50% cholesterol was present, and the 
final difference in DNA concentration is only two fold 
(Itani et al. used 1000 ng DNA per 10 6 cells, Schaeffer-
Ridder et al used 500 ng.). The 100 fold difference observed 
must be due to either the nature of the liposome preparation 
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or the cell types or fine detail in the experimental 
protocol. 
Transformation of Ltk- cells with pSV2-neo in LUV prepared 
by calcium induced fusion also yielded an efficiency of 0.02 
(Nakatsuji et al. 1987), suggesting that the cell line is 
not limiting the transformation efficiency. For further 
comparison, calcium phosphate transformation of the Ltk-
cells yielded an efficiency of 0.0005, approximately the 
same as the REV mediated transformation. There is however a 
danger in trying to draw conclusions by comparisons of 
transformation frequencies from different reports, as the 
same method applied to the same cell line may yield vastly 
differing results depending on how soon after transformation 
the selective agent was added (Itani et al. 1987). 
SV40 DNA in REV liposomes composed of PS has been found to 
be more infective than the free DNA, and the addition of 
glycerol or polyethylen glycol increased the infectivity, 
however only to values comparable to calcium phosphate 
mediated infectivity (Fraley et al. 1981). 
All of the above experiments have utilised the affinity of 
some cells for negatively charged lipid. The applicability 
of targeted liposomes to gene transfer has been investigated 
(Machy et al. 1988) using large (0.4 µm) REV liposomes to 
which protein A had been coupled. Targeting was achieved by 
incuba~~n of the cells with anti-HLA monoclonal antibodies 
and subsequent incubation with the liposomes. While 
successful binding of these liposomes to the target cells 
was achieved, in the absence of electroporation, no 
significant transformation occurred. Electroporation of the 
cells subsequent to liposome binding did however promote 
transformation, indicating effective delivery of the 
liposomal contents. In the absence of targeting negligible 
binding of liposomes to cells took place, however 
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electroporation still promoted transformation albeit at a 
frequency five fold less than for targeted liposomes. This 
data suggests that liposomes targeted via antibodies to HLA 
do not promote the nuclear delivery of their contents, 
although significant binding does take place. It is argued 
in the paper that the transformation due to targeted 
liposomes is representative of only those liposomes actually 
bound to the cell, in which case the efficiency of 
transformation is improved several hundred fold over 
untargeted liposomes, however the methods section of the 
paper indicates that the total number of liposomes present 
is identical in both the targeted and control experiments. 
In this case the further argument that transfection depends 
on the electroporation mediated generation of either a pore 
between the cell and bound liposomes or fusion of the bound 
liposomes with the cell membrane is open to debate since the 
relatively high (compared to non-electroporated) 
transformation with control liposomes represents DNA 
delivery from liposomes not bound. That transformation 
occurs even with control liposomes argues that the 
transformation is not specific. One can provide an 
alternative explanation by postulating that electroporation 
causes perturbation of the cell membrane and induces long-
lived fusogenic states (Sowers 1987) which are able to fuse 
with liposomes and the binding of liposomes to the cell 
surface simply increases the probability ·of contact with 
such sites within the life time of the state. Since the 
fusogern.~ state is not laterally mobile (Sowers 1987), only 
a few of the bound liposomes can be in contact with it, 
possibly explaining why the targeting does not cause more of 
an increase in transformation frequency. Bates et al. (1987) 
point out that electrical fusion of small liposomes with 
cells is unlikely because the field induced membrane 
potential is directly proportional to the particle radius, 
and hence the vastly differing radii of liposomes and cells 
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may make it impossible to form pores in the liposomes 
without totally lysing the cells. 
The development of a cationic lipid DOTMA (N[l-(2,3-
dioleyloxy)propyl]-N,N,N-triethyl-ammonium) has prov.ided a 
novel method of liposome mediated transformation. An aliquot 
of the liposomes prepared in the absence of DNA, will bind 
to DNA in solution by virtue of the tertiary amine on the 
lipid,resulting in surface bound DNA. Subsequent 
electrostatic interaction with the cells promotes the 
delivery of the DNA into the cells (Felgner et al. 1987). 
The frequency of stable transformation with the pSV2neo 
plasmid was 15 times greater using the liposomes than was 
obtained using calciwn phosphate. 
Liposomes have also been used to promote the delivery of 
foreign genes in vivo (Cudd and Nicolau 1984, Wang and Huang 
1987, Nandi et al. 1986), a process which is only achievable 
by liposome technology. 
Thus liposomes are able to promote the delivery of 
transfecting DNA into cells, however the efficiency is 
highly dependant on the technique used. Since DNA alone is 
in most cases unable to transform cells, any transformation 
that occurs indicates a liposome mediated delivery, and 
hence a potentially better assay for liposome uptake than 
toxicity due to drugs. 
-. 
Transforming DNA. 
Assaying stable transformation or transfection of a cell 
line is most readily achieved by the expression of a gene 
conferring resistance to an inhibitor of growth, or 
expression of an essential gene in a cell line deficient in 
that gene. The latter case requires the availability of 
mutants deficient in a gene, typically the thyrnidine kinase 
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gene. The former case obviates this necessity, and is as 
such more widely applicable. 
A variety of genes conferring drug resistance on manunalian 
cells are available (reviewed by Esser and Dahmen 1987), 
amongst them are resistance genes to aminoglycoside 
antibiotics, metallo-glycopeptide antibiotics, heavy metals 
and fungicides. 
One of the most versatile of these is the bacterial 
phosphotransferase gene conferring resistance to neomycin 
antibiotics (neo). The aminoglycoside G418 (Geneticin) which 
interferes with the function of the 80S ribosomes, and 
blocks protein synthesis in eukaryotes is similar in 
structure to the bacterial antibiotics neomycin and 
kanamycin, and can be inactivated by the bacterial gene 
products, hence expression of the neomycin resistance gene 
in manunalian cells confers resistance of these cells to 
G418. The pSV2neo plasmid contains the bacterial gene for 
neomycin resistance under the control of the SV40 early 
region promoter (Southern and Berg 1982). This plasmid can 
be maintained in bacterial cells in the presence of 
neomycin, and when introduced into mammalian cells is able 
to insert into the genome and be expressed conferring 
resistance to G418. The frequency of calcium phosphate 
induced stable transformation varying between 7 X 10- 6 to 3 
X 10- 4 depending on the cell type. 
Linear ~ Circular DNA 
The comparable transformation frequencies with linear or 
circular plasmids have been investigated (Potter et al. 
1984, Machy et al. 1988), with a finding that linearised 
plasmid DNA is significantly more efficient than circular 
DNA at transforming cells, presumably due to increased ease 
of integration into the genome. The linearisation site is 
also important (Johnson and Phelps 1988), with optimal sites 
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for linearisation being far away from either end of the 
resistance genes. 
Results and discussion 
The following experiments were undertaken to establish 
whether ricin-B-chain targeted liposomes could promote the 
delivery of pSV2neo DNA into cells, and if so, whether 
subsequent stable transformation was a valid assay of 
liposomal delivery. 
Liposomal encapsulation of DNA 
The pSV2neo plasmid was maintained in. E.coli and isolated 
and purified by standard methodology. After purification on 
caesium chloride gradients the plasmid was subject to 
restriction enzyme digestion and shown to exhibit the 
correct cleavage sites, confirming that it was the correct 
plasmid. The DNA was then cleaved with EcoRl to linearise 
it. This site was chosen because it is well removed from the 
neo gene and from the SV40 promoter, and because fairly 
large quantities were required, and EcoRl is relatively 
cheap. 
The linearised plasmid (1 mg/ml)was encapsulated in 
liposomes composed of EYPC/CHOL/PS/PE-MBP (9.5:10:2.5:2.5) 
by a mc:m~fication-of the reverse phase procedure as 
described in methods. Since the normal procedure requires 
sonication, and I observed that even at the lowest setting 
of the probe sonicator significant degradation of the linear 
DNA occurred within the time·period required for 
emulsification of the organic and aqueous phases, the 
procedure was modified so that sonication was not required. 
This was achieved by vortexing the two phases together and 




procedure no degradation was discernible, and after 
extrusion through 0.2 µm membranes and separation from 
unencapsulated DNA by ficoll gradient density 
centrifugation, the encapsulation of the DNA was 15%. This 
is equivalent to 5 µg of DNA per µmol phospholipid, which 
corresponds to approximately one plasmid molecule per 
vesicle. 
Since 85% of the DNA is not incorporated within the 
liposomes, this represents a significant wastage of precious 
material. Attempts to recover the unentrapped DNA for reuse 
were unsuccessful as the ficoll interfered with ethanol 
precipitation and could not be dialysed out. Alternative 
density gradient media compatible with ethanol or propanol 
precipitation or dialysable (eg. metrizamide) may overcome 
this problem. 
Liposomes were targeted with ricin B chain as described 
previously. 
Sensitivity of Hepatoma cells to G418 
In order for the transformation assay to be effective, the 
cells must be sensitive to the antibiotic, and the 
antibiotic must be used at a concentration where it exerts 
an effect. The determination of the required concentration 
is shown in fig 7.1. 
This demonstrates that below 400 µg/ml (real G418 cone 200 
µg/ml oecause the G418 used was only 50% by welght 
antibiotic) there is inhibition of growth, however the time 
period required is large. Furthermore at low concentration 
of antibiotic more cell divisions occurred, and after 
several days the cells reached confluence. Once confluent 
cell death did occur, however leaving patches which by 
visual inspection resembled colonies. These 'colonies' died 
later and detached from the plates, but could result in 
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Fig 7.1: G418 sensitivity of hepatoma cells. Hepatoma cells 
in mid-log phase were replated at 10 5 cells per well in six 
well dishes in complete medium with 10% FCS. G418 at various 
concentrations was added and cell viability assayed after 
1,2 4 and 8 days by trypan blue exclusion. The G418 used was 
only 50% by weight antibiotic. Single data points were used. 
-;1 . 
insufficient time was allowed for them to die. Subsequent 
experiments used 800 µg/ml G418. Care was taken to ensure 
that at this concentration the G418, which is acidic, was 
well buffered by the addition of HEPES buffer. 
Targeted liposome delivery of DNA 
Hepatoma cells were incubated at 37°C in suspension with 
_increasing concentrations of targeted or untargeted DNA-
containing liposomes, and then plated out and selected for 
G418 resistance as described in methods. After 10 days the 
number of resistant colonies in each well was scored, and 
the resistant frequency expressed as the number of colonies 
per 10 5 cells plated. The results (fig 7.2) show that 
untargeted liposomes do not promote the uptake and 
expression of their DNA, whereas targeted liposomes are able 
to promote the transformation of the cells, resulting in the 
appearance of colonies resistant to the antibiotic. Naked 
DNA, at comparable concentrations does not result in 
transformation, indicating that DNA alone is unable to enter 
the cells, and hence the liposome mediated transformation is 
indicative of internalisation of the liposomes. 
This is in agreement with the observation (previous chapter) 
that untargeted liposomes do not bind to the cells to a 
significant extent, and targeted liposomes are able to bind 
to the cells and to deliver some of their contents into the 
cells. 
The ma,n.mal frequency of transformation is 0.012%, or 12 
colonies per 10 5 cells exposed to the liposomes. This 
frequency is attained with 2 µg of plasmid, corresponding to 
400 nmol of lipid, and remains at a plateau, decaying 
slightly by 10 µg plasmid (2000 nmol lipid). Data on 
fluorescent liposome binding (previous chapter) show that 
maximal binding occurs with 100 nmoles of lipid, and since 
binding is probably a prerequisite for internalisation, one 
would not expect any increase in internalisation once 
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Fig 7.2: RTB-targeted liposome mediated transformation of 
hepatoma cells. Increasing quantities of pSV2-neo plasmid 
DNA in liposomes either targeted with ricin-B-chain or not 
targeted, was added to 10 5 cells and transformation detected 
as described in methods. Data points for untargeted 
liposomes are single experiments, for targeted liposomes the 
average of triplicates performed on a single day. 
maximal binding has been obtained. When the data for 
transformation is plotted on the same graph as that for 
binding (fig 7.3), it appears that the liposomes which 
mediate transformation have a lower affinity for the cells 
than those carrying calcein. While a comparison of the two 
experiments is hampered by the different time periods used 
for the assays, since both liposomes were targeted with the 
same ligand, and the binding of the ligand to the liposomes 
was the same (data not shown), the presence of two different 
affinities suggests that either; 
1) There are sites on the cell to which liposomes bind with 
a lower affinity than to other sites, and it is only from 
these sites that uptake leading to transformation is 
possible (because of internalisation avoiding a degradative 
pathway). Such sites may exist as areas sparsely populated 
with glycoproteins, and if the number of liposomes which 
bind to these is low, their binding will not be noticed by 
fluorescence above the very high background binding, hence 
it will not be seen in the fluorescence binding assay. Or, 
2) Only a subpopulation of the liposomes are able to mediate 
DNA delivery because of their size, and likewise, because of 
their size, exhibit a slightly lower affinity for the cell. 
Thus the size of the liposome determines not only whether it 
is internalised or not, but also the route of 
internalisation, possibly avoiding lysosomes and hence 
delivering intact DNA to the nucleus. 
-· 
Since all the cells bind targeted liposomes (as confirmed by 
fluorescence microscopy) and at least 5-10000 liposomes are 
bound per cell, representing 5-10000 plasmid molecules on 
the surface of every cell. However only 12 cells out of 10 5 
actually incorporate the DNA into the genome and express it. 
This low frequency of transformation must be due to either; 
1) Only a small population of the cells internalise the 
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Fig 7.3: Comparison of binding and transformation data. The 
data for the binding of targeted fluorescent liposomes (fig 
6.3) and for transformation mediated by targeted liposomes 
containing DNA (fig 7.2) expressed in terms of lipid 
present. 
2) All of the cells internalise some of the liposomal 
contents, however only a small population are competent to 
stably insert and express the plasmid, or, 
3) Insufficient DNA is being delivered into the cells, and 
in only a small proportion is the small amount delivered 
able to evade the activity of intracellular nucleases, and 
to reach the nucleus. 
In order to ascertain whether the limiting frequency of 
0.012% was due to insufficient DNA being delivered into the 
cytoplasm, two other transformation protocols were 
investigated with the same cells and the same DNA for 
comparative purposes. 
Calcium phosphate precipitation 
pSV2neo was transferred in Hepatoma cells using the method 
of Wigler et al. (1977) as modified and described in Current 
Protocols (1986). Contrary to claims in the literature that 
this is a technically simple technique, I found it to be 
highly variable, occasionally yielding no transformants. 
While no detailed investigation of the parameters was 
undertaken it appeared to depend on the batch of calcium 
chloride used, how rapidly the cells were dividing prior to 
transformation, and of course how long the precipitate was 
allowed9 to form. 
The data presented in fig 7.5 represent the transformation 
frequency with increasing concentrations of DNA. This shows 
that the calcium phosphate technique yields fewer 
transformants than the targeted liposomes, and requires more 
DNA. Transformation mediated by liposomes is therefore 
superior in this case to calcium phosphate mediated 
transformation. It appears that there is no plateau, and 
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hence the limiting factor is likely to be the cytosolic 
delivery of the DNA. 
Electroporation 
Electroporation of cells makes them transiently permeable to 
macromolecules, permitting DNA to diffuse into the cell, and 
since such diffusion is independent of metabolic processes, 
is therefore a good indicator of the parameters limiting 
liposome mediated DNA transfer. The electroporation itself 
is subject to a variety of parameters, including cell 
diameter and resistivity of the medium, and hence the 
conditions for optimal electroporation need to be 
established for each cell line used. Fig 7.4 shows the 
effect of increasing the pulse voltage on the transformation 
frequency of the pSV2neo plasmid on the hepatoma cells. The 
optimal pulse voltage was 1200 V, and hence this was used 
for subsequent electroporation. 
The efficiency of transformation by electroporation is shown 
in fig 7.5, which demonstrates that electroporation is able 
to transform the cells with a higher frequency than that 
achievable by targeted liposomes, yet still reaches a 
plateau, in this case 33 colonies per 10 5 cells transformed. 
This plateau could be due to limited competence of the 
cells, or to limited quantities of DNA entering the cell. 
Eviden-C-~s that more transformations have occurred than for 
targeted liposomes, indicating that the cells aie capable of 
being transformed at a higher frequency than that achieved 
by liposomes, and hence the plateau observed with liposomes 
probably represents a limit in the amount of DNA being 
delivered. Interestingly, at low concentrations of DNA, the 
liposomes mediate transformation at a slightly higher 
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Fig 7.4: Effect of pulse voltage on the transformation 
frequency of pSV2neo on hepatoma cells. 40 µg of linearised 
plasmid was added to 5 X 10 6 cells in PBS at 4°C and pulsed 
once at the voltage shown. The conditions of electroporation 
and selection for transformants are described in methods. 
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Fig 7.5: Comparison of transformation frequencies for 
liposome mediated transformation, electroporation, and 
calcium phosphate mediated transformation. Data points are 
average of triplicates. 
saturating levels, the delivery by targeted liposomes is 
more efficient than by electroporation. 
Comparison 
The same plasmid has been delivered into the same cells by 
three different techniques, and the results are widely 
differing, probably representative_of the different modes of 
uptake of the DNA in the three methods. While 
electroporation mediated delivery is independent of the 
cells metabolism and promotes the delivery of macromolecules 
directly into the cytoplasm, cellular uptake of calcium 
phosphate precipitates requires an endocytotic process which 
probably results in much of the DNA being degraded by 
lysosomal enzymes, resulting in a much lower frequency of 
transformation. The liposomal delivery is probably due also 
to an endocytotic mechanism, although fusion of some the 
bound liposomes with the plasma membrane is a possibility. 
That it is more efficient than calcium phosphate could be 
due to an alternative endocytotic route, and also protection 
of the DNA in liposomes from nucleases, and its better 
efficiency at low concentrations than electroporation 
reflects the concentrating effect of binding the liposomes 
to the cells, effectively increasing the local 
concentration. 
-. 
That transformation has occurred demonstrates conclusively 
that there has been liposome mediated transfer of the DNA 
into the cells. The absence of transformation with 
untargeted liposomes further demonstrates the requirement of 
strong interaction of the liposomes with the cells. However 
while it demonstrates delivery, it is not clear that it is 
either 1) an efficient method of transformation, or, 




Efficiency: While optimal transformation frequency was 
observed with 2 µg of DNA for the liposome mediated 
transformation, whereas 4 µg were required for the same 
frequency by the electroporation procedure, it must be 
remembered that the preparation of the 2 µg sample of 
liposomal DNA required 10 µg of DNA to start with. 
Furthermore the DNA for electroporation can be stored 
indefinitely in the frozen state. Liposomes require to be 
frozen in the presence of cryoprotectants (Machy and 
Leserman 1984) and even then undergo some leakage on 
freezing. Finally, the skill and number of steps required in 
preparing targeted liposomal DNA is far greater than for the 
electroporation procedure. Hence the liposomal procedure is 
not more efficient than the electroporation procedure. 
Quantitative validity: Greassmann and Graessmann (1975) 
have demonstrated that the infectivity of microinjected DNA 
is directly proportional to the quantity of injected DNA. 
This would then suggest that the plateau of transformation 
frequency observed for both liposomal and electroporation 
mediated transformation is due to a limit being reached in 
the number of DNA molecules entering the cells. This is more 
readily apparent for the liposomal transformation, where the 
plateau probably correlates with a maximum internalisation 
rate being reached, however the plateau for electroporation 
is not readily explained. Since electroporation yields the 
cells o:-a.nsiently permeable to macromolecules, the quantity 
of DNA entering the cell should be proportional to the 
concentration of DNA outside the cell, in which case the 
plateau is due to a limitation being imposed on the stable 
insertion and expression of the DNA. This suggests that 
factors other than total quantity of intracellularly 
delivered DNA affect transformation frequency, hence 
quantitative assessment of liposomal delivery based on 












range established by alternative techniques such as 
electroporation or microinjection. 
Such a condition does apply to the above experiments, so a 
quantitative assessment may be valid: 
Assuming that electroporation makes the cell transiently 
totally permeable to the DNA, then after diffusion the 
concentration of DNA in the cell will be identical to the 
concentration in the medium. The concentration of DNA which 
would yield 0.012% transformation in the electroporation 
method is approximately 4 µg of DNA per ml. If the diameter 
of a Hepatoma cell in suspension is 15 µm (see micrographs 
of liposomes bound to cells), then the volume of the cell is 
1766 µm 3 • If the concentration of DNA in the cell is 4 
µg/ml, then 7 X 10- 15g of DNA is present in the cell, 
representing approximately 800 molecules. Since there is 
roughly one plasmid per vesicle, this transformation 
efficiency (which is the optimal for liposomal delivery) 
represents the cytosolic delivery of 800 liposomes. This is 
a large number of liposomes, and yet only 12 transformants 
occurred, indicting the very low probability of foreign DNA 
becoming stably inserted and expressed in the genome. 
The assumption made that after electroporation the 
concentration inside is equal to that outside is empirical, 
based on the report that at critical voltage the increase in 
membrane conductance corresponds to loss of up to 0.1% of 
t~e membrane area (Kinosita et al. 1988) which accounts for 
a large area of pores, and such pores persist almost 
indefinitely at 4°C (Kinosita and Tseng, 1977). Since the 
cells were kept at 4°C for 10 minutes after poration the 
pores will have persisted for that time, allowing diffusion 
of DNA into the cell. Taking the diffusion coefficient of 
the plasmid as being 2 X 10- 7 cm~s- 1 (based on BMV Cantor 
and Schimmel), in water at 20°C it will diffuse 6.3 µmin 1 
96 
second, roughly the radius of the cell. Hence the limitation 
to the DNA entering the cell is imposed by the size and 
number of the pores. From fig 7.4 it is evident that 
increasing the pulse voltage beyond 1.2 KV does not increase 
the transformation frequency. Since a higher voltage should 
increase the pore size or number, and hence the rate of 
diffusion, it is likely that maximal DNA internalisation has 
been achieved by a pulse of 1.2 KV, and that this represents 
equilibration with the external medium. 
A further complication in the assessment is that 30 - 40% of 
the cells electroporated died due to electroporation, not 
G418 sensitivity. Had these cells not died they would have 
contributed towards an increased frequency of 
transformation, lowering the estimation of liposome 
internalisation. 
Conclusion: 
The ricin-B-chain is able to promote the binding and 
internalisation of liposomes to hepatoma cells, mediating 
the delivery of foreign DNA to the nucleus where it becomes 
expressed. As a procedure for delivering foreign DNA it is 
superior to calcium phosphate precipitation, but inferior to 
electroporation. Further, the wastage of material during 
liposome preparation and storage, as well as the technical 
difficulties, make electroporation in this case a far 
supericn:- method. 
Maximal transformation was obtained when the lipid 
concentration was 400 µM, at which concentration an 
estimated maximum of 800 liposomes per cell had delivered 
their contents into the cytoplasm. In comparison to this, 
methotrexate delivery was optimal at 50 µM lipid (previous 
chapter). At 50 µM lipid no transformation could be 
detected, therefore although this data demonstrates that at 
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high concentrations internalisation of the liposomal 
contents does occur, it is still not possible to determine 
whether the toxicity of methotrexate in targeted liposomes 
was due to liposomal delivery or leakage at the membrane. 
Thus, liposome mediated transformation unequivocally 
demonstrates the internalisation of the liposomal contents, 
however as an assay for liposomal delivery it is hampered by 
the very low probability of scoring a 'hit', due to the·very 
low probability of the internalised DNA becoming inserted in 
the genome and being expressed. The low frequency of 
positive responses could very well lead to situations in 
which liposomal uptake is not detected, and hence as a 
routine assay for liposomal delivery it is not ideal. 
Furthermore it is hampered by technical details, requiring 
that all solutions are DNase free, the liposomes are sterile 
at all times, and ten to fourteen days are required to 
select for transformants. 
Because of these problems I tried to develop an alternative 
assay for liposome mediated delivery which; 
1) Was more sensitive than transformation assays and less 
dependant on unknown factors such as insertion and 
expression. 
2) Was more rapid, ideally giving results the same day. 
3) Did not require such strict maintenance of sterility, 
freeing laminar flow hoods for other research. 
4) Did""not use such large quantities of precious materials 
such as plasmids. 
5) Would provide unequivocal and hopefully quantitative 
demonstration of liposomal delivery. 





TARGETED LIPOSOME DELIVERY OF DNASEl INTO CELLS 
The methodologies available for ascertaining the successful 
intracellular delivery of liposomal contents often present 
problems ; 
1) Fluorescence microscopy is a good indicator of whether 
liposomes have bound, but in my experience it has been 
difficult to differentiate between surface bound liposomes 
and liposomes entrapped within intracellular vesicles, and 
the appearance of diffuse fluorescence, normally associated 
with cytoplasmic delivery, I have found can be confused with 
out-of-focus punctate fluorescence, especially at high 
magnification (narrow depth of focus) and when a large 
number of liposomes have been bound. 
2) The encapsulation of small drugs such as methotrexate, 
and monitoring the resulting toxicity is not ideal because 
the drug is able to enter the cell unaided, hence leakage 
from the liposomes can present difficulties in 
interpretation of the results, and if extensive exposure of 
the cells to the liposomes is required, the time period 
magnifies this difficulty. Modifying the drug so that the 
free drug is unable to enter the cells (eg methotrexate-... 
gamma-aspartate Heath et al. 1983) improves this, however 
since small drugs are often resistant to lysosomal 
inactivation, successful delivery of a small drug is not 
correlateable to that of a macromolecule. 
3) The delivery of transfecting DNA into cells, while 
overcoming the above drawbacks, is hampered by the apparent 
lack of direct correlation between cytosolic delivery and 
transformation efficiency, the latter being affected by a 
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variety of factors controlling the ability of the 
transforming DNA to be delivered into the nucleus, insert 
into the genome, to remain there, and to be expressed. A 
slight technical drawback is the length of time required for 
positive selection of the transformed cells (typically 10 to 
14 days). Transient expression of exogenous DNA is likewise 
affected by factors other than the total cytosolic delivery, 
including its topology (Weintraub et al. 1986) and its 
association with factors such as nuclear proteins (Kaneda et 
al. 1989). 
An ideal assay system for liposomal delivery would involve 
the delivery of a macromolecule that was unable to enter the 
cell unaided, and that exerted an enzymatic effect on a 
substrate within the cell, rapidly producing an easily 
identifiable product. Such a system would hopefully permit 
the detection of low numbers of liposomes and within a time 
frame permitting an analysis of the kinetics of uptake. 
An example of such a molecule is DNasel. It is unlikely to 
be ~ble to enter the cell by itself, hence leakage from 
liposomes will not interfere with the results, and once in 
the cell is small enough to gain access to the inside of the 
nucleus where a large quantity of substrate in the form of 
the genomic DNA is available, and the product, smaller DNA, 
should be readily discernible from the starting material. 
Furthermore, unlike toxicity or transformation assays, the 
assay ~ld not require the cell to be actively metabolising 
or dividing, hence avian erythrocytes or similar non-




The interaction of bovine pancreatic DNase (DNase 1, EC 
3.1.4.5) with isolated chromatin or with intact nuclei has 
been investigated in detail since it is one of the principle 
probes for the determination of chromatin structure (Lutter 
1978, reviewed Felsenfeld 1978). Partial digestion of either 
isolated chromatin or intact nuclei with DNasel and analysis 
of the resulting fragments by gel electrophoresis yields a 
'ladder' of discreet bands corresponding to multiples of 
monomers of approximately 200 base pairs of DNA. This arises 
from the preferential digestion of the unprotected DNA in 
the spacer region between nucleosomes, with the DNA of the 
nucleosome being less susceptible to attack. Continued 
digestion results in the dissapearance of higher multiples 
and a dominance of monomers or nucleosome cores, and finally 
even those are digested away. 
While minute quantities of DNase 1 are able to achieve 
digestion of chromatin in isolated nuclei, the presence of 
inhibitors of DNase 1 present in eukaryotic cells is likely 
to significantly reduce the activity of cytoplasmically 
delivered enzyme. Actin has been shown to have a very high 
affinity (Ko= 2 X 10- 7 M) for bovine DNase 1 (Mannherz et 
al. 1980), forming .a 1:1 complex with the enzyme and 
inhibiting its activity (Hitchcock et al. 1976). It is 
unlikely that such an interaction is of significant 
physio.tt,gical importance because DNase 1 from rat tissue is 
not inhibited by actin (Lacks 1981). Because there is a 
finite amount of actin within a cell it may be necessary to 
deliver enough DNase to bind to the actin before any 
digestion of the DNA is able to take place, this may 
significantly decrease the sensitivity of the assay. 
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DNasel has previously been encapsulated in liposomes and 
shown to exert an intracellular effect by inducing dose-
dependant cytotoxicity and somatic mutations in cells 
exposed to the liposomes (Zajak-Kaye and Ts'o 1984). While 
this experiment demonstrates that liposome mediated delivery 
of DNasel into cells is possible, and the delivered enzyme 
is able to digest the cellular DNA, the assays used required 
extensive incubation times. Toxicity was measured after 7 
days, and phenotypic expression of the neoplastic 
transformation required incubation for 28 days. These 
authors did note that at low concentrations of liposomes 
there was no noticeable effect on the cells, a phenomenon 
ascribed to scavenging of the DNase by actin. While it would 
be useful to gauge from this paper how much enzyme was 
delivered and by how many liposomes, very severe 
inconsistencies within the report concerning the ratio of 
enzyme to lipid, the percentage encapsulation and even the 
molecular weight of the enzyme preclude this. Nonetheless, 
since these authors used LUV vesicles with a reported low 
(2%) efficiency of encapsulation, and binding of the 
liposomes was mediated by the negative charge on the lipid, 
it is possible that lectin mediated targeting of REV 
vesicles may result in superior delivery. 
The experiments described below were initiated to ascertain 
whether lectin-targeted liposomes could mediated the 
delivery of DNasel into cells, and whether such delivery 
could be assayed by monitoring the appearance of short DNA 
fragments on agarose gels, and if so, whether this technique 




DNase 1 entrapment 
The entrapment of DNasel into reverse phase evaporation 
liposomes without losing activity, and the subsequent 
analysis of the activity of the entrapped material presented 
several problems which required the development of new 
techniques. One of the main problems was that release of the 
entrapped enzyme by detergents resulted in inactivation of 
its enzymatic activity. This was overcome by using melittin, 
a lytic peptide from bee venom, to lyse the liposomes. The 
techniques used and the results obtained are described in 
detail in appendix B. 
It was found that entrapment of biologically active DNase 1 
in REV liposomes was possible only if the aqueous phase 
contained 20% glycerol, and that under these conditions, the 
process of encapsulation significantly increased the 
activity of the enzyme. The increase in activity appeared to 
be due to the presence of the lipid, hence an exact 
determination of encapsulation was not possible, but it 
appeared that at least 20% of the DNase 1 activity became 
associated with the liposomes, corresponding to 50 Kunitz 
units of enzyme per µmol lipid. 
Liposome mediated delivery of DNasel into cells 
In ordE!'!:'· to ascertain whether functional delivery of the 
DNase 1 could be achieved by the liposomes, and the time 
period required to detect the appearance of DNA fragments, 
cells were incubated with either free DNase 1, or DNasel 
entrapped within RTE-targeted liposomes. Incubation was 
performed at 37°C for increasing time periods, after which 
the reaction was terminated by the addition of EDTA and 
phenol. The EDTA served to chelate any divalent ions present 
which effectively stops all DNase 1 activity, and the phenol 
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served to solubilise the cells and liposomes, and to 
inunediately denature the proteins, providing protection from 
further nuclease activity, and also releasing DNA from the 
chromatin for subsequent isolation. The DNA was isolated and 
purified from the cells as described in methods, and then 
applied to an agarose gel to ascertain whether any cleavage 
of the chromatin had occurred. The results are shown in fig 
8 . 1 . 
This demonstrates that free DNasel is unable to enter the 
cell, whereas liposomally targeted DNasel is able to enter 
the cell and pass into the nucleus where it digests some of 
the high molecular weight chromosomal DNA into shorter 
pieces, appearing as a smear on the gel. Thus, functional 
delivery of the liposomal contents is unequivocally 
demonstrated. 
It is interesting that the digestion of the DNA only becomes 
noticeable after 60 minutes of incubation. The virtual 
absence of digestion after 30 minutes is due presumably to 
the complex kinetics of liposome internalisation or fusion, 
saturation of possible inhibitors such as actin, diffusion 
into the nucleus, and the kinetics of DNase 1 activity on 
DNA. The latter is likely to introduce a lag period in the 
appearance of DNA fragments due to its mechanism of action; 
DNase 1 cleaves DNA by nicking single strands, hence, at low 
concentrations of the enzyme there is a time lag before both 
strandsget.nicked at the same site, producing a fragment. 
Although fig 8.1 shows that the internalisation of the DNase 
1 has been mediated by the liposomes, it is possible that 
this internalisation is not a function of the targeting of 
liposomes, but simply due to association of the enzyme with 
liposomes, enhancing its activity. Likewise the absence of. 
digestion with free DNase 1 is not directly comparable 
because the encapsulated enzyme has a much higher activity. 
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Fig 8.1: 
1% agarose gel of DNA isolated from hepatoma cells incubated 
with either DNasel or RTB targeted liposomal DNasel. 
Hepatoma cells in mid-log phase were released from monolayer 
growth with EDTA and resuspended ~n PBS/Ca/Mg at 2.5 X 10 5 
cells/ml. The liposome concentration was 500 nmol/ml which 
corresponds to a DNase 1 concentration of 20 µg/ml. Free 
Dnase 1 was 20 µg/ml. 
Lane 1 : Lambda standard. Lanes 2,4,6,8 ; cells incubated 
with free enzyme, reaction terminated after 0, 30, 60, 120 
minutes respectively. Lanes 3,5,7,9 ; cells incubated with 
liposomaly entrapped enzyme and reactions terminated after 
0, 30, 60, 120 minutes respectively. 
To confirm that the digestion above was due to release of 
the liposomal contents into the cell, and that this release 
was due to the targeting of the liposomes, cells were 
interacted with either targeted liposomes, targeted 
liposomes and lactose, or untargeted liposomes. In all cases 
the liposomes contained DNasel. Free DNase 1 at a ten fold 
higher concentration than previously was also incubated with 
cells. The results are shown in fig 8.2. 
This demonstrates that neither untargeted liposomes, nor RTE 
targeted liposomes in the presence of lactose, are able to 
significantly promote the delivery of DNasel into the cell. 
It also further confirms that free DNasel is unable to enter 
the cell within the time period of the experiment, and hence 
the liposomal delivery must be due to liposome mediated 
internalisation of the enzyme. 
Since it has been shown (chapter 5) that there is some 
binding of RTB-liposomes to cells in the presence of 
lactose, an event ascribed to increased non-specific 
interaction of the liposomes with the cells, the absence of 
delivery of DNase 1 in the presence of lactose (fig 2 lanes 
3,6) suggest that the internalisation of the contents of the 
RTB targeted liposomes is dependant on the sugar binding 
properties of the lectin. There are two components within 
this argument: the first is that in the presence of 
compet.±ng sugar the total binding is significantly less (10% 
of the binding in the absence of lactose) and hence there is 
less DNase 1 available for internalisation; and the second 
is that the binding is mediated via an alternative mechanism 
which may not be capable of mediating uptake. 
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Since DNase 1 is normally stored in the lysosomal apparatus, 
from which its escape would be detrimental to the cell 
(Sablina 1978), it is unlikely that any lysosomally 
delivered DNase 1 is subsequently able to escape into the 
cytoplasm. Hence the nuclear delivery of DNase 1 suggests 
that internalisation of the liposomal contents via a route 
other than the lysosomal pathway has occurred. The event 
most likely to mediate such delivery is fusion of the bound 
liposomes with the plasma membrane. 
Although fusion of phosphatidylcholine vesicles with cells 
has not previously been demonstrated (as discussed in 
chapter 1), it is conceivable that targeting via the ricin-
B-chain is able to mediate fusogenic events as well as 
endocytosis. Such an effect may be a result of b9th the 
structure of the ricin-B-chain, and also the widespread 
distribution of galactosyl residues on the cell surface, 
potentially resulting in multimeric binding of a single 
liposomes which would then undergo distortion and 
concomitant thermodynamic stress, making fusion of the 
liposome with the plasma membrane a more likely event. 
Liposome-liposome fusion has been shown to be significantly 
enhanced when the liposomes are brought into close proximety 
by agglutination of glycolipid containing vesicles with 
Ricci nus convnunis agglutinin (Sundler and Wijkander 1983), 
indicating that this lectin is capable of establishing 
interb.riayer contact. It is therefore quite conceivable that 
the ricin-B-chain, a very similar lectin from the same 
source and with the same sugar specificity, is able to 
mediate a similar effect. To this extent it is worth 
considering that lectin mediated targeting is capable of 
binding the liposomes directly to glycolipids within the 
plasma membrane, potentially establishing much closer 
proximety of the two membranes than antibody mediated 
targeting, which binds the liposomes to proteins on the cell 
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surface. Hence lectin mediated targeting may be able to 
promote fusion to a far greater extent than antibody 
mediated targeting of liposomes. 
Such a mechanism may also explain the disparity between 
binding and transformation in the previous chapter. If 
cytoplasmic internalisation of the bound liposomes is 
mediated primarily by binding close to the membrane surface, 
since such sites are less available than large surface 
glycoproteins, the binding will be of a lower affinity and 
hence more liposomes will be required to achieve maximal 
internalisation than maximal binding. 
It would be interesting to obtain an estimate of the 
quantity of enzyme that has been delivered to the nucleus. 
Since a simple radioactive labelling of the enzyme and 
subsequent isolation of the nuclei and assessment of 
associated radioactivity would be hampered by leakage out of 
the nucleus during nuclei isolation, and also the binding of 
DNase 1 to proteins such actin which will co-purify with the 
nuclei, the best method is to perform parallel digestions 
under conditions in which the concentration of enzyme in the 
nucleus is known. For this reason nuclei isolated from 
hepatoma cells were incubated with increasing quantities of 
DNasel for 120 minutes at 37°C, and the extent of digestion 
of the chromosomal DNA determined by the same method as for 
whole ~lls. The nuclei for this experiment were isolated by 
the method of Smith et al. (1988) which avoids the use of 
detergents and harsh conditions, and produces nuclei 
transcriptionally active nuclei. 
Fig 8.3 shows that increasing the DNasel concentration 
results in increasing quantities of digestion until all of 
the large molecular weight DNA is degraded. While a 




1% agarose gel of DNA from isolated hepatoma nuclei 
incubated with increasing quantities of DNasel at 37 degrees 
for 120 minutes. 2.5 X 10 5 nuclei were resuspended in 100 µl 
of nuclei storage buffer containing 10 mM Mg-- and various 
quantities of DNase 1 expressed as Kunitz units; 
Lane l; 4 Units. 
Lane 2; 2 Units. 
Lane 3; 1 Units. 
Lane 4 . 
' 0.5 
Units. 
Lane 5; 0.2 Units. 




Lane 8; 0 Unit. 
not possible, a qualitative assessment shows that digestion 
of the nuclei with 1 unit of enzyme yields similar digestion 
to that obtained by targeted liposomes in the same time 
period. Assuming that in the nuclei digestion the 
concentration of enzyme in the nuclei is equal to that in 
the solution, then a concentration of 10 U/ml achieves 
digestion similar to that experienced by the nuclei in the 
cells. It can then be further argued that the concentration 
of DNase- 1 in the cells after targeting is at least 10 U/ml. 
Since the cell has a diameter of 15 µm, its volume is 1.7 X 
10- 12 1, which at 10 U/ml is equivalent to an intracellular 
1.7 X 10- 0 U of enzyme. It is possibly greater than this 
since the potential inhibition of the enzyme by actin may 
mask some activity. This corresponds to approximately 400 of 
the liposomes having delivered their contents into the 
cytoplasm. Interestingly this figure is within the same 
order of magnitude as that estimated by liposomal mediated 
delivery of transfecting DNA (chapter 7), and yet is two 
orders of magnitude lower than that quoted by Zajac-Kaye and 
Ts'o (1984). As mentioned previously, the report by these 
authors does contain contradictions preventing any numerical 
assessment of the binding, but they do quote a figure of 10 7 
molecules of DNase 1 having been internalised per cell. The 
RTB mediated delivery of 400 liposomes per cell corresponds 
to 1.2 X 10 5 molecules per cell, significantly less than 
that found by these authors. 
As a comparison to assess whether this technique worked with 
other cell types, and also to determine the dependence of 
the digestion on liposomal concentration, Friend 
erythroleukemia cells were incubated for 120 minutes with 
increasing quantities of targeted liposomes containing 
DNasel. Analysis of the digestion of the DNA is shown in fig 
8 . 4 . 
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Fig 8.4: 
1% agarose gel of DNA isolated from Friend cells incubated 
with increasing quantities of targeted liposomal DNasel at 
37 degrees for 120 minutes. 2.5 X 10 5 cells in 1.0 ml RPMI 
medium containing 10% FCS were incubated with: 
Lane 1; No liposomes added. 
Lane 2. I 30 nmoles liposomes 
Lane 3 ; 60 nmoles liposomes 
Lane 4 . I 125 nmoles liposomes 
Lane 5; 250 nmoles liposomes 
Lane 6 ; 500 nmoles liposomes 
Lane 7. I 1000 nmoles liposomes. 
DNA was isolated and analysed as described in methods. 
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Fig 8.2: 
1% agarose gel of DNA isolated from hepatoma cells incubated 
with 500 nmol of liposomes (containing 20 µg DNasel) or 200 
µg of free DNase 1. Incubation was performed in EMEM medium 
with 10% FCS for 60 or 120 minutes at 37°C. 
Lane 1: Lambda standard. 
Lanes 2,3,4 ; 60 minutes incubation. Lanes 5,6,7,8; 120 
minute incubation. 
Lanes 2,5 . RTB targeted liposomes. 
' 
Lanes 3,6 . Targeted liposomes in presence of 50 mM lactose. I 
Lane 4,7 . Un targeted liposomes. ' 
Lane 8 ; Free DNasel . 
There is slight digestion of DNA in the absence of liposomes 
(lane 1), due probably to the presence of some dead cells 
and cell debris in the sample of Friend cells which grow in 
suspension. This does not occur with the Hepatoma cells 
where any dead cells are removed when rinsing the monolayer 
with medium prior to harvesting the cells. 
30 nmoles of liposomes (lane 2) does not promote a 
significant increase in digestion over the control, 
indicating that insufficient enzyme reaches the nucleus to 
exert an effect. This could be due either to no liposomes 
delivering their contents into the cell, or to the binding 
of any delivered enzyme by actin. It is difficult to 
differentiate between the two possibilities. Since binding 
occurs at 30 nmoles of lipid, failure of the bound liposomes 
to mediate internalisation may represent the location of 
binding not being permissive for uptake. To this extent it 
is conceivable that initially the binding of the liposomes 
to the cells is via an exposed glycoprotein, which may 
result in the liposome being kept away from the plasma 
membrane hence minimising the chance of internalisation. 
Higher concentrations possibly result in binding to the less 
exposed glycoproteins and glycolipids decreasing the 
intermembrane distance and increasing the probability of 
internalisation through either an endocytotic or fusion 
mechanism. 
Increa~ng the concentration of liposomes results in 
significant increases intensity of the degraded DNA, 
pointing to increased nuclear fate of the liposomal 
contents. The digestion appears to plateau at 500 nmoles of 
phospholipid added, similar to the plateau observed for the 
delivery of transforming DNA, and may indicate a saturation 
of binding being reached. Since the binding to Friend cells 
should be similar to that for hepatoma cells, the apparent 
plateau of delivery at 500 nmoles tends to confirm the 
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previous postulate that the binding that mediates cytosolic 
delivery of the liposomal contents occurs with a lower 
affinity than the bulk binding. 
Fig 8.4 shows very clearly a 'ladder' of digestion, 
resulting from preferential digestion of the linker DNA 
between nucleosomes. Such a digestion pattern is expected 
from DNA packaged into nucleosomes (Felsenfeld 1978), hence 
its absence in the digestion of hepatoma cells is 
intriguing. That there is no evidence of a repeat length in 
the digestion of isolated hepatoma nuclei demonstrates that 
this is not an artifact of liposome mediated delivery of 
nuclease, and points therefore to the possibility that the 
difference between the digestion pattern of the two cell 
types is a function of the DNA packaging. To this extent the 
Friend erythroleukemia cell, which is almost fully 
differentiated, is likely to have less DNA actively 
transcribing than the hepatoma cell, and concomitantly, a 
more tightly packaged chromatin. 
Comment on the methods 
Several different methods were compared for their use in 
stopping the reaction of the DNasel with the DNA and 
subsequent isolation of the DNA for size analysis on agarose 
gels. ThB method finally employed is described in detail in 
the methods section. It comprises stopping the reaction with 
phenol, followed by two phenol extractions, ether extraction 
to remove the phenol, RNase digestion to degrade the RNA 
which otherwise interferes significantly, and an optional 
ethanol ex~raction, depending on the concentration of the 
DNA. This method was chosen because it is rapid, the entire 
procedure including running the gel achievable in a day, 
however it is difficult to obtain reproducible quantities of 
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DNA during the phenol extractions because the solution is so 
viscous and the DNA is not readily separated from the 
protein interface. An alternative approach (also described 
in methods) more suited to analysing large numbers of 
samples is to stop the reaction with an EDTA/SDS/proteinase 
K solution at 50 degrees, and to incubate at this 
temperature for 16 hours followed by RNase digestion. 
Subsequent phenol extraction and ethanol precipitation is 
not interfered with by large quantities of protein. The 
disadvantage of this approach is that it requires at least 2 
days, and since larger volumes are used, ethanol 
precipitation is mandatory. Quantitative resuspension of the 
precipitated DNA is dependant on the DNA being very clean 
and being only air-dried after precipitation. 
Conclusion 
The entrapment of DNasel in liposomes, and the isolation of 
DNA from cells interacted with the liposomes provides an 
unequivocal and sensitive assay of cellular delivery of the 
liposomal contents. The assay is rapid, permitting many 
variables to be investigated within a short time period and 
furthermore the time period of the assay obviates the 
necessity for ultra-sterile working conditions and the 
concomitant expense. 
The ability to deliver nucleases directly into living cells 
may ha~ great impact on the field of chromatin structure, 
where isolated nuclei are at present the best substitutes 
available as models of the living cell. Since the process of 
isolating the nuclei may produce rearrangement of the 
chromatin, a process in which the enzymatic digestions are 
performed in vivo will provide a less artifactual assessment 
of DNA arrangement. Further, the ability to digest the DNA 
while it is actively transcribing within the cell may result 
in a more detailed understanding of the process of packaging 
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and expression of active genes. To this extent targeted 
liposome mediated delivery of DNase 1 provides not only an 
assay of liposome effectiveness, but also a powerful tool 





It has been demonstrated that melanocyte stimulating hormone 
is able to mediate the binding of liposomes to melanoma 
cells via the receptor for the hormone, and yet although 
binding occurs, there was no evidence of internalisation of 
the liposomal contents. Since the hormone was able to 
mediate both the binding and internalisation of ricin-A-
chain resulting in increased toxicity towards melanoma 
cells, it is apparent that binding of the hormone to the 
receptor does mediate endocytosis. Hence the absence of 
functional delivery of the liposomal contents could be due 
to either too few liposomes being internalised and the assay 
being insufficiently sensitive to detect such levels, or to 
the large size of the liposomes preventing their 
internalisation via the MSH receptor. 
To provide a comparison to this, liposomes were targeted 
with ricin-B-chain, a lectin known to mediate the 
internalisation of molecules to which it is bound. This 
ligand was able to mediate both the binding and 
internalisation of the liposomes, functional delivery being 
demonstrated by the cellular uptake of liposomally entrapped 
methotrexate, transfecting DNA, and also DNase 1. 
Whereas MSH mediated targeting resulted in the specific 
bindingof at most 1000 liposomes per cell, the lectin 
mediated targeting yielded much greater binding, with 
saturation at 11000 liposomes per cell. The saturation 
levels for both are far below the receptor number, and for 
the lectin mediated binding appear to be due to a physical 
limit being reached beyond which no more liposomes are able 
to pack on the cell surface. In contrast, the binding via 
the MSH receptor appears to be limited due to the localised 
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distribution of the receptor, and the subsequent masking of 
binding sites by liposomes. 
The ability of the two ligands to mediate the 
internalisation of liposomally entrapped methotrexate is 
vastly different. Even when the specific binding via MSH is 
saturated, at which point those cells expressing the 
receptor bind approximately 1000 liposomes, no cellular 
to~icity occurs. Lectin mediated targeting on the other hand 
results in the delivery, and concomitant toxicity, of the 
drug far below the saturation level. Half maximal toxicity 
occurs at a liposome concentration which results in 2500 
liposomes binding per cell, and represents a ten fold 
increase in toxicity over untargeted liposomes. Although 
this indicates functional targeting, it indicates that a 
large number of liposomes do need to be attached to the cell 
for toxicity to occur, and hence the absence of toxicity of 
MSH targeted liposomes could be due to insufficient 
liposomes binding to the cell. This explanation becomes more 
credible when one considers that the MSH mediated binding 
occurs for only 30% of the cells life cycle and that at any 
moment the cells bind on average only 300 liposomes per 
cell. The concentration of ricin-B-chain targeted liposomes 
that mediate a comparable binding (300 liposome per cell), 
does not result in any toxicity. 
It is therefore concluded that melanocyte stimulating 
hormone-~s not a good ligand by which to target liposomes to 
cells even though the receptor expresses a high affinity for 
the hormone, does mediate endocytosis of the hormone, and 
the hormone can be linked to liposomes without concomitant 
loss of recognition by the receptor. It is also concluded as 
a general rule that receptor expression and density will 
play a critical role in functional delivery of targeted 
liposomes. While the MSH receptor is expressed at a density 
of approximately 10 4 per cell, which should mediate binding 
114 
comparable to that for ricin-B-chain, its localised 
distribution masks most of the receptors, making them 
unavailable for liposome binding, and its cell-cycle 
dependant expression results in only a fraction of the cells 
at any moment binding the liposomes. 
In contrast to the delivery of a small drug such as 
methotrexate, the ricin-B-chain mediated delivery of 
liposomally entrapped nuclease or transfecting DNA requires 
saturation of the binding sites. Since maximal delivery of 
the liposomal contents occurs at a concentration of 
liposomes higher than that which results in maximal binding, 
it is concluded that the binding that mediates the nuclear 
delivery of the liposomal contents occurs with a lower 
affinity than the bulk binding. It is possible that nuclear 
delivery of the liposomal DNA or nuclease results primarily 
from fusion between the liposomes and the plasma membrane, 
in which case only the binding events which bring the two 
membranes into close proximity will result in functional 
delivery of the contents. To this extent the binding of the 
lectin to glycolipids in the plasma membrane may be the 
primary route of delivery of liposomal contents which would 
probably be degraded within an endocytotic route, and such 
binding may occur with a lower affinity than that to the 
more exposed glycoproteins. 
It is concluded therefore that the ricin-B-chain is a useful 
ligand-1:>Y which to promote the binding and rapid cytosolic 
or nuclear internalisation of liposomes, and as such may 
prove to be a valuable tool in experiments requiring 
intracellular delivery of biological agents. 
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Chapter 10 
MATERIALS AND METHODS 
Materials 
The reagents used were supplied as follows 
Merck (Darmstadt) - Acrylamide, DMF, TEA, TFA, Hydrogen 
Peroxide, Silica F 254 plates for TLC. 
Sigma (St. Louis, Mis., USA) Calcein, DPPC, DPPS, DPPE, 
DSPC, EYPS, SPDP, Melittin, MSH, Methotrexate, Geneticin 
Pierce (Rockford, Ill. USA) DTBP, EDC, DTNB, DTT 
Pharmacia Fine Chemicals (Uppsala, Sweden) Sephadex G-25, 
Sepharose 4B, Ficoll 400. 
Carlo Erba (Milan, Italy) HPLC grade acetonitrile 
Amersham 3 H-Tyrosine, 3 H-Leucine, 3 H-Thymidine, 125-I, cAMP 
assay kit. 
Flow laboratories Tissue culture media. 
State vaccine (Cape Town, S.Africa) Foetal calf serum -. 
All other reagents were of analytical grade, and obtained 
from commercial sources. 
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Purification of reagents 
Many of the reagents used were found to be of insufficient 
purity and were purified prior to use. Their purification 
procedure is outlined : 
Diethyl Ether was found to contain peroxides which are 
potentially damaging to lipids and to proteins. The 
peroxides were removed by shaking the ether with an equal 
volume of 10% sodium sulphite and then washing the ether 
several times with water. Storage of the ether resulted in 
regeneration of peroxides, so this procedure was performed 
immediately prior to all uses of ether. 
Triethylamine (TEA) was distilled from a solution with 
ninhydrin and used within several weeks. Storage for longer 
periods, even at -20 degrees, resulted in the formation of 
primary amines. 
Dimethylformamide (DMF) was refluxed over phosphorous 
pentoxide and then distilled off, retaining the fraction 
distilling between 151 and 154 °C. It was stored over 
molecular sieve which had been dehydrated and washed with 
distilled DMF. 
MSH 
The MSH purchased from Sigma contained only 80% MSH by 
weightr,It was purified on HPLC using a Cl8 column and a 0 
to 70% (v/v) acetonitrile in 0,05% (v/v) TFA. The resulting 
single peak was dried and stored as the TFA salt after 
quantitation by amino acid analysis. 
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Melittin 
Melittin was found to contain only 50% by weight peptide, 
and was contaminated with phospholipase activity. It was 
purified on HPLC, quantitated by amino acid anylysis, and 
tested for phospholipase activity (Smith et al. 1988). It 
was found to have less than 0.01 units of phospholipase A2 
activity per mg peptide. 
Lipids 
DPPE, DPPS, DPPC, DSPC were shown to be pure by TLC and by 
microcalorimetry, and were used without further 
purification. Cholesterol was recrystalised twice from hot 
methanol before use. 
Egg yolk lecithin was isolated from fresh egg yolks by the 
procedure of Singleton et al. (1965) on alumina. TLC showed 
it to be contaminated with lysolecithin so it was further 
purified on silicic acid by applying the lecithin (4g) in 10 
ml of chloroform to a column (200 X 25 mm) of silicic acid 
(Merck) which had been heated to 110 degrees for 1 hr and 
then suspended in chloroform. The column was eluted with 2 
column volumes each of 0, 10, 20, 30, 50% methanol in 
chloroform. The lecithin eluted with 30% methanol. TLC 
showed it to be homogenous with no trace of lysolecithin, 
nor any colouration. The lecithin was stored under nitrogen 
at -20 "ti13grees. 
TLC of lipids was performed on Silica F254 plates (Merck) 
and development was in chloroform/ methanol/ water 
(65:25:4). Detection was by iodine vapour. The presence of 
amino groups for PS and PE was achieved by spraying with a 
1% solution of ninhydrin in acetone and heating the plate at 
80 degrees for 10 minutes. 
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Calcein was recrystallised from hot ethanol (Allen 1984), 
made up to 100 mM in 25 mM sodium phosphate, the pH adjusted 
to 7.4 and the osmolarity adjusted to 280 mosM. After filter 
sterilisation the calcein solution was stored frozen. 
General methods : 
HPLC : All HPLC analytical and preparative sep~ration was 
performed on a Millipore-Waters HPLC equiped with two model 
6000A pumps, a model U6K injector, a model 441 absorbance 
detector equiped for monitoring absorbance at 230 run, and a 
model 680 gradient controller. The column used was aµ-
Bondapak C-18 (end-capped) 4 X 300 mm operated at a flow 
rate of 1.0 ml/min. Samples were eluted using a 0-70% 
acetonitrile gradient in 0.05% trifluoracetic acid. The 
shape of the gradient is shown for each application in 
results. 
Tissue culture 
All cell lines were grown at 37 degrees, 5% CO2, 95% RH. 
Bl6 Fl mouse melanoma cells were grown in McCoys SA media 
with 10% FCS. No antibiotics were used. Cells were 
subcultured 1:10 weekly. 
Hepatonm: cells were grown in DMEM with 10% FCS and 
penecillin and streptomycin. 
Friend erythroleukemia cells were grown in RPM! media with 
10% FCS and penecillin and streptomycin. 
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Microscopy 
Fluoresence photographs were taken on Pan F (Ilford) film 
with a Nikon inverted microscope equiped with fluoresence 
optics. 
Freeze fracture electron microscopy: A sample of the 
liposomes without any cryoprotectant was frozen between two 
gold discs by immersion in nitrogen slush (prepared by 
placing a container of liquid nitrogen under vacuum), and 
immediately placed into a Balzers freeze fracture unit 
maintained at -170°C. A vacuum of 10-s Twas immediately 
established and the sample fractured by separation of the 
two gold discs. The sample was shadowed with platinum by 
evaporation for 10 seconds, followed by carbon coating by 
gradual evaporation of the carbon rods for 1 minute. The 
sample was removed and the replica floated off the discs 
onto 1% sodium hypochlorite. The replica was picked up with 
copper grids coated with formvar and viwed on a Zeiss TEM. 
Scanning electron microscopy: Cells were grown overnight on 
glass coverslips in six-well tissue culture dishes. After 
treatment with liposomes for the required time period the 
coverslips were rinsed three times with PBS. Fixation was 
achieved by immersing the coverslips sequentially in : 
1% osmium tetroxide in PBS pH 7.5 280 mOsm for 30 minutes, 
2% glutaraldehyde, 2% formaldehyde in PBS pH 7.5 280 mOsm 
for 30 "Trrinutes, 
30% ethanol in water for 2 min, 
50% ethanol in water for 2 min, 
70% ethanol in water for 2 min, 
90% ethanol in water for 2 min, 
100% ethanol. 
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The critical point drying and gold coating were performed by 
Morven Griffiths. Details are outlined briefly: 
The samples were dried in a Polaron critical point dryer for 
90 minutes, after which the coverslips were stuck onto 
aluminium stubs and covered with gold-palladium in a Balzers 
evaporation unit. Samples were viewed on a Cambridge 200 SEM 
at a 30° tilt. 
To visualise liposomes on polycarbonate membranes, 
liposomes which had already been extruded through a 
polycarbonate membrane (0.2 um) were extruded through a 
fresh membrane and the membrane immediately removed from the 
filter holder, fixed and stained as above. 
MSH biological activity assays 
Adenylate cyclase: Cells from a mid-log phase culture were 
collected with EDTA (0.1% in PBS) and were seeded into 24-
well plates at 10 5 cells per well in 1.0 ml McCoys SA medium 
supplemented with 10% fetal calf serum. After 24 h 
incubation the cells were rinsed with PBS-Ca-Mg (Phosphate 
bufferd saline containing ca•• and Mg··). Hormone or 
conjugate was added in PBS and the cells incubated at 37°C 
for 30 minutes. The medium was decanted and the 1.0 ml 0.2 M 
HCl in~~hanol at 4°C added. The cAMP was extracted into 
this by overnight incubation at -20°C. The ethanol was 
aspirated into eppendorf vials and evaporated extensively in 
vacuo. The residue was dissolved in 0.1 ml 50 rnM Tris-HCl 
containing 1 rnM EDTA and the cAMP determined using the 
Arnmersham 3 H-cAMP/cAMP binding protein kit. Occasionally the 
protein content was determined using the method of Lowry et 
al. (1951) however this was found to be highly reproducible 
accross the plate and hence data is presented as pmoles cAMP 
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per well averaged accross duplicate wells. It was found that 
if the cells had reached stationary phase prior to seeding 
into the 24-well dish, the magnitude of ~he hormonal 
response was significantly decreased. 
Tyrosinase: Cells from a mid-log phase culture were 
collected with EDTA (0.1% in PBS) and were seeded into 24-
well plates at 10 5 cells per well in 1.0 ml McCoys SA medium 
supplemented with 10% fetal calf serum. After 24 h hormone 
was added in sterile PBS, and incubation continued for a 
further 24 hours at which time 0.5 uCi L-(3,5- 3 H]tyrosine 
was added and incubated for 24 hrs. The amount of 3 H20 in 
the medium was then determined by a modified method of 
Pomerantz(l965). The medium (1ml) was applied to a column 
comprising a pasteur pipette containing 0.5 ml Dowex AG SOW, 
above which was a glass wool plug, and 0.5 ml activated 
charcoal. The medium was washed through this column with a 
further 2 ml of water, and a 1.0 ml aliquot of the combined 
eluant mixed with scintillation fluid and counted. 
Preparative procedures 
MSH-SH-:· MSH was thiolated by interaction of MSH in 100 mM 
sodium phosphate pH 7.5 with a 20 fold molar excess of 
dithio-bis-propionimidate (DTBP) for two hours at 25°C. A 
100 fold excess of dithiothreitol (DTT) was then added and 
reduction allowed to proceed for a further two hours. If the 
material was not needed immediately it was stored at -20°C 
in this form. Prior to use the reaction mixture was 
separated on HPLC by running isocratically in 0.05% TFA for 
20 minutes to remove the vast excess of reducing agent, and 
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then running a gentle gradient from 30 to 45% of eluant B 
(70% acetonitrile in 0.05% TFA) to separate the modified and 
unmodified peptide. 
The modified peptide was dried on a spin-vap apparatus, 
redissolved in the desired buffer and used immediately. 
CM-MSH: Carboxymethylated MSH was prepared by incubating 
freshly prepared MSH-SH with a five fold molar excess of 
iodoacetic acid in 100 mM sodium phosphate pH 7.5 for four 
hours followed by separation on HPLC as described for MSH-· 
SH. For the preparation of radiolabelled CM-MSH 3 H-iodo-
acetic acid was used. 
125I-MSH: Radio-iodinated MSH was prepared by 
lactoperoxidase mediated iodination of the peptide and 
subsequent purification on HPLC. 
To 10 ug of MSH in 100 ul 100 mM phosphate buffer (pH 7.5) 
was added 1 ul of a 100 ug/ml freshly prepared 
lactoperoxidase solution, 25 ul of a 4.5 mCi/ml Na 125 I 
(carrier free in phosphate buffer), and finally, after 
mixing, 10 ul of a freshly prepared 10 uM hydrogen peroxide 
solution. The reaction was allowed to proceed at 4°C for 1 
hour. 100 ul of a lM OTT solution was then added to reduce 
any methionine sulphoxide (Lambert et al. 1982), and 
incubation continued at 24°C overnight. The products were 
isolated on HPLC. Since the iodinated MSH is slightly 
retard~c:t on HPLC compared to the non-iodinated species, and 
the iodinated form comprises only a minute proportion of the 
sample, the iodo-MSH can not be detected by absorbance at 
230 run, and hence must be detected by counting the 
radioactivity. Lacking on-line gamma detection facilities 
this was achieved by collecting the eluate of the HPLC in 
fractions and counting those for radioactivity. A typical 
elution profile is shown in fig 9.1. The iodo-MSH was 






















: .. I 
' . , 
.. ·I 
'. 1 
! : ::: l 
I-. ·J 
1·_:·._-.--J 'I :·. 
~ 1·., 
,> J 11 
t_:_:_:J 1::1 
~. . . ; · I 
i -- -;-1 . . -~··I 
·1 { ij 
. Fl/ I h 






















Fig 9.1: Purification of i 25 I-MSH. MSH iodinated by the 
lactoperoxidase method was purified on HPLC using a C-18 
column (Waters) and eluted in an acetonitrile gradient in 
0.05% trifluoracetic acid. Dashed line indicates 
acetonitrile gradient, solid line absorbance at 230 run, 
shaded area radioactivity. 
The test-tube was then attached to a venturi vacuum pump, 
and the contents exposed to a vacuum of 0.2 Atm. In the case 
of DNA encapsulation vortexing continued during this period. 
In other cases the tube was vortexed intermitently untill 
the emulsion had formed a hard gel. Vortexing was then 
performed continously untill the gel liquidised. The vacuum 
was then increased for 5 minutes to remove any traces of 
ether. 
The aqueous phase 
100 mM Calcein; 1 
in PBS containing 
in PBS/Ca/Mg. 
was either . . 
mM methotrexate; 1 







Immediately after liposome formation the liposomes were 
extruded through sterile 0.2 urn polycarbonate membranes and 
separated from unentrapped material by centrifugation of 
Ficoll gradients. 
Ficoll centrifugation: The separation method was based on 
the method of Fraley et al. (1981). Liposomes were mixed 
with an equal volume of 20% Ficoll in a centrifuge tube. 
This was then overlayed with 2.0 ml of 5% Ficoll and 0.5 ml 
PBS. After centrifugation for 20 minutes the liposomes 
banded at the 5% Ficoll- PBS interface and could be 
aspirated in a volume of approximately 200 ul. This process 
removed 95-98% of the unentrapped material, a small quantity 
being carried between liposome aggregates. If greater purity 
was requ~red the process was repeated. 
Precautions were taken to ensure that the Ficoll did not 
impose osmotic imbalance on the liposomes. To ensure that 
the Ficoll solutions had the same osmotic pressure as the 
liposomes the solutions were dialysed against PBS. 
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Leakage assesment : Liposomes (10 nmoles) prepared to 
contain 100 mM calcein were incubated in buffer or in medium 
as described for 24 hours. The fluorescence of the sample 
was then determined on an Aminco spectrofluorometer 
(excitation at 490 nm, emmision at 520 nm). 10 ul of 10% 
Triton X-100 was then added which lysed the liposomes 
completely. The resulting fluorescence yielded a figure for 
100% leakage. 0% leakage was assesed from a freshly dialysed 
sample of the liposomes. 
Toxicity assays 
The effect of cytotoxic drugs and toxins on cells was 
determined by incubating the drug, or liposomally entrapped 
drug with cells, and monitoring the incorporation of either 
a radiolabelled nucleotide into the DNA for methotrexate, or 
a radiolabelled amino acid into protein for ricin and ricin 
conjugates. The time period of incubation of toxin or drug 
with the cells is dependant on the experiment. 
Methotrexate: 
The effect of MTX or liposomally entrapped MTX on B16 
melanoma cells was determined by seeding the cells into 24-
well plates at 5 X 10 4 cells/well. After 24 hours in medium 
with 10% FCS, MTX or liposomes containing MTX were added. 24 
hours later 0.5 uCi 3 H-thymidine was added to each well and 
incubati.on continued for a further 24 hours. The 
incorporation of the 3 H-thy into the cellular DNA was 
assayed by harvesting the cells onto glass fibre filter 
paper strips using a cell harvester (Titertek cell 
harvester, Flow laboratories, Rockville,MD) with an 
attachment for 24 well plates. The filters were submerged in 
5% trichloracetic acid for 5 minutes, washed in ethanol, 
dried and counted in a scintillation counter. 
128 
Ricin chains 
The crude lectins from Ricinus communis were prepared by a 
modification of the method of Kornfeld et al. (1974). Castor 
bean seeds (100 g) were homogenised in a Waring blender with 
500 ml PBS , and left to extract for 2 hours at 4 degrees. 
The homogenate was poured through cheese cloth and the 
filtrate centrifuged at 10000g for 30 mins. The supernatant 
was brought to 75% saturation with solid ammonium sulphate, 
centrifuged at 10000g for 30 mins. The precipitate was 
dissolved in PBS, dialysed extensivly, recentrifuged, and 
applied to a Sepharose 4B column (Pharmacia, Sweden). After 
extensive washing with PBS the crude lectins were eluted 
with 10% lactose. 
After extensive dialysis the lectins were purified to yield 
the agglutinin and toxin components by affinity 
chromatography on alpha-L-rhamnosyl polyacrylamide 
(Horejsi,V. 1979). 
The affinity column was prepared by the method of Horejsi 
(Horejsi,V., Kocourek J., 1974). 10 g of Rhamnose (Merck) 
was refluxed with 20 ml allyl alchohol into which dry HCl 
gas had been bubbled until the weight of the alchohol 
increased by 0.6 g. Refluxing was at 80 degrees for 4 hours 
with stirring. The dark brown solution was neutralised with 
25% NH4 and the alchohol removed by vacuum distillation at 
70 degrees. The resulting allyl rhamnose was copolymerised 
with acrylamide by mixing; 
10 g acr'ylamide, lg bis-acrylamide, 4g allyl rhamnose, in 
100 ml water. 0.1 g ammonium persulphate was added and 10 ul 
TEMED. The solution polymerised within 10 minutes. 
The polymerised gel was then cut into small pieces, 
homogenised in a dounce homogeniser, and filtered through a 
200 mesh gauze. After decanting the fines, this material was 
poured into a column (250 X 25) and washed with PBS. 
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Crude lectins were applied to the column and eluted with 
PBS. Only ricin toxin eluted. Subsequent elution of ricin 
aglutinin was achieved by washing the column with 10% 
lactose. 
SDS polyacrylamide gel electrophoresis showed the crude 
lectins to have been separated out into pure agglutinin, 
yielding a single band with molecular weight of 120000, and 
ricin toxin, yielding two close bands of molecular weight 
60000 and 61000. The toxin component was not contaminated by 
any agglutinin. 
RTA 
Ricin A chain was purified from ricin toxin by applying 
ricin toxin to a Sepharose 4B colurnn,.washing extensivly 
with TBS, and then eluting the RTA with 1% OTT in TBS. The 
A-chain which was shown to be pure by SOS PAGE was 
sterilised by filtration and stored at 4 degrees in 20 % 
glycerol, 1% DTT in TBS. Quantitation was achieved by 
monitoring the absorbance at 280 run and taking the published 
figure of A2eo = 7.65 (Olsnes 1984). 
Immediately prior to use the required amount was dialysed 
against several changes of PBS to remove reducing agent. 
Toxicity was determined by inhibition of protein 
biosynthesis in a cell-free assay. 
RTB -· 
Ricin B chain was purified from ricin toxin by incubating 
the toxin with 1% OTT in TBS overnight at 4 degrees, 
applying the toxin to a Sepharose 4B column, and after 
washing with seven column volumes of TBS, eluting the B-
chain with 10% lactose in TBS. The B-chain was sterilised by 
filtration and stored in 10% lactose, 1% OTT in PBS. 
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RTA-MSH 
The conjugate between MSH and RTA was prepared by a 
modification of the method of Youlle and Neville (1982). 
100 ug of freshly prepared MSH-SH containing a trace of 
i 25 I-MSH-SH (yielding a final specific activity of 30 
mCi/rnmol) was dissolved in 200 ul 50 mM sodium borate, 1 mM 
EDTA, pH 8.5. 60 ul of 0.1 M 5,5'-dithiobis(2-nitro benzoic 
acid). After 2 hours at 25°C the modified peptide was 
separated from unreacted DTNB on HPLC as described for MSH-
SH purification. The modified peptide was not evaporated to 
dryness because difficulty was experienced getting it back 
into solution. Most of the solvent was removed by 
evaporation with a gentle stream of nitrogen, leaving 
approximately 0.5 ml to which was added 0.5 ml 100 mM 
phophate buffer pH 8.0. The yield of peptide judged by 
radioactivity was 80%. There did appear to be loss of 
peptide due to the formation of some insoluble material. 
This was added to 1.0 ml freshly reduced RTA (1 mg/ml) in 
PBS, representing a 1.5 fold excess of peptide over toxin, 
and incubated at 4°C for 16 hours. Unbound peptide was 
separated from the toxin by dialysis against several changes 
PBS at 4°C, and the remaining radioactivity determined. 
FITC-RTA-MSH: 100 ug of RTA-MSH in 200 ul PBS was added to 
20 ug FITC in 100 ul 0.2 M NaHCQ3 pH 8.5. After incubation 
for 1 hour at 4°C the mixture was dialysed against several 
changes of PBS at 4°C. 
-· 
Cell-free protein biosynthesis : The ability of ricin A-
chain (RTA) and of conjugates of the A-chain to inhibit 
protein biosynthesis in a cell-free system was assayed by 
the method of Olsnes (1981). A commercial rabbit 
reticulosyte lysate assay system (BRL) was used. Ten fold 
dilutions of the A-chain or toxin conjugate in 50 mM OTT 
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were made into eppendorf vials in 10 ul PBS. Control was 






2M potassium acetate, 
1 mM cold amino acids mixture (leucine deficient), 
TMV-RNA (from kit), 
human placental RNase inhibitor, 
3 H-Leucine, 
52 ul lysate. 
Incubation was performed at 30°C. After 10, 30 and 60 
minutes 20 ul aliquots were withdrawn and added to tubes 
containing 1.0 ml 0.1 M pottasium hydroxide. 30 minutes 
after the last aliquot was added the protein was 
precipitated by adding 0.2 ml 50% trichloracetic acid. The 
precipitated protein was collected onto glass fibre filter 
disks and washed with 10 ml of 5% trichloracetic acid. After 
drying, the filters were counted by scintillation counting. 
The toxicity is measured as DPM per minute during the linear 
part of the curve. Graphically it is expressed as a 
percentage of the velocity (DPM/min) of the control (no 
toxin present). 
Cellular protein biosynthesis 
The in vitro inhibition of protein biosynthesis in whole 
cells by ricin, ricin-A-chain or RTA conjugates was 
performed by a slight modification of the method of Youle 
and Nevi.~le (1982). 10 4 cells in 0.1 ml medium were added to 
each well of a 96 well plate and incubated for 24 hours. 
Toxin which had been sterilised by filtration through 0.2 um 
membranes was added at the highest concentration required in 
10 ul volumes, and the dilutions performed by making serial 
10 fold dil~tions accross the tissue culture plate. 
Incubation was continued for 48 hours at which time 0.1 uCi 
of 3 H-Leucine was and incubation continued for 6 hours. The 
medium was aspirated and the cells detached with 0.2 ml 1 mM 
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EDTA, 0.01 mg/ml trypsin in PBS. The cells were then 
collected onto glass fibre filter paper with a titertek cell 
harvester. The filters were submerged in 5% trichloracetic 
acid for 5 minutes, washed in ethanol, dried and counted in 
a scintillation counter. 
Transformation 
The plasmid pSV2neo was obtained from Dr I Parker, and grown 
up in E.coli (strain JM109) in the presence of neomycin 
using standard techniques for plasmid preparation and 
isolation (Maneatis 1984). Care was taken to ensure that the 
plasmid was very pure. The integrity of the plasmid was 
verified by restriction enzyme mapping. For transformation 
studies the plasmid was linearised with EcoRl followed by 
two phenol extractions, two chloroform extractions and 
ethanol precipitation. 
Lioosome mediated transformation: 
Hepatoma cells growing in mid-log phase were harvested with 
lrnM EDTA in PBS and resuspended in PBS/Ca/Mg at 10 5 cells/ 
ml. Liposomes containing DNA, or free DNA was added, and the 
cells incubated at 37°C for 1 hour. 3 ml of DMEM containing 
10% FCS was added and the cells poured into 1 well of a six 
well d~h. Incubation was continued for 48 hours at which 
time fresh medium containing 800 ug/ml G418 was added and 
incubation continued for 12 days. The number of colonies was 
then counted. 
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Calcium Phosphate Transfection 
The calcium phosphate transfection of cells was performed 
according to the method of Wigler et al. (1978) as modified 
and reported by Kingston (Current protocols). 
The cells were replated at 1 X 10 5 cells/ well 48 hours 
after addition of the DNA, and G418 (800 ug/ml) added. 
Medium was replaced every fourth day. 
Colonies were counted after 12 days by washing the cells 
with PBS, fixing with 70% ethanol and staining with crystal 
violet. Only colonies clearly visible to the naked eye were 
counted. 
Electroporation 
Electroporation was performed using a Bio-rad Gene Pulser 
electroporation apparatus. 
Hepatoma cells were grown to 50% confluence in DMEM medium, 
harvested with 1 rnM EDTA, washed twice with ice cold PBS and 
suspended in PBS at 4 degrees at 5 X 10 6 cells/ ml. 
0 to 20 ug of linearised pSV2neo plasmid was added to 1 ml 
of cell suspension in disposable electroporation cuvettes 
(Bio-Rad) with an electrode gap of 4 mm. The cells were 
incubated with the DNA for 10 minutes on ice prior to 
electroporation. 
Electroporation conditions were established by varying the 
voltage of the pulse from Oto 2000 V with 40 ug of plasmid 
present;-.· The capacitance of the apparatus was set at 25 uF. 
Only single pulses were employed. The optimal setting was 
found to be 1200 V which was the setting used for all 
subsequent experimentation. 
After electroporation the cells were incubated on ice for 10 
minutes. The cells were then plated at 1 X 10 5 cells/ well 
in six wel.l dishes and incubated in medium for 48 hrs prior 
to adding G418 at 800 ug/ml. Colonies were selected for and 
counted as described for calcium phosphate. 
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DNasel delivery 
Hepatoma cells were grown to 50% confluence, harvested with 
1 mM EDTA in PBS, and resuspended in prewarmed complete 
medium (DMEM with 10% FCS) at 1 X 10 6 cells/ ml. 
Friend erythroleukemia cells were harvested from mid log 
phase growth by centrifugation and resuspended in complete 
medium (RPMI with 10% FCS) at 1 X 10 6 cells/ ml. 
Liposomes or free DNasel were added at various 
concentrations to 250 ul aliquots of the cells and the 
reaction terminated at various times as described below. 
Method 1: This method is fast but requires care during the 
phenol extractions because of the small volumes and the 
large amount of protein at the interface. 
The reaction mixture in an eppendorf vial is microfuged for 
30 seconds, the supernatant decanted, and the pellet 
vortexed vigorously with 200 ul of phenol and 200 ul of 100 
mM EDTA. This is then centrifuged for 10 minutes in a 
microfuge, the supernatant aspirated and phenol extracted 
with a further 200 ul. The supernatant from this is 
extracted twice with 400 ul of fresh diethyl ether. 10 ug of 
DNase free RNase (1 mg/ml, prepared by heating RNase 
solutic5fr at 100 degrees for 10 minutes ) is added and 
incubated at 50 degrees for 30 minutes. The material can be 
analysed on a gel at this stage, 20 ul yielding visible 
bands, however a further phenol extraction and ether wash 
resulted in less material sticking in the wells. 
Method 2 : This method yields identicle· results to the above 
procedure, but was found to be preferable when a large 
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number of samples had to be processed and processing time 
was not a consideration. 
The reaction was terminated by centrifuging the reaction 
mixture in an eppendorf vial, and resuspending the pellet in 
1 ml of (100 mM EDTA / 10 mM Tris pH 8 / 1% SDS / 0.1% 
Proteinase K) at 50 degrees, and incubating for 16 hours at 
50 degrees. 50 ul of DNase free RNase was added and 
incubation continued for a further 30 minutes. The solution 
was then extracted twice with 1 ml of phenol, twice with 1 
ml of ether, and ethanol precipitated with 3 ml 100 ethanol. 
After washing with 80% ethanol the DNA was air dried by 
inverting the tubes over tissue paper. It was found that 
vacuum drying invariably over-dried some of the samples, and 
subsequent solubilising of the DNA was impaired, resulting 
in variable concentrations of DNA. The DNA was dissolved in 
100 ul of TE and applied to the gel. 
Analysis by agarose gels 
Samples were applied to 1% agarose gels in TBE and run for 
4-5 hours at 150 V. DNA was visualised by ultraviolet light 
and photographed using Technical Pan film. 
Nuclei isolation: 
Nuclei were isolated from cells by the method of Smith et 
al. 19!rn-. Briefly: After harvesting, the cells were 
suspended in 0.34 M sucrose in Buffer A (15 rnM NaCl, 65 rnM 
KCl, 0.15 rnM spermine, 0.5 rnM spermidine, 15 rnM Tris, pH 
7.4, 15 rnM ~-mercaptoethanol, 0.1 rnM phenylmethylsulphonyl 
fluoride, 0.2 mM EDTA, 0.2 rnM EGTA). Melittin (1 ug per 10 6 
cells) was added and the cells briefly homogenised in a 
Dounce homogeniser. The homogenate was centrifuged at 1500 g 
for 15 minutes and resuspended in a small volume of the 
above 0.34 M sucrose in Buffer A. Nine volumes of 2.3 M 
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sucrose were added and the mixture cent~ifuged at 50000g for 
45 minutes. The pellet was resuspended in nuclei storage 
buffer (12.5% v/v glycerol in Buffer A). 
Nuclei digestion: 
2.5 X 10 5 Nuclei in 50 ul of nuclei stc~age buffer were 
added to 50 ul nuclei storage buffer ccntaining 10 mM Mg~~ 
and DNase 1 at the concentrations shown in the legends. 
Incubation was performed at 37°C for 120 minutes at which 
time the reaction was terminated by the addition of 100 ul 
phenol. DNA was isolated and analysed as desribed above. 
-. 
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APPENDIX 1: 
During the course of this thesis many interesting 
observations were made which were investigated, but turned 
out to have no immediate bearing on the main topic of 
receptor mediated targeting. Some led to publication, others 
were not persued in sufficient depth to permit any firm 
conclusions. Some of these are outlined briefly for the 
record. 
MELITTIN AS AN ANCHOR FOR LIGANDS ON LIPOSOMES 
Melittin from bee venom is a 26 amino acid long peptide, of 
which the first twenty amino acids are predominantly 
hydrophobic, and the rest hydrophilic and predominantly 
positively charged. The sequence is ; Gly-Ile-Gly-Ala-Val-
Leu-Lys-Val-leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-
Lys-Arg-Lys-Arg-Gln-Gln-CONH2 (Habermann and Jentsch 1967). 
The sequence thus confers on the peptide a structure 
resembling that of an ionic detergent, and to a large extent 
the peptide is able to behave simmilarly to a detergent, 
being able to lyse erythrocytes and liposomes (Sessa et al. 
1969). 
The mode of action of melittin on lipid membranes has been 
reviewed (Bernheimer and Rudy, 1986). On interaction with -· lipid bilayers melittin inserts into the bilayer and causes 
massive perturbation of the bilayer structure resulting 
initially in the leakage out of the contents of the vesicle 
or cell, and at higher concentrations in the disruption and 
fragmentation of the bilayer. That its haemolytic ability is 
not due simply to its behaviour as a cationic surface active 
but that other structural features of the peptide are 
critical for its action is demonstrated by investigations of 
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fragments and modifications of melittin (Schroder et al. 
1971). These authors also observed that the 1-20 hydrophobic 
fragment of the peptide had full surface activity but was 
however unable to lyse erythrocytes, indicating a 
requirement of the C-terrninal hexapeptide for lytic 
activity. 
On the basis of melittins ability to insert spontaneously 
and with high affinity into lipid bilayers, it was 
investigated as a candidate for an anchor by which to bind 
ligands to liposomes subsequent to liposome preparation and 
purification. Since whole melittin perturbs liposomes 
resulting in the leakage of the contents it was reasoned 
that the 1-20 fragment which has been reported to have no 
haemolytic ability may fulfill the function. For this 
purpose the 1-20 fragment was prepared from whole melittin 
by enzymatic digestion and HPLC purification, and assayed 
for its ability to insert into bilayers and to induce 
leakage of the liposomal contents. 
Materials and methods: 
Preparation of 1-20 fragment (MELi-20): 10 mg Melittin 
(Sigma) in 1.0 ml 10 rnM Tris/HCl (pH 8.0) 1 rnM CaCl2 and 1 
rnM DTE was digested with Clostripain (50 ug) at 37°C for 12 
hours followed by the addition of Carboxypeptidase B (100 
ug) and'"tontinuing digestion for a further 12 hours at 37°C. 
The insoluble hydrophobic core fragment was isolated by 
centrifugation for 10 minutes at 3000g. The pellet was 
redissolved in 20% acetonitrile in 0.05% trifluoracetic acid 
and purified by HPLC (Waters) on a u-Bondapak Cl8 reverse 
phase colwnn using a 20-100% acetonitrile in 0.05% TFA 
gradient. The MELi-20 fragment eluted well after any 
remaining melittin and was quantitated by amino acid 
analysis. To test for the presence of contaminating whole 
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melittin 100 nmol of the purified fragment was hydrolysed 
and the absence of Arginine and Glutamic acid (hydrolytic 
product of Glutamine) confirmed by amino acid analysis which 
would detect 0.1 nmoles of the amino acids. 
Membrane insertion: The ability of the peptides (melittin 
and MELi-20) to insert into bilayers was monitored by the 
intrinsic fluorescence of the tryptophani9 residue (Dufourcq 
and Faucon 1977). Phospholipid vesicles were prepared using 
egg yolk lecithin by the reverse phase evaporation procedure 
(Szoka and Papahadjopopoulos 1981) in PBS. Increasing 
quantities of liposomes were added to 10 ug of melittin or 
13 ug of MELi-20 in 0.5 ml PBS in an Aminco 
spectrofluorometer and the emmision spectra of the peptide 
scanned after incubation for 5 minutes at 25°C (excitation 
at 280 nm). Fluorescence titration curves were analysed 
according to the method of Bashford et al. (1979). 
Leakage from vesicles: 
1) The lytic effect of the peptides was assayed by 
monitoring the release of calcein from the liposomes. 
Liposomes were prepared containing 100 mM calcein and 
separated from unencapsulated calcein by Ficoll gradient 
density centrifugation. Peptide at the desired concentration 
was added to 10 nmoles of liposomes in 0.5 ml PBS. After 20 
minutes at 25°C the fluorescence was measured (Excitation 
was at 490 nm, emmision at 520 nm) and compared against the 
fluoregc.ence after adding triton X-100 to a final 
concentration of 0.1% which yields 100% lysis. At 100 mM 
calcein is highly quenched, and as it leaks out of hte 
liposornes becomes fluorescent providing a very sensetive 
assay for liposorne disruption. 
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Results: 
MELi- 20 purification: Amino acid analysis showed the 
dominant peak from HPLC to have a composition corresponding 
to its assignment as the 1-20 fragment. When 100 nmoles was 
hydrolysed and applied to the analyser less than 0.2 nmoles 
of arginine was detected indicating that the contamination 
of the fragment with whole melittin is less than 0.2%. 
Membrane interaction: Fig 1 shows the emmision spectra 
resulting from the interaction of 13 ug of MELi-20 with 
increasing quantities of liposomes containing PBS. The 
enhancement of the relative fluorescent intensity and the 
shift of the emmision maxima to shorter wavelengths reflects 
the decreased polarity of the solvent environment of the 
tryptophan residue, and indicates the incorporation of the 
tryptophan residue into the bilayer. 
The shift in the emmision maxima is taken as a parameter of 
the amount of peptide that has become associated with the 
lipid. When this is plotted against the amount of lipid 
present (Fig 2) for both MELi-20 and melittin it is apparent 
that at large lipid concentrations there is no further 
change in the emmision, which is expected since all the 
peptide will have become associated with lipid. The 
advantage of using emmision maxima rather than emmision 
intensity in this experiment is that the intensity, unlike 
the wa~length, is affected by the scattering properties of 
the liposomes. Corrections for liposome light scattering by 
controls without melittin are not possible since at low 
lipid concentrations the melittin significantly perturbs the 
liposomes and hence the light scattering properties. 
A comparison of the data for the two peptides is not readily 
obtainable from fig 2 since the final (at infinite lipid 




Fig 1: Fluorescence spectra of MELi-20 (10 ug in 0.5 ml PBS) 
in the presence of increasing quantities of liposornes. 
Excitation at 280 run. A; control, B; 15 runole lipid, C; 30 




















Lipid (n moles) 
Fig 2: Shift in emmision maxima with increasing lipid 
concentrations for melittin and MELi-20. 
differ. A more informative comparison is obtained by the 
formula (Basford et al. 1979); 
e-1 = (eb-1)-Ka, (e-l)ln.m 
where e = optical paramater observed I initial 
eb = characteristic enhancement of optical parameter 
Ka = dissociation constant 
m = membrane concentration 
n = number of binding sites per unit of membrane. 
This equation predicts that a plot of e-1 vs e-llm will 
yield a straight line with an ordinate intercept of eb-1, 
and a slope of Kain. The value of Kain provides a good 
indication of the relative affinities of the two peptides 
for lipid membranes (Fig 3). 
From figure 3 it is evident that although the two peptides 
have different characterisitic enhancements, determined from 
the intercept, the slopes are nearly identical for the two 
peptides. This suggests that the peptides have very simmilar 
affinities for lipid bilayers and therefore the 1-20 
fragment will behave simmilarly to melittin in its ability 
to insert spontaneously and quantitatively into liposomes. 
An int~sting conclusion which can be drawn from fig 2 is 
that for both peptides there is no further change in 
spectral properties when more than 60 runoles of lipid are 
present, and hence 60 runoles of lipid, which represents a 15 
fold molar excess over the peptide, is sufficient to adsorb 
all of the peptide out of solution. Therefore under 
conditions in which the lipid quantity exceeds the peptide 
quantity by more than 15 fold, the binding of the peptide to 
the membrane will be quantitative. 
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Fig 3: Comparison of affinities of melittin and MELi-20 for 
lipid bilayers by method of Bashford et al. (1979). The 
ordinates are ; (Observed emmision maxima/ initial maxima) 
- 1 vs (Observed I initial -1)/ membrane concentration. The 
slope has gradient Ka/n. 
The two peptides were then compared for their ability to 
promote the leakage of calcein out of liposomes (Fig 4). 
From fig 4 it can be seen that the fragment has 
significantly less lytic activity than whole melittin, yet 
it is still able to promote the leakage of calcein from the 
liposomes. Comparing the concentrations required to yield 
50% lysis in 20 minutes shows that melittin is 50 to 100 
fold more potent than the fragment. If the lytic property of 
the fragment was due to the presence of contaminating whole 
melittin, the contamination would have to be in the order of 
1 to 2%, yet amino acid analysis shows less than 0.2% of the 
fragment to be whole melittin. Therefore the lytic effect 
observed for the fragment is a property of the hydrophobic 
core of melittin. 
From this it can be concluded that not all of the detergent-
like properties of melittin are due to its structural 
similarities to ionic detergents, but that the hydrophobic 
core alone is able to perturb the bilayer to a sufficient 
extent to promote lysis. This has not previously been 
demonstrated, possibly because the haemolysis assay employed 
by most investigators is less sensitive than the assay 
described here or because the erythrocytes have a different 
lipid <Xlmposition to the liposomes. 
There is disagreement within the literature regarding the 
mechanism of action of melittin (for review see Bernheimer 
and Rudy 1985) and specifically regarding the orientation of 
melittin within the bilayer. One hypothesis is that melittin 
exists as a tetramer spanning the bilayer (Vogel and Jahnig 
1986) and forming a hydrophilic pore through the membrane. 
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Fig 4: Peptide induced leakage of calcein from liposomes. 
Melittin or MELi-20 were added to liposomes containing 100 
mM calcein and the fluorescence monitored after 20 minutes. 
The fluorescence was compared against fluorescence after 
adding triton X-100 which induced 100% lysis. 
The other principle hypothesis proposes that melittin lies 
in the membrane with the helix axis approximately parallel 
to the plane of the bilayer and with the hydrophilic surface 
exposed to the aqueous phase (Terw-illiger et al. 1982). The 
ability of the hydrophobic core to promote lysis can be 
interpreted in terms of both hypotheses; 
If the peptide lies horizontally in the membrane as a ridgid 
-bent rod which is expected from its crystal structure 
(Teerw-illiger and Eisenberg 1982) this will probably cause 
disruption of the bilayer and may also cause a surface area 
difference across the bilayer which may lead to lysis. On 
the other hand if the peptide spans the bilayer and forms 
tetramers with a pore in the middle, the 1-20 fragment will 
also be capable of doing this. In this case the absence of 
the positively charged C-terminal hexapeptide may result in 
closer association of the peptides and hence a more compact 
tetramer and also smaller pores. This could account for the 
present but diminished lytic activity. 
A r~mification of this result is that using the 1-20 
fragment of melittin as an anchor by which to attach 
proteins to liposomes will probably result in lysis of the 
liposomes and loss of the contents, hence this avenue of 
research was not persued further. 
These experiments did however themselves produce interesting 
observa-t~ons that were persued further. These were ; 
1) Since melittin can lyse cells, the observation (fig 2) 
that melittin can be quantitatively adsorbed from solution 
by small quantities of lipid, suggests that in lysing cells, 
all of the melittin becomes adsorbed from solution. To this 
extent melittin behaves very differently from normal 
detergents. This led to a novel and superior method for 
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isolating intracellular organelles described in the next 
chapter. 
2) That melittin could cause the rapid and complete release 
of BSA from within liposomes, it was used to lyse liposomes 
where detergent would have inactivated the material being 
released. This application is described later. 
-. 
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ISOLATION OF NUCLEI FROM MELITTIN-DESTABILISED CELLS 
From the data shown in fig 2 in the previous chapter, and 
also based on the published report (Sessa et al. 1969) that 
the haemolytic property of melittin could be abolished by 
prior interaction with liposomes, I reasoned that ~he lytic 
action of the peptide would allow lysis and release of the 
intracellular contents of the cell under conditions in which 
all of the lytic agent had been adsorbed by the plasma 
membrane, and thus the intracellular contents would not 
become exposed to any detergent or lytic agent. To this 
extent the detergent-like lytic property of melittin differs 
from conventional detergents. 
To investigate whether this property could be used to 
provide a tool whereby intracellular organelles were 
isolated without exposure to lytic agent, and whether such a 
technique was preferable to conventional detergent 
solubilisation, nuclei were isolated from cells by three 
different techniques, and the quality of the nuclei 
determined by monitoring the transcriptional activity. 
This work was done in collaboration with collegues in my 
laboratory and is described in the publication reproduced 
here. ~. 
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Kl:Y WOKDS: melittin; detergi.:n1: nuclei isolation: tissue culture: nuclear membrane. 
The isolation in high yield of nuclei from 
cultured cells requires efficient disruption of 
the cell envelope. Whereas cell-cell adhesion 
in tissue enhances the shearing forces during 
homogenization and thus facilitates the dis-
integration of the cell envelope, this assisting 
etfrct is absent in cultured cells. To achieve 
effective lysis in isolated cells, homogeniza-
tion in the presence of a nonionic Jetergent 
such as Triton X-100 has become the 
method of choice (I). Nonionic detergents 
disrupt the plasma membrane primarily 
through the solubilization of membrane 
phospholipid (2). The detergent, however, 
also disrupts all intracellular membranes, in-
cluding the nuclear membrane (3), making 
the isolation and purification of the latter by 
sucrose gradient density centrifugation im-
possible. In addition the detergent may affect -. 
intranuclear biological activities. We have 
therefore examined alternatives to the use of 
detergents in order to isolate intact nuclei 
from cultured cells. 
Melittin from bee venom is an etlective 
lytic agent. Its mode of action has been re-
cently reviewed (4). Melittin is an amphiphi-
1 This work was supporti.:d hy a grant from the 
f-"ounJa11on uf Research Devt!lopmcnt ( FR DI uf tht: 
CSIR to C.v.lL 
'To ~horn corre~pondence shoulJ be addressed. 
lie peptide of which the first 20 amino acids 
are predominantly hydrophohic. The re-
maining residues are all hydrophilic, four 
heing positively charged. This amino acid se-
quence confers on the peptide a structure re-
sembling that of an ionic detergent (5). ~k-
littin is ahle to lyse hoth. erythrocytes anJ 
artificial bilayer memhranes (liposomes). at 
very low concentrations. In inducing lysis 
melittin hinds to the plasma membrane and 
is absorbed into the lipid phase, from which 
it is not released to further interact with other 
membranes (6). If proteins are present in the 
membrane melittin may also be capable of 
interacting with them ( 7). 
We reasoned that the ahility of melittin to 
perturb membranes and to be readily ab-
sorbed from solution into the lipid phase 
would not only facilitate cell lysis hut also 
result in only minimal exposure of the cellu-
lar contents to melittin. The latter would 
hopefully partition essentially into the 
plasma memhrane. 
MATERIALS AND METHODS 
Purification o( mi.1lilli11 and preparation o( 
liposomes. Commercially available melitti n 
may contain phospholipase(s) A2. The hy-
drophobic characteristics nf phospholipase 
· A2 suggest that they may be efficiently re-
0003-2697 /XX $3 00 Jl)(I 
( up,.r1~ht ,,_, J lJKM h~ ..\l'Jlkmu...· Pri:u. Im: 
\II ri~ht\ ol r1.:pruJw.tHJ11 1n Jll'.Y lurm h:~ncd. 
ISOLATION OF DESTABILIZED-CELL NUCLEI 391 
moved by chromatography on a hydropho-
bic column (8). We have purified melittin 
(Sigma) by high pressure liquid chromatog-
raphy ( HPLC) on a µBondapak C 18 reverse 
phase column (Waters) using a 0-100% ace-
tonitrile gradient in 0.05% tritluoroacetic 
acid (TFA ). 3 Phospholipase A2 activity was 
determined hy the method of llayaishi (9). 
Less than 0.005 unit of phospholipase 
A2 was present per milligram of purilled 
melittin. 
Calcein (Sigma) was purified by gel filtra-
tion on Sephadex G25. Large unilamellar 
phosphatidylcholine vesicles ( 15 µmol phos-
pholipid/ml) were prepared by the reverse 
phase evaporation procedure ( I 0) with an 
aqueous solution of 100 mM calcein. The 
vesicles were extruded through 0.2-µm pore 
diameter polycarbonate membranes (Nu-
cleopore) and separated from unencapsu-
lated calcein by gel filtration on Sepharose 
48. Fluorescence measurements were per-
formed on an Aminco spectrolluorometer. 
Egg yolk phosphatidylcholine (Sigma) 
formed a single spot on thin layer chro-
matography ( chloroform: methanol:acetic 
acid:water (25: 15:4:2)). 
The lytic etfects of melittin on liposomes 
were monitored by following the increase in 
fluorescence ofcalcein as it leaked out of the 
liposomes and was no longer self-quenching 
( 11 ). Melittin or Triton X-100 was added to 
0.05 µmot of calcein-containing liposomes at 
a concentration of 0-10 µM (melittin) or 
0-10 mM (Triton X-100). Fluorescence in-
tensity was measured after 20 min and com--. 
pared to the intensity after incubation of the 
liposomes with 30 mM Triton X-100, which 
was taken as I 00% lysis. 
In order to monitor the absorption of me-
littin from solution by isolated plasma mem-
branes, the minimum concentration of me-
littin required to elicit 100% release of cal-
cein from calcein-loaded liposomes was 
established. Increasing amounts of rat liver 
plasma membrane were incubated for 20 
J Abbreviation used: TFA. tritluoroacetic acid. 
min at that concentration of melittin. Lipo-
somes containing calcein (0.05 µmol lipid) in 
0.1 ml of 0.15 M NaCl,().() I M sodium phos-
phate, pH 7 A, were then added and incu-
bated for 20 min, alter which the percentage 
of lysis that had occurred was measured. 
lsolatio11 o( nuclei. Friend erythroleuke-
mia cells were grown in suspension culture in 
lscove's Modification of Dulhecco's medium 
at 37°C, 5% CO 2 , 95% humidity. Cells were 
harvested by centrifugation at 1500g for 5 
min, resuspended in Earle's balanced salt so-
lution, and again pelleted. The c"ells were re-
suspended in 0.34 M sucrose in Buffer A es-
sentially as descrihed by Hewish and Bur-
goyne ( 12) ( 15 mM NaCl, 65 mM KC!, 0.15 
mM spermine, 0.5 mM spermidine, 15 mM 
Tris, pH 7.4, 15 mM ~-mercaptoethanol, 0.1 
mM phenylmethylsulfonyl fluoride, 0.2 mM 
EDTA, 0.2 mM EGT A). At this point melit-
tin or Triton X-100 was added to the desired 
concentration. The cells were centrifuged to 
remove excess melittin or detergent and re-
suspended in 0.34 r-.t sucrose in Butter A to a 
concentration of I Oll cells/ml. The cells were 
homogenized at 700 rpm using a Pierce I .O-
m! rotary homogenizer with a clearance of 
0. I 0-0.15 mm or with a I-ml tight-fitting 
Dounce homogenizer (Pierce). Breakage of 
cells and nuclei was monitored by light mi-
croscopy. The homogenate was centrifuged 
at 1500g for 15 min and resuspended in a 
small volume of 0.34 M sucrose in Bulfer A. 
Nine volumes of 2.3 M sucrose in Buffer A 
were added and the mixture centrifuged at 
50,000g for 45 min. The pellet comprising 
purified nuclei was resuspended in storage 
hufter (12.5% (v/v) glycerol in Buffer A) to a 
DNA concentration of I mg/ml. DNA was 
determined at 00260 in 4 M NaCl. 
Transcription. The transcription assay on 
isolated nuclei was carried out essentially as 
described by Marzlutf using [a- 32 P]GTP 
(I. 77 Ci/m mo!) ( 13 ). Transcription was 
monitored by assaying for the incorporation 
of [32 P]GMP into TC.A.-precipitable material 
retained on Whatman GF/C filters. 
392 SMITH ET AL 
Isolation of nllclear envelopes. Nuclear en-
velopes were isolated from purified nuclei 
according to the method of Bornens and 
Courvalin (14). The envelopes were purified 
by centrifugation on a discontinuous sucrose 
gradient and collected at the 45/50% inter-
face and stored in liquid nitrogen until used. 
RESULTS AND DISCUSSION 
Triton X-100 is a nonionic detergent often 
used to lyse cultured cells ( l ). We initially 
compared the lytic effects of melittin and 
Triton X-100 on liposomes. Melittin was 
found to induce complete lysis at almost 
1000-fold lower molar concentration than 
Triton X-100 (Fig. 1 ). 
In order to establish how effectively melit-
tin would partition into plasma membrane 
and be removed from solution, 40 pmol of 
melittin, the minimum quantity necessary to 
induce 100% lysis of a standard aliquot of 
calcein-loaded liposomes, was incubated 
with increasing amounts of rat liver plasma 
membrane. Preincubation of melittin with as 
little as 70 ng (protein) of plasma membrane 
completely inhibited lysis of the calcein-
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FIG. I. Increasing amounts of melittin (•)and Triton 
X-100 (a) were added to a standard aliquot of calcein-
loaded liposomes and calcein release was monitored 
after 20 min of incubation. Liposomes were 50 nmol of 
phosphatidyl choline in I 00 µI of phosphate-buffered 
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FIG. 2. Removal of melittin from solution by plasma 
membrane. Fifteen pico moles of melittin (•)or IO nmol 
of Triton X-100 (a) (the minimum lytic concentrations 
for a standard aliquot of calcein-loaded liposomes) was 
preincubated with varying amounts of rat liver plasma 
membrane prior to addition to I 00 µl of phosphate-buf-
fered saline containing 50 nmol (lipid) of calcein-con-
taining liposomes. 
been removed from solution (Fig. 2). How-
ever, in the case of Triton X-100, the mini-
mum concentration needed to lyse a stan-
dard aliquot of calcein-loaded lipsosomes 
still induced at least 80% lysis even after 
·preincubation with as much as 100 µg of 
plasma membrane (Fig. 2). These results in-
dicate that not only is melittin a better lytic 
agent than Triton X- l 00 but it is able to par-
tition quantitatively into the plasma mem-
brane and thus be effectively removed from 
solution. 
We incubated Friend erythroleukemia 
cells with various amounts of melittin. We 
found that amounts greater than 2 µg (720 
pmol) per 106 cells began to induce sponta-
neous lysis of the cells. When melittin was 
added at a ratio of l µg (360 pmol) per 106 
cells, no lysis occurred but the cells could be 
easily broken by very brief homogenization 
(one to five strokes), leaving the nuclei intact. 
If lower amounts of melittin were used, in-
creased homogenization was needed to break 
the cells, resulting in damage to the nuclei. 
The yield of nuclei obtained using l µg of 
melittin/ l 06 cells was routinely between 9 5 
and l 00%, the same as that obtained when 




Nuclei isolation Nuclei Nuclear membrane 
method (%) (µg protein/ !OM nuclei) 
Homogt:01Lat1on 
only <25 49 
Mt:littin >95 56 
Melittin" 48 
Triton X-100 >95 <l 
Note The yield of nuclei represents that obtained after 
the cells are homogeni~ed with five strokes of a Dou nee 
homogenizer. The yield of nuclear membrane represents 
material recovered from equal amounts of intact nuclei 
after punfication of the mt:mbrane by sucrose gradient 
centrifugation. 
u Pun lied nuclear envelope incubated with excess me-
littin ( !00 µg/mg protein) and rerun on a sucrose gra-
dient. 
0.5% (v/v; 7 .5 µmol/ I 06 cells) Triton X-100 
was used to lyse the cells (Table I). When 
attempts were made to break the cells with-
out the use of detergent or melittin, extensive 
homogenization-up to 20 strokes-was 
needed to achieve 80% lysis. This resulted in 
progressive damage to the nuclei as evi-
, denced by breakage and clumping. Briefer 
j homogenization (five strokes) in the absence 
1 of detergent or melittin yielded intact nuclei 
but only 20% lysis of cells (Table I). 
1 
In order to assess the effect of melittin on 
the yield of nuclear membranes, equal 
amounts of intact nuclei isolated in the pres-
ence of melittin and Triton X-100 and in the 
absence of additives were used as starting 
material for the iso1ation of nuclear mem-
branes. 
Nuclei obtained from cells broken by ho-
mogenization only yielded membranes 
banding typically at the 45/50% interface 
with a buoyant density of 1.2 after sucrose 
gradient centrifugation (Fig. 3). The yield of 
nuclear membrane, expressed as protein, was 
49 µg per 108 nuclei (Table I). Nuclei iso-
lated from cells broken using melittin yielded 
membranes with the same buoyant density 
(Fig. 3). Fifty-six micrograms nuclear mem-
brane protein was obtained per !Og cells 
(Table I). Thus the yield of nuclear mem-
brane protein isolated from cells disrupted 
using melittin is almost identical to that ob-
tained from cells broken by homogenization 
only, although the yield of nuclei by the lat-
ter method is considerably lower. Further-
more if isolated nuclear membranes were ex-
posed to excess melittin ( I 00 µg/mg mem-
brane protein) virtually no solubilization of 
protein occurred (Table I) and the buoyant 
density of the membranes remained the 
same, indicating no significant loss of phos-
pholipid. On the other hand attempts to iso-
late envelopes from nuclei of Triton X-100 
lysed cells yielded no material at the 45-50% 
interface (Fig. 3, Table I), indicating the ab-
sence of intact nuclear envelopes. Lowering 
the concentration of Triton X-100 in the 
isolation buffers resulted in reduced lysis of 
cells but identical damage to nuclear enve-
lopes. This result was expected given the 
known ability of Triton X-100 to extract 
membrane phospholipid (1,3). 
Transcriptional activity in nuclei from 
cells broken using melittin was indistinguish-
able from that of nuclei isolated from cells 
broken by homogenization only (Fig. 4 ). 
However, the latter could be isolated only in 
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FIG. 3. Punfication of nuclear envelopes on a stepwise 
sucrose gradient from nuclei isolated using homogeniza-
tion only(·-·-). melittin (-), and Triton X-100 
(- - -). The gradient was fractionated continuously 
using an lsco density gradient fracuonator. The yield of 
the envelopes is reflected in Table l. 
394 SMITH ET .. ~L. 
was applied to avoid damage. Nuclei from 
cells lysed with Triton X-100 exhibited at 
best 40% of the transcriptional activity of 
nuclei isolated using melittin (Fig. 4). This 
result is not surprising as penetration of the 
nucleus by the detergent and breakdown of 
the chromatin structure is well documented 
and histones have been shown to he the 
major species of nuclear protein leach-
ing from nuclei of cells lysed with Triton 
X-100(2). 
We have shown that melittin, at the very 
low amount of 360 rmol/ l 06 cells, destabi-
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FIG. 4. Transcriptional activity ofnucki isolated using 
homogenization only (l:::.), melittin (0), and Triton 
X-100 (•I. Transcription was monitored by incorpora-
tion of[ 32 P]GMP into RNA. Each incubation contained 
nuclei corresponding to 150 µg DNA. 
-· 
with minimal homogenization. Nuclei are 
recovered in high yield with intact nuclear 
membr~rnes and a transcrirtional activity 
over two times greater than that found in 
nuclei from cells lysed using Triton X-100. 
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Following the arguments for the rapid and quantitative 
adsorbtion of lytic concentrations of rnelittin by lipid 
bilayers, rnelittin was used to release the contents of 
liposomes where conventional detergent mediated lysis 
resulted in inactivation of the liposornmal contents. 
THE ENCAPSULATION AND ASSESMENT OF ENZYMATIC ACTIVITY OF 
DNASE 1 IN LIPOSOMES. 
Prior to attempting to deliver DNase 1 into cells by 
encapsulation within targeted REV liposomes, it was 
necessary to determine what proportion of the enzyme had 
been encapsulated, and whether the process of encapsulation 
of the enzyme had significantly altered the enzymatic 
activity of the DNase 1. For this reason a technique had to 
be developed whereby the enzymatic activity of the 
encapsulated enzyme could be monitored. This required that 
the enzyme be released from the inside of the liposomes, but 
that the method of disrupting the liposomes, and hence 
releasing the enzyme, did not itself inactivate the enzyme. 
The release of liposomal contents, whether for assesment of 
enzymatic activity or for determination of encapsulation, is 
normally achieved by lysis of the liposomes in a detergent 
such as~riton X-100, however if detergents denature the 
enzyme, or interfere with the subsequent assay, an 
alternative procedure for release of the liposomal contents 
must be used. Kirby and Gregoriadis (1984) have investigated 
this problem when trying to ascertain the biological 
activity of. factor Vlll encapsulated within liposomes. These 
authors found that factor Vlll activity was decreased when 
the enzyme had come into contact with detergent, and hence 
162 
tried alternative techniques such as sonication, solvent 
extraction, freeze-drying, and detergent extraction. None of 
these techniques for disrupting liposomes when applied to 
factor Vlll alone did not decrease the activity. It would 
therefore be desirable to have a reagent which caused total 
lysis of the liposomes, but did not affect enzymatic 
activity, and since it would be convenient to take the 
sample of lysed liposomes and assay activity directly 
without having to separate the enzyme first, the reagent 
should not intefere with any assay. 
Liposomal encapsulation of DNasel. 
DNase 1 at 3 mg/ml in 20% glycerol in PBS was encapsulated 
in liposomes by the reverse phase evaporation procedure of 
Szoka and Papahadjopopoulos (1978). It was found that the 
presence of 20% glycerol in the aqueous phase prevented the 
DNase 1 coming out of solution when the diethyl ether was 
added, and was necesary to prevent the complete inactivation 
of the enzyme during sonication in the presence of diethyl 
ether. 
The liposomes were separated from unencasulated enzyme by 
ficoll gradient desity centrifugation. An aliquot of the 
purified liposomes was lysed with triton X-100 (final 
concentration 0.1%), and the various stages of preparation 
assayed for enzymatic activity by monitoring increased 
absorbence at 260 nm of a 0.1 mg/ml calf thymus DNA in 
PBS/Ca/Mg solution. The activities are shown in fig 1. 
Comparing the enzymatic activity of free DNase 1 with that 
of enzyme in liposomes prior to Ficoll separation, it 
appears that the process of encapsulation causes an increase 
in the activity of the enzyme. This is probably due to an 
association of the enzyme with the lipid bilayer because 
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Fig 1. DNase 1 activity of various stages of preparation of 
liposomally encapsulated DNasel. 10 µg DNase 1 in 20% 
glycerol in PBS (B), liposome sample (100 n.moles lipid, 10 
µg enzyme) prior to separation on Ficoll (D), liposomes 
subsequent to separation (100 n.moles lipid) (A), 10 µg DNase 
1 in the presence of empty liposomes (100 nmoles lipid) (C). 
The samples were incubated with calf thymus DNA (0.1 mg/ml 
in PBS/Ca/Mg), and the increase in absorbance at 260 nm with 
time monitored. 
increase in activity. It is possible that association of the 
enzyme with a lipid bilayer decreases its mobility and hence 
increases the chance of the enzyme cutting both strands of 
DNA within close proximity. This will have the effect of 
increasing the rate at which the hyperchromic shift in the 
DNA occurs, and therefore increasing the activity. 
The increase in activity of free enzyme in the presence of 
100 nmoles of lipid is not as great as when the enzyme was 
present during liposome formation. This is probably due to 
greater association of the enzyme with the lipid during 
bilayer formation than if added subsequent to the formation. 
That there is association of the enzyme with the liposome 
membrane is further shown by the enzymatic activity of 
liposomes after separation on Ficoll. The activity in this 
sample is most readily ascribed to the presence of adsorbed 
enzyme on the outside of the liposomes. 
When the purified liposomes containing enzyme are lysed with 
triton X-100 all of the enzymatic activity is lost (fig 2), 
indicating an inability of the enzyme to function in the 
presence of the detergent, and hence the unsuitability of 
triton X-100 for releasing encapsulated enzyme. On the other 
hand when melittin is used to lyse the liposomes there is a 
very significant increase in activity compared to that of 
intact liposomes. -. 
An exact interpretation of how much enzyme is released on 
lysis, and hence an estimate of the encapsulation 
efficiency, is hampered by the effect of the bilayer on the 
enzymatic activity. A comparison with free enzyme in the 
presence of added lipid is not really valid since this 
appears to give less association than when the enzyme is 
present during liposome formation, hence a comparison was 
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Fig 2: Action of triton X-100 and melittin on liposomaly 
entrapped DNase 1. Liposomes (100 nmoles of lipid) was 
incubated with either PBS (B), 0.1 nmoles of melittin (C) or 
10 nmoles of triton X-100 (A) for 20 minutes at 4°C. The 
enzymatic activity was monitored as above. 
unencapsulated enzyme, and yet had been lysed to release any 
encapsulated enzyme with 0.1 nmoles of melittin (Fig 3). 
Fig 3 shows that 100 runoles of melittin-lysed liposomes 
previously separated from unencapsulated enzyme has 
approximately the same rate of digestion of DNA as 25 runoles 
of melittin-lysed liposomes which have not been separated 
from unencapsulated enzyme. If the total activity present is 
composed of three components: 
1) Intraliposomal enzyme 
2) Membrane associated enzyme 
3) extraliposomal enzyme, 
the activity of the melittin lysed liposomes previously 
separated from unencapsulated enzyme can be ascribed to 
factors 1 and 2. The activity of the melittin lysed 
liposomes not separated from unencapsulated material is due 
to factors 1, 2 and 3. Thus subtraction of activity of the 
former from the latter yields activity not associated with 
the liposomes, which is 75 to 80 % of the total activity. 
From this it can be concluded that approximately 20 to 25% 
of the added enzyme becomes entrapped or associated with the 
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Fig 3: Enzymatic activity of increasing quantities of 
liposornes prepared in the presence of DNase 1 as described 
above and lysed with rnelittin. 0.1 runole Mellitin was added 
to unseparated liposornes 5 runol lipid (A), 15 runol lipid 
(B), 25 runol lipid (D), or to 100 runol lipid of liposornes 
separated from unencapsulated enzyme (C). 
